
<html lang="en"     class="pb-page"  data-request-id="b0e07833-24f7-492e-b896-427996de59e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b01621;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-2;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity" /></meta><meta name="dc.Creator" content="Shaoyi  Sun" /></meta><meta name="dc.Creator" content="Qi  Jia" /></meta><meta name="dc.Creator" content="Alla Y.  Zenova" /></meta><meta name="dc.Creator" content="Michael S.  Wilson" /></meta><meta name="dc.Creator" content="Sultan  Chowdhury" /></meta><meta name="dc.Creator" content="Thilo  Focken" /></meta><meta name="dc.Creator" content="Jun  Li" /></meta><meta name="dc.Creator" content="Shannon  Decker" /></meta><meta name="dc.Creator" content="Michael E.  Grimwood" /></meta><meta name="dc.Creator" content="Jean-Christophe  Andrez" /></meta><meta name="dc.Creator" content="Ivan  Hemeon" /></meta><meta name="dc.Creator" content="Tao  Sheng" /></meta><meta name="dc.Creator" content="Chien-An  Chen" /></meta><meta name="dc.Creator" content="Andy  White" /></meta><meta name="dc.Creator" content="David H.  Hackos" /></meta><meta name="dc.Creator" content="Lunbin  Deng" /></meta><meta name="dc.Creator" content="Girish  Bankar" /></meta><meta name="dc.Creator" content="Kuldip  Khakh" /></meta><meta name="dc.Creator" content="Elaine  Chang" /></meta><meta name="dc.Creator" content="Rainbow  Kwan" /></meta><meta name="dc.Creator" content="Sophia  Lin" /></meta><meta name="dc.Creator" content="Karen  Nelkenbrecher" /></meta><meta name="dc.Creator" content="Benjamin D.  Sellers" /></meta><meta name="dc.Creator" content="Antonio G.  DiPasquale" /></meta><meta name="dc.Creator" content="Jae  Chang" /></meta><meta name="dc.Creator" content="Jodie  Pang" /></meta><meta name="dc.Creator" content="Luis  Sojo" /></meta><meta name="dc.Creator" content="Andrea  Lindgren" /></meta><meta name="dc.Creator" content="Matthew  Waldbrook" /></meta><meta name="dc.Creator" content="Zhiwei  Xie" /></meta><meta name="dc.Creator" content="Clint  Young" /></meta><meta name="dc.Creator" content="James P.  Johnson" /></meta><meta name="dc.Creator" content="C. Lee  Robinette" /></meta><meta name="dc.Creator" content="Charles J.  Cohen" /></meta><meta name="dc.Creator" content="Brian S.  Safina" /></meta><meta name="dc.Creator" content="Daniel P.  Sutherlin" /></meta><meta name="dc.Creator" content="Daniel F.  Ortwine" /></meta><meta name="dc.Creator" content="Christoph M.  Dehnhardt" /></meta><meta name="dc.Description" content="Herein, we report the discovery and optimization of a series of orally bioavailable acyl sulfonamide NaV1.7 inhibitors that are selective for NaV1.7 over NaV1.5 and highly efficacious in in vivo mo..." /></meta><meta name="Description" content="Herein, we report the discovery and optimization of a series of orally bioavailable acyl sulfonamide NaV1.7 inhibitors that are selective for NaV1.7 over NaV1.5 and highly efficacious in in vivo mo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 30, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01621" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01621" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01621" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01621" /></link>
        
    
    

<title>Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01621" /></meta><meta property="og:title" content="Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0022.jpeg" /></meta><meta property="og:description" content="Herein, we report the discovery and optimization of a series of orally bioavailable acyl sulfonamide NaV1.7 inhibitors that are selective for NaV1.7 over NaV1.5 and highly efficacious in in vivo models of pain and hNaV1.7 target engagement. An analysis of the physicochemical properties of literature NaV1.7 inhibitors suggested that acyl sulfonamides with high fsp3 could overcome some of the pharmacokinetic (PK) and efficacy challenges seen with existing series. Parallel library syntheses lead to the identification of analogue 7, which exhibited moderate potency against NaV1.7 and an acceptable PK profile in rodents, but relatively poor stability in human liver microsomes. Further, design strategy then focused on the optimization of potency against hNaV1.7 and improvement of human metabolic stability, utilizing induced fit docking in our previously disclosed X-ray cocrystal of the NaV1.7 voltage sensing domain. These investigations culminated in the discovery of tool compound 33, one of the most potent and efficacious NaV1.7 inhibitors reported to date." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01621"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01621">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01621&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01621&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01621&amp;href=/doi/10.1021/acs.jmedchem.8b01621" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 908-927</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01609" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01606" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na<sub>V</sub>) 1.7 with Potent Analgesic Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Shaoyi Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shaoyi Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shaoyi++Sun">Shaoyi Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi Jia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi Jia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Jia">Qi Jia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alla Y. Zenova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alla Y. Zenova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alla+Y.++Zenova">Alla Y. Zenova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael S. Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael S. Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+S.++Wilson">Michael S. Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sultan Chowdhury</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sultan Chowdhury</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sultan++Chowdhury">Sultan Chowdhury</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thilo Focken</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thilo Focken</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thilo++Focken">Thilo Focken</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1993-2476" title="Orcid link">http://orcid.org/0000-0003-1993-2476</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Li">Jun Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shannon Decker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shannon Decker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shannon++Decker">Shannon Decker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael E. Grimwood</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael E. Grimwood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+E.++Grimwood">Michael E. Grimwood</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean-Christophe Andrez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-Christophe Andrez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Andrez">Jean-Christophe Andrez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ivan Hemeon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ivan Hemeon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ivan++Hemeon">Ivan Hemeon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tao Sheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Sheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Sheng">Tao Sheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chien-An Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chien-An Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ChemPartner, Building No. 5, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chien-An++Chen">Chien-An Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andy White</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andy White</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ChemPartner, Building No. 5, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andy++White">Andy White</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David H. Hackos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David H. Hackos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Hackos">David H. Hackos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lunbin Deng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lunbin Deng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lunbin++Deng">Lunbin Deng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Girish Bankar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Girish Bankar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Girish++Bankar">Girish Bankar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kuldip Khakh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kuldip Khakh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kuldip++Khakh">Kuldip Khakh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elaine Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elaine Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elaine++Chang">Elaine Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainbow Kwan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainbow Kwan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainbow++Kwan">Rainbow Kwan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophia Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophia Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophia++Lin">Sophia Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen Nelkenbrecher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Nelkenbrecher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Nelkenbrecher">Karen Nelkenbrecher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin D. Sellers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin D. Sellers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+D.++Sellers">Benjamin D. Sellers</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4194-1240" title="Orcid link">http://orcid.org/0000-0002-4194-1240</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio G. DiPasquale</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio G. DiPasquale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+G.++DiPasquale">Antonio G. DiPasquale</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jae Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jae Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jae++Chang">Jae Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jodie Pang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jodie Pang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jodie++Pang">Jodie Pang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luis Sojo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luis Sojo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luis++Sojo">Luis Sojo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Lindgren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Lindgren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Lindgren">Andrea Lindgren</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew Waldbrook</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew Waldbrook</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Waldbrook">Matthew Waldbrook</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiwei Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiwei Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiwei++Xie">Zhiwei Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clint Young</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clint Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clint++Young">Clint Young</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James P. Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James P. Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+P.++Johnson">James P. Johnson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">C. Lee Robinette</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">C. Lee Robinette</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C.+Lee++Robinette">C. Lee Robinette</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles J. Cohen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles J. Cohen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+J.++Cohen">Charles J. Cohen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian S. Safina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian S. Safina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian+S.++Safina">Brian S. Safina</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link">http://orcid.org/0000-0001-8134-9949</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel P. Sutherlin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel P. Sutherlin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Sutherlin">Daniel P. Sutherlin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel F. Ortwine</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel F. Ortwine</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#523d2026253b3c377c36333c3b373e1235373c377c313d3f"><span class="__cf_email__" data-cfemail="c0afb2b4b7a9aea5eea4a1aea9a5ac80a7a5aea5eea3afad">[email protected]</span></a>. Phone 650-225-2749 (D.F.O.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+F.++Ortwine">Daniel F. Ortwine</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christoph M. Dehnhardt</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christoph M. Dehnhardt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Xenon Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c4a7a0a1acaaaca5b6a0b084bca1aaabaae9b4aca5b6a9a5"><span class="__cf_email__" data-cfemail="791a1d1c111711180b1d0d39011c171617540911180b1418">[email protected]</span></a>. Phone 604-679-9736 (C.M.D.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christoph+M.++Dehnhardt">Christoph M. Dehnhardt</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5213-6354" title="Orcid link">http://orcid.org/0000-0001-5213-6354</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01621&amp;href=/doi/10.1021%2Facs.jmedchem.8b01621" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 908–927</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 30, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 October 2018</li><li><span class="item_label"><b>Published</b> online</span>30 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01621" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01621</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D908%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShaoyi%2BSun%252C%2BQi%2BJia%252C%2BAlla%2BY.%2BZenova%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D2%26contentID%3Dacs.jmedchem.8b01621%26title%3DIdentification%2Bof%2BSelective%2BAcyl%2BSulfonamide%25E2%2580%2593Cycloalkylether%2BInhibitors%2Bof%2Bthe%2BVoltage-Gated%2BSodium%2BChannel%2B%2528NaV%2529%2B1.7%2Bwith%2BPotent%2BAnalgesic%2BActivity%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D927%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01621"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2011</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01621" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shaoyi&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Alla&quot;,&quot;last_name&quot;:&quot;Y. Zenova&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;S. Wilson&quot;},{&quot;first_name&quot;:&quot;Sultan&quot;,&quot;last_name&quot;:&quot;Chowdhury&quot;},{&quot;first_name&quot;:&quot;Thilo&quot;,&quot;last_name&quot;:&quot;Focken&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Shannon&quot;,&quot;last_name&quot;:&quot;Decker&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;E. Grimwood&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Andrez&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;Hemeon&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Sheng&quot;},{&quot;first_name&quot;:&quot;Chien-An&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;White&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Hackos&quot;},{&quot;first_name&quot;:&quot;Lunbin&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Girish&quot;,&quot;last_name&quot;:&quot;Bankar&quot;},{&quot;first_name&quot;:&quot;Kuldip&quot;,&quot;last_name&quot;:&quot;Khakh&quot;},{&quot;first_name&quot;:&quot;Elaine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Rainbow&quot;,&quot;last_name&quot;:&quot;Kwan&quot;},{&quot;first_name&quot;:&quot;Sophia&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Nelkenbrecher&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;D. Sellers&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;G. DiPasquale&quot;},{&quot;first_name&quot;:&quot;Jae&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Jodie&quot;,&quot;last_name&quot;:&quot;Pang&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;Sojo&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Lindgren&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Waldbrook&quot;},{&quot;first_name&quot;:&quot;Zhiwei&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Clint&quot;,&quot;last_name&quot;:&quot;Young&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;P. Johnson&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;Lee Robinette&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;J. Cohen&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;S. Safina&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Sutherlin&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;F. Ortwine&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;M. Dehnhardt&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;908-927&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01621&quot;},&quot;abstract&quot;:&quot;Herein, we report the discovery and optimization of a series of orally bioavailable acyl sulfonamide NaV1.7 inhibitors that are selective for NaV1.7 over NaV1.5 and highly efficacious in in vivo models of pain and hNaV1.7 target engagement. An analysis of the physicochemical properties of literature NaV1.7 inhibitors suggested that acyl sulfonamides with high fsp3 could overcome some of the pharmacokinetic (PK) and efficacy challenges seen with existing series. Parallel library syntheses lead to the identification of analogue 7, which exhibited moderate potency against NaV1.7 and an acceptable PK profile in rodents, but relatively poor stability in human liver microsomes. Further, design strategy then focused on the optimization of potency against hNaV1.7 and improvement of human metabolic stability, utilizing induced fit docking in our previously disclosed X-ray cocrystal of the NaV1.7 voltage sensing domain. These investigations culminated in the discovery of tool compound 33, one of the most potent and eff&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01621&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01621" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01621&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01621" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01621&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01621" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01621&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01621&amp;href=/doi/10.1021/acs.jmedchem.8b01621" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01621" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01621" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01621%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DSun%26date%3D2019%26atitle%3DIdentification%2Bof%2BSelective%2BAcyl%2BSulfonamide%25E2%2580%2593Cycloalkylether%2BInhibitors%2Bof%2Bthe%2BVoltage-Gated%2BSodium%2BChannel%2B%2528NaV%2529%2B1.7%2Bwith%2BPotent%2BAnalgesic%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D2%26spage%3D908%26epage%3D927%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291645" title="Acyls">Acyls</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/jmcmar.2019.62.issue-2/20190124/jmcmar.2019.62.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein, we report the discovery and optimization of a series of orally bioavailable acyl sulfonamide Na<sub>V</sub>1.7 inhibitors that are selective for Na<sub>V</sub>1.7 over Na<sub>V</sub>1.5 and highly efficacious in in vivo models of pain and hNa<sub>V</sub>1.7 target engagement. An analysis of the physicochemical properties of literature Na<sub>V</sub>1.7 inhibitors suggested that acyl sulfonamides with high f<sub>sp3</sub> could overcome some of the pharmacokinetic (PK) and efficacy challenges seen with existing series. Parallel library syntheses lead to the identification of analogue <b>7</b>, which exhibited moderate potency against Na<sub>V</sub>1.7 and an acceptable PK profile in rodents, but relatively poor stability in human liver microsomes. Further, design strategy then focused on the optimization of potency against hNa<sub>V</sub>1.7 and improvement of human metabolic stability, utilizing induced fit docking in our previously disclosed X-ray cocrystal of the Na<sub>V</sub>1.7 voltage sensing domain. These investigations culminated in the discovery of tool compound <b>33</b>, one of the most potent and efficacious Na<sub>V</sub>1.7 inhibitors reported to date.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drugs that block voltage-gated sodium channels (Na<sub>V</sub>s) are widely used therapeutically as antiarrhythmics, anticonvulsants, anesthetics, and analgesics. Non-subtype-selective sodium channel blockers such as mexiletine and carbamazepine have been used for the treatment of neuropathic pain conditions. Unfortunately, this class of drugs is known to exhibit dose-limiting side effects in patients, such as somnolence, dizziness, and nausea, that limit their utility as analgesic agents.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> These adverse effects are thought to be derived in large part from a lack of selectivity on the Na<sub>V</sub> family of channels. Nine Na<sub>V</sub> isoforms are known (Na<sub>V</sub>1.1–Na<sub>V</sub>1.9), and there are indications<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> that isoform selective blockers may have an improved therapeutic index compared to nonselective compounds presently in use. In particular, Na<sub>V</sub>1.7 is a highly validated target for the treatment of pain conditions based on human genetic studies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Congenital insensitivity to pain (CIP), caused by a genetic deficiency of the SCN9A gene encoding Na<sub>V</sub>1.7, is a rare autosomal recessive disorder characterized by the complete absence of pain sensation typically associated with noxious stimuli.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5−10)</a> Individuals with CIP show no deficits in motor or cognitive function.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Conversely, gain-of-function mutations in SCN9A result in painful conditions, including inherited erythromelalgia (IEM),<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> paroxysmal extreme pain disorder,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and small fiber neuropathies.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These findings indicate that Na<sub>V</sub>1.7 has an essential role in mediating pain signaling in humans and suggest that selective Na<sub>V</sub>1.7 antagonism may be a highly effective strategy to treat painful conditions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Na<sub>V</sub>1.5 is the predominant sodium channel in cardiac myocytes and has been identified as an important off-target to avoid in Na<sub>V</sub>1.7 drug discovery. Inhibition of Na<sub>V</sub>1.5 has been demonstrated to lead to cardiac arrhythmias.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> As a consequence, our optimization campaign focused on establishing selectivity for Na<sub>V</sub>1.7 over Na<sub>V</sub>1.5. Due to a high sequence homology among Na<sub>V</sub> isoforms, compounds that are highly specific for Na<sub>V</sub>1.7 have been difficult to identify despite considerable efforts by the pharmaceutical industry. Recently, subtype-selective small-molecule Na<sub>V</sub>1.7 inhibitors have been reported.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24 ref25">(19−25)</a> An example is aryl sulfonamide <b>1</b> (<b>PF-05089771</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which selectively (>600-fold) blocks Na<sub>V</sub>1.7 over Na<sub>V</sub>1.5 and was advanced into clinical trials.<a onclick="showRef(event, 'cit20a cit20b cit20d'); return false;" href="javascript:void(0);" class="ref cit20a cit20b cit20d">(20a,b,d)</a> Our earlier work described the discovery of two structurally distinct series of aryl sulfonamide Na<sub>V</sub>1.7 inhibitors exemplified by <b>2</b><a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> and <b>3</b>,<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a> as well as the X-ray structure of the binding site on hNa<sub>V</sub>1.7.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We have also recently disclosed a novel class of triazolyl sulfonamide Na<sub>V</sub>1.7 inhibitors, exemplified by <b>4</b>.<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected subtype-selective Na<sub>V</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although potent on Na<sub>V</sub>1.7 and highly selective against Na<sub>V</sub>1.5, aryl sulfonamides such as <b>3</b><a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a> displayed poor absorption, distribution, metabolism, and excretion properties. Therefore, we sought to identify alternative chemical series to mitigate these liabilities. A literature survey on selective Na<sub>V</sub>1.7 inhibitors revealed a primary focus on aryl sulfonamides, with only a single paper on a companion series of acyl sulfonamides.<a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a> This report did not contain a characterization of the analogues in in vivo models of pain. We and others<a onclick="showRef(event, 'cit21b cit22a'); return false;" href="javascript:void(0);" class="ref cit21b cit22a">(21b,22a)</a> found that for many series, large multiples of Na<sub>V</sub>1.7 half-maximal inhibitory concentration (IC<sub>50</sub>) values are needed to achieve acceptable efficacy in in vivo models. We have recently reported in vivo studies on a class of acyl sulfonamides<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> that showed efficacy at low Na<sub>V</sub>1.7 IC<sub>50</sub> multiples. However, the design and optimization of compounds that are highly active in in vivo assays has so far been elusive, which prompted the current study on acyl sulfonamide optimization that focused on improving in vivo efficacy.</div><div class="NLM_p">An analysis of the patent landscape through 2013 for aryl and acyl sulfonamide Na<sub>V</sub>1.7 inhibitors<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> guided our start of the program. We noticed that acyl sulfonamides occupy a more favorable physicochemical property space such as lower molecular weight (MW) and cLogP (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). For example, aryl sulfonamides displayed an average cLogP of 4.1 and an average MW of 490, while acyl sulfonamides showed an average cLogP of 3.0 and an average MW of 400. Given that optimization very often involves increases in molecular weight and cLogP, acyl sulfonamides represented an attractive series for progression within Lipinski property space, which was an important criterion for us at the start of the program.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Additionally, acyl sulfonamides represented a less explored chemical series compared to aryl sulfonamides,<a onclick="showRef(event, 'cit20a cit22a'); return false;" href="javascript:void(0);" class="ref cit20a cit22a">(20a,22a)</a> providing an opportunity to deepen our understanding of this class of compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acyl sulfonamides generally occupy a more favorable physicochemical property space (average cLogP of 3.0 vs 4.1 and MW of 400 vs 490 for acyl vs aryl sulfonamides) for achieving oral bioavailability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Known acyl sulfonamides such as <b>5</b> (<b>PF-05241328</b>)<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> or <b>6</b><a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a> have a highly planar architecture due to the presence of multiple aromatic rings. The number of aromatic rings in a molecule has been shown to negatively affect aqueous solubility and has been associated with an increased attrition risk in drug development,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> suggesting a need for the identification of acyl sulfonamides with improved druglike properties. Our strategy to increase favorable properties focused partly on increasing f<sub>sp3</sub> (fraction of sp<sup>3</sup> carbons relative to the total carbon count).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These efforts culminated in <b>33</b>, a potent, molecularly selective, metabolically stable Na<sub>V</sub>1.7 inhibitor that demonstrated efficacy in various models of pain.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were evaluated in vitro in a radioligand binding assay (LBA) that measured the displacement of aryl sulfonamide [<sup>3</sup>H]GX-545 from human embryonic kidney (HEK) membranes that expressed hNa<sub>V</sub>1.7 including β1.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Effects in cells were assessed by whole-cell patch voltage clamp electrophysiology (EP) measurements of sodium currents mediated by human hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 heterologously expressed in HEK293 cells.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The LBA was used as a high-throughput assay to guide design and to establish binding to a preferred site in voltage sensing domain 4 (VSD4) of Na<sub>V</sub>1.7.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The functional potency data obtained by EP are biologically more relevant as they track the movement of the channel in a cell but are associated with a larger measurement error.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Given these assay characteristics, we were most interested in compounds that showed high potencies in both assays.</div><div class="NLM_p">Acyl sulfonamide <b>7</b>,<a onclick="showRef(event, 'cit21c ref32'); return false;" href="javascript:void(0);" class="ref cit21c ref32">(21c,32)</a> possessing a pendant adamantyl group, was discovered in early efforts to explore ether-linked saturated rings. This compound inhibited hNa<sub>V</sub>1.7 with an IC<sub>50</sub> of 0.07 μM in the LBA (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A voltage clamp assay confirmed the ligand binding result (IC<sub>50</sub> = 0.006 μM) and indicated that <b>7</b> was highly selective against hNa<sub>V</sub>1.5 (IC<sub>50</sub> = 1.9 μM, Na<sub>V</sub>1.5/Na<sub>V</sub>1.7 = 340-fold). Further profiling showed that <b>7</b> had good permeability, moderate solubility (31 μM), no significant cytochrome P450 (CYP) inhibition for isoforms tested (>10 μM for CYPs 3A4, 1A2, 2C19, 2C9, and 2D6), and no human ether-a-go-go-related gene liability (IC<sub>50</sub> > 10 μM). However, <b>7</b> showed moderate and poor stabilities in mouse and human liver microsomes (MLMs = 32 ml/min/kg), HLMs = 19 ml/min/kg), respectively. Initial in vivo pharmacokinetic (PK) evaluation in mouse showed good oral bioavailability and exposure. The observed exposure, despite moderate mouse liver microsomal stability, was most likely a result of high plasma protein binding (PPB, >99.9% bound) that restricted the intrinsic clearance of the molecule. We were cognizant of the fact that high plasma protein binding would require exquisite potency to achieve efficacy in vivo without requiring very high exposure. In addition, optimization of metabolic stability was particularly important for these highly bound analogues as their low volume of distribution required good metabolic stability to achieve a half-life suitable for twice-a-day dosing. Hence, our optimization focused particularly on increasing potency and HLM stability. Given its potency, selectivity, and biopharmaceutical properties, <b>7</b> represented a good starting point for a lead optimization campaign.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity and Pharmacokinetic Properties of Compound <b>7</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]<b>GX-545</b> LBA IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNa<sub>V</sub>1.7 EP IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNa<sub>V</sub>1.5 EP IC<sub>50</sub> (μM)/sel. h1.5/1.7</td><td class="colsep0 rowsep0" align="left">1.9/340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM CL<sub>hep</sub> (ml/min/kg) (human/mouse)</td><td class="colsep0 rowsep0" align="left">19/28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCKI <i>P</i><sub>app</sub> (A to B)</td><td class="colsep0 rowsep0" align="left">13 × 10<sup>–6</sup> cm/s</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (%)h/m</td><td class="colsep0 rowsep0" align="left">99.9/99.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse IV PK (1 mg/kg)</td><td class="colsep0 rowsep0" align="left">CL: 9.2 ml/min/kg, <i>V</i><sub>ss</sub>: 1.2 l/kg, <i>t</i><sub>1/2</sub>: 1.7 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PO PK (30 mg/kg)</td><td class="colsep0 rowsep0" align="left">AUC: 240 μMh, <i>t</i><sub>1/2</sub>: 3.5 h, <i>C</i><sub>max</sub>: 45 μM, <i>F</i>: 100%</td></tr></tbody></table></div></div><div class="NLM_p">To better understand how the present acyl sulfonamides might interact with VSD4 of the Na<sub>V</sub>1.7 receptor, we modeled representative analogues into the crystal structure of VSD4 via induced fit docking. A proposed fit of <b>7</b> in VSD4 is shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, supported in part by mutagenesis and small-molecule X-ray data. For the aryl sulfonamide <b>GX-936</b>, a large loss of potency was seen for the R1608A and R1608K mutations (3000× and 400×, respectively), whereas the R1602A mutation caused little change in affinity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In contrast, mutagenesis studies with acyl sulfonamide <b>7</b> showed that both R1608 and R1602 were required for binding, with 300× and 50× decreases in potency observed for the R1608A and R1602A mutations, respectively. We therefore postulated that the acyl sulfonamide warhead anion is delocalized between the carbonyl and sulfonyl moieties, making hydrogen bonding and ionic interactions with both R1608 and R1602. Sulfonyl oxygens are known to form hydrogen bonds with arginines, although the interaction is often weak. The combination of SO<sub>2</sub> to R1608 and the amide carbonyl oxygen to R1602 interactions proposed for acyl sulfonamides rationalizes the roughly equipotent affinity between the acyl and aryl classes of inhibitors. A small-molecule X-ray structure of the sodium salt of <b>7</b> grown in aqueous media (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) shows a sodium ion complexed to an ionized amide carbonyl oxygen, which may partially exist as its imino tautomer, consistent with our hypothesis and binding to R1602 in VSD4. This proposed fit results in the linker phenyl ring being offset from the analogous aryl sulfonamide phenyl ring in the X-ray crystal structure of <b>GX-936</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and is consistent with the lack of corresponding structure–activity relationship (SAR) between aryl and acyl sulfonamides. Specifically, the linker phenyl in <b>7</b> is predicted to be translated approximately 1.5–1.7 Å out of the active site, providing room for the adamantyl group and substituted cyclohexyl rings of the present series to fit into a mostly hydrophobic region flanked by W1538, V1541, F1583, M1582, and the side-chain carbon atoms of D1586. This fit would drive the chlorine of <b>7</b> into a different region than that occupied by the cyano in <b>GX-936</b>, essentially occupying the center of the channel.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induced fit docking of <b>7</b> into VSD4 of the hNa<sub>V</sub>1.7 receptor, shown in cyan. The active site cavity and helices are from the induced fit version. Key residues and distances are shown. The cocrystal structure of <b>GX-936</b> and VSD4 of Na<sub>V</sub>1.7<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK0">5EK0</a>) is superimposed and shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small-molecule crystal structure of the sodium salt of <b>7</b> (crystals grown in 50% MeOH solution), with sodium ions complexed to the charged oxygen atom shown as orange spheres. Two molecules of methanol are also shown. For details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray structure of Na<sub>V</sub>1.7 VSD4 represents one conformation of a flexible system designed to enable outward movement of S4 during a depolarization. This flexibility and induced fit of ligands introduce uncertainty in the modeling calculations. Other states of this protein can no doubt exist. Nonetheless, the modeling experiments using induced fit docking have served to rationalize parts of the SAR such as phenyl ring and sulfonamide substitution and provided design guidance throughout the project.</div><div class="NLM_p">With these data in hand, we focused our attention on improving the potency and metabolic stability of compound <b>7</b>. We were cognizant of the fact that large lipophilic groups like adamantane are main contributors to high metabolic clearance, so our initial SAR exploration focused on a diverse set of replacements aimed at understanding the impact on potency and metabolic stability (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Since metabolic stability is very often linked to lipophilicity,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we also tracked measured LogD (mLogD) and cLogP as well as lipophilic ligand efficiency (LLE) (calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and cLogP) in the initial set of compounds to understand if there is a correlation. In addition, lowering lipophilicity is an established medicinal chemistry strategy to decrease the risk for drug promiscuity and unwanted pharmacology.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The difference between cLogP and mLogD reflects the compound’s ability to exist as deprotonated species at pH 7.4.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Adamantane Replacements on Na<sub>V</sub>1.7 Potency and HLM Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0018.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Ligand binding assay using [<sup>3</sup>H]<b>GX-545</b>. IC<sub>50</sub>s are an average of at least two independent determinations.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub>s are an average of two independent determinations.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Predicted hepatic clearance (CL<sub>hep</sub>) extrapolated from in vitro experiments in human liver microsomes (CL<sub>hep</sub> = 19 ml/min/kg correlates to a 100% extraction ratio);<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> nd: not determined.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">mLogD at pH 7.4.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">LLE was calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and cLogP.</p></div></div><div></div></div><div class="NLM_p">Cyclohexane <b>8</b> demonstrated a 7-fold loss in hNa<sub>V</sub>1.7 potency, but a slight increase in HLM stability compared to <b>7</b>. Incorporation of an oxygen atom into the cyclohexyl ring (<b>9</b>) was not tolerated. Extending the linker by one carbon (<b>10)</b> only slightly increased the potency while negatively affecting metabolic stability. Shortening the linker (<b>11</b>) or reducing the ring size by one carbon (<b>12</b>) resulted in a further decrease in potency but enhanced metabolic stability. As expected, metabolic stability and lipophilicity of the left-hand portion of the molecule were generally correlated, with cyclopentyl ether <b>12</b> and ethylcyclopropyl ether <b>13</b> being the most stable in this subset. However, both displayed unacceptably low potency in the LBA.</div><div class="NLM_p">In this initial library, we found a relatively good correlation between mLogD and HLM stability. For example, <b>13</b> showed one of the lowest mLogD values (0.4) and was also the most stable in HLMs (HLM CL<sub>hep</sub> = 7 mL/(min/kg). On the other hand, the homologated cyclohexane <b>10</b>, which showed one of the highest mLogD values compared to other analogues in this subset, had low stability in HLMs (CL<sub>hep</sub> = 19 mL/min/kg). However, in a larger data set, this tendency could not be confirmed. We suspect that structural features are overriding the HLM-lipophilicity trend.</div><div class="NLM_p">Considering that <b>7</b> displayed the highest potency in a functional assay and the highest LLE, we used this building block for further optimization to explore the SAR of substituents on the phenyl core (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A 2-fluoro substitution was essential for hNa<sub>V</sub>1.7 potency, as removal (<b>14</b>) or replacement with chlorine (<b>15</b>) resulted in significant drops in potency. Replacement of the 5-chlorine in <b>7</b> with fluorine (<b>16</b>) also significantly reduced potency. Likewise, replacement of the 5-chlorine with methyl (<b>17</b>), ethyl (<b>18</b>), or isopropyl (<b>19</b>) was not beneficial to potency. However, introducing a cyclopropyl group as a chloro replacement (<b>20</b>) turned out to be highly favorable, providing a greater than 10-fold potency enhancement with minimal increases in molecular weight or lipophilicity (cLogP = 3.5 and 3.6 for <b>7</b> and <b>20</b>, respectively), resulting in a significant gain in LLE. Unfortunately, modification of the phenyl ring had no impact on HLM stability. The marked increase in potency of <b>20</b> over <b>7</b> may be a result of the cyclopropyl making additional hydrophobic contacts with the protein, or simply being more compatible with the adjacent hydrophobic membrane environment.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Substitutions on the Phenyl Core on Na<sub>V</sub>1.7 Potency and HLM Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0019.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Ligand binding assay using [<sup>3</sup>H]<b>GX-545</b>. IC<sub>50</sub>s are an average of at least two independent determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub>s are an average of two independent determinations.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Predicted hepatic clearance (CL<sub>hep</sub>) extrapolated from in vitro experiments in human liver microsomes (CL<sub>hep</sub> = 19 mL/(min kg) correlates to a 100% extraction ratio);<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> nd: not determined.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">LLE was calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and cLogP.</p></div></div><div></div></div><div class="NLM_p">Given the high potency and LLE for <b>20</b>, we now explored ways of improving the metabolic stability of the adamantane itself. Metabolite identification (MetID) studies on <b>7</b> indicated that the adamantal skeleton was subject to oxidative metabolism. We therefore decided to investigate blocking potential sites of metabolism and reducing lipophilicity by incorporating polar substituents on this ring system. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, introduction of a polar substituent (<b>21</b>) significantly enhanced HLM stability, but compromised potency on hNa<sub>V</sub>1.7 Other attempts to block the potential sites of oxidative metabolism via introduction of fluorine (<b>22</b> and <b>23</b>) resulted in negligible effect on HLM stability for <b>22</b> and markedly decreased HLM for <b>23</b>. Both <b>22</b> and <b>23</b> displayed significant loss of hNa<sub>V</sub>1.7 potency compared to <b>7</b>. Given <b>23</b> had relatively good potency and stability, we wanted to probe if replacing Cl with cyclopropyl would increase potency and retain HLM stability as seen for <b>20</b>. While cyclopropyl analogue <b>24</b> did indeed show potency increases in ligand binding and EP, its HLM stability decreased significantly. Finally, substitution of each tertiary carbon on the adamantane with fluorine (<b>25</b>) substantially improved stability but again at a marked cost in hNa<sub>V</sub>1.7 potency and LLE relative to <b>7</b> or <b>20</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects of Adamantane Modification on Na<sub>V</sub>1.7 Potency and HLM Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0020.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Ligand binding assay using [<sup>3</sup>H]<b>GX-545</b>. IC<sub>50</sub>s are an average of at least two independent determinations.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub>s are an average of two independent determinations.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Predicted hepatic clearance CL<sub>hep</sub> extrapolated from in vitro experiments in human liver microsomes (CL<sub>hep</sub> = 19 ml/min/kg correlates to a 100% extraction ratio);<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> nd: not determined.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">LLE was calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and clogP.</p></div></div><div></div></div><div class="NLM_p">Lessons taken from the SAR developed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> influenced the design of the next round of analogues (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Specifically, our goal was to incorporate strategies used successfully to block metabolism of the adamantyl group on the synthetically less complex cyclohexyl ring while also taking advantage of potency improvements realized in the core. We also wanted to maintain the relatively high f<sub>sp3</sub> count of the overall molecule. Replacing the 5-chloro in <b>8</b> with a cyclopropane (<b>26</b>) led to a significant boost in Na<sub>V</sub>1.7 potency, particularly in the functional assay, but unfortunately retained the HLM instability seen with previous analogues. MetID studies revealed three major metabolites resulting from oxidation of the cyclohexyl ring (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Further improvements in stability were obtained through gem-difluorination at the 4-position of the cyclohexyl ring (<b>27</b>). This compound also retained the LLE shown by <b>26</b>. However, it showed only moderate LBA potency compared to others in the series. We next turned to examining the effect of varying the acyl sulfonamide substitution on potency and stability. Interestingly, replacement of the <i>N</i>-methylsulfonyl substituent in <b>27</b> with <i>N</i>-cyclopropylsulfonyl (<b>28</b>) or <i>N</i>-(2-methoxyethyl)sulfonyl (<b>29</b>) enhanced stability. Potency was retained in <b>28</b>, while <b>29</b> was much less potent, presumably due to size limitations in this region of the protein.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of the major metabolic pathway of <b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of Cyclohexane Modification on Na<sub>V</sub>1.7 Potency and HLM Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0021.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Ligand binding assay using [<sup>3</sup>H]<b>GX-545</b>. IC<sub>50</sub>s are an average of at least two independent determinations.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub>s are an average of two independent determinations.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Predicted hepatic clearance CL<sub>hep</sub> extrapolated from in vitro experiments in human liver microsomes (CL<sub>hep</sub> = 19 ml/min/kg correlates to a 100% extraction ratio);<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> nd: not determined.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">LLE was calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and cLogP.</p></div></div><div></div></div><div class="NLM_p">From this small SAR study of the warhead, we learned that our ability to modulate potency and stability via changes in acyl sulfonamide substitution was limited. We therefore turned our attention back to the cyclohexyl-ether appendage. We examined the effect of adding methyl groups<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> by incorporation of a substituent on the tertiary carbon at the 1-position of the cyclohexyl ring. Compound <b>30</b> provided a moderate improvement in both potency and stability over <b>29</b>. Increasing the size of the substituent at the tertiary position had a detrimental effect on stability (<b>31</b>). Therefore, the methyl group was incorporated as a preferred substituent for further cyclohexane explorations. Replacing the 4-difluoro group in <b>30</b> with a trifluoromethyl (<b>32</b>) retained potency relative to <b>30</b>, but decreased stability. As an alternative to blocking metabolically labile sites by fluorine atoms, we also explored the incorporation of strained systems. An example is <b>33</b>, which showed the highest functional activity against hNa<sub>V</sub>1.7 (IC<sub>50</sub> = 0.6 nM) and retained moderate stability in human microsomes and hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Profiles of Compounds <b>30</b> and <b>33</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>30</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na<sub>V</sub>1.7, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (human/mouse/rat)</td><td class="colsep0 rowsep0" align="left">3/2.5/9</td><td class="colsep0 rowsep0" align="left">0.6/2.2/3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hNa<sub>V</sub>1.5, 1.1, 1.2, 1.6, IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">260/48/6/49</td><td class="colsep0 rowsep0" align="left">50/6/2/38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inh. TTX-R at (10 μM)</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver microsomes CL<sub>hep</sub> (ml/min/kg)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (human/mouse/rat/dog)</td><td class="colsep0 rowsep0" align="left">2/38/10/7</td><td class="colsep0 rowsep0" align="left">12/65/22/nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocytes CL<sub>hep</sub> (ml/min/kg)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (human/mouse/rat/dog)</td><td class="colsep0 rowsep0" align="left">2.8/17/4.3/3.5</td><td class="colsep0 rowsep0" align="left">13/6.0/5.2/7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP 3A4/2C9/2C19/2D6/1A2, IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>10/>10/>10/>10/>10</td><td class="colsep0 rowsep0" align="left">>10/6.1/>10/>10/>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MDCK1, <i>P</i><sub>app</sub> (A to B) × 10<sup>–6</sup> cm/s, ratio (BA/AB)</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MDCK1-MDR1, <i>P</i><sub>app</sub> (A to B) × 10<sup>–6</sup> cm/s, ratio (BA/AB)</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MDCK2-mBCRP, <i>P</i><sub>app</sub> (A to B) × 10<sup>–6</sup> cm/s, ratio (BA/AB)</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB (%) (human/mouse/rat)</td><td class="colsep0 rowsep0" align="left">99.6/99.8/99.8</td><td class="colsep0 rowsep0" align="left">99.9/99.9/99.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility (μM)</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mLogD/LLE(EP/mLogD)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a><sup>,</sup><a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.4/6.8</td><td class="colsep0 rowsep0" align="left">2.1/7.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are an average of two independent determinations using PatchXpress electrophysiology technique.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Predicted hepatic clearance (CL<sub>hep</sub>) extrapolated from in vitro human, mouse, and rat microsome experiments.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Predicted hepatic clearance (CL<sub>hep</sub>) extrapolated from in vitro human, mouse, rat, and dog hepatocyte experiments.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Measured mLogD at pH 7.4.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">LLE was calculated using hNa<sub>V</sub>1.7 EP IC<sub>50</sub> and mLogD.</p></div></div></div><div class="NLM_p">Compounds <b>30</b> and <b>33</b> were selected for further characterization against a panel of human and rodent Na<sub>V</sub> isoforms as they showed distinct advantages over other analogues. Compound <b>33</b> showed the highest potency in EP, high LLE, and moderate stability, whereas <b>30</b> showed acceptable potency and HLM stability as well as the highest LLE in the cyclohexane series. Although <b>33</b> showed good selectivity over hNa<sub>V</sub>1.5, it was only about 10- and 2-fold selective against hNa<sub>V</sub>1.1 and hNa<sub>V</sub>1.2, respectively. Compounds <b>30</b> and <b>33</b> also did not inhibit (IC<sub>50</sub> >10 μM) mNa<sub>V</sub>1.8 in tetrodotoxin-resistant (TTX-R) channels in mouse dorsal root ganglion (DRG) neurons. Compound <b>30</b> showed high selectivity over hNa<sub>V</sub> 1.5 and greater selectivity against hNa<sub>V</sub> 1.1 than acyl sulfonamide <b>33</b>.</div><div class="NLM_p">Compounds <b>30</b> and <b>33</b> were also tested against mouse and rat Na<sub>V</sub>1.7, where they showed potencies similar to those of the human isoform. The invariant human, rat, and mouse Na<sub>V</sub>1.7 potencies are a distinct characteristic that distinguish the present acyl sulfonamide series relative to other reported acyl and aryl sulfonamides (e.g., <b>4</b>) that bind to the VSD4 site. We believe that the increased conformational flexibility between cycloalkylether and phenyl core allow our compounds to adopt a binding mode in rat Na<sub>V</sub>1.7 that is similar to the one shown in compound <b>7</b> in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, and adapt that binding mode to residue changes in the VSD between human, mouse, and rat. The less flexible, more deeply binding aryl sulfonamides such as <b>4</b> cannot readily adjust to the residue differences in the rNa<sub>V</sub>1.7 binding pocket and are less potent as a result. Gratifyingly, both <b>30</b> and <b>33</b> were selective for hNa<sub>V</sub>1.7 over hNa<sub>V</sub>1.5. No significant drug–drug interaction risk was observed, as <b>30</b> and <b>33</b> did not show notable CYP inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). We tracked permeability in a mouse Madin–Darby canine kidney cell line (MDCK)2–breast cancer resistance protein (BCRP) cell line, which contains the main transporter found at the blood–brain barrier, to better understand the brain exposure of our compounds. Compound <b>33</b> had good permeability and low efflux, while <b>30</b> proved to be a mouse BCRP (mBCRP) substrate. Both compounds showed high protein binding in human, mouse, and rat (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). We also evaluated <b>33</b> in a CEREP panel of 33 receptors at 10 μM concentration, where we saw >75% inhibition of only two targets: Na<sub>V</sub> ion channels (80%) and PPARγ (91%). The mLogD values at pH 7.4 were acceptable for both <b>30</b> (mLogD = 1.4) and <b>33</b> (mLogD = 2.1). Notably, LLE when calculated based on mLogD was high for both <b>30</b> and <b>33</b> and in line with low off-target activity described for <b>33</b>.</div><div class="NLM_p">On the basis of their overall in vitro potencies and DMPK profiles, <b>30</b> and <b>33</b> were selected for further in vivo evaluation. Their PK profiles were determined in mouse and rat, and <b>33</b> was also evaluated in dog. The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. Consistent with the predicted CL<sub>hep</sub> and high plasma protein binding, both compounds exhibited very low plasma clearance (CL). Both <b>30</b> and <b>33</b> displayed moderate half-lives (<i>t</i><sub>1/2</sub>) in mice. Compound <b>30</b> and <b>33</b> showed increased half-lives in rat intravenous (IV) experiments, with <b>33</b> showing acceptable half-lives in dog IV and PO studies. They also displayed low volume of distribution (<i>V</i><sub>ss</sub>) values in these animal species, presumably because of high plasma protein binding. In agreement with their high permeability and solubility, both compounds displayed good to moderate oral plasma exposures (area under curve (AUC)) and bioavailabilities (<i>F</i>). The oral bioavailabilities of <b>33</b> in mice, rats, and dogs were 31, 49, and 68%, respectively.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Profiles for Compounds <b>30</b> and <b>33</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">IV</th><th class="rowsep1 colsep0" colspan="4" align="center">PO</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (ml/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="left">15.6</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">350</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="left">16.9</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">113</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left">nc</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Average of three male FVB mice, dosed IV with 1 mg/kg of compound <b>30</b> or <b>33</b> in 5% dimethyl sulfoxide (DMSO)/35% poly(ethylene glycol)-400 (PEG400)/60% phosphate-buffered saline (PBS) or dosed PO with 30 mg/kg of compound <b>30</b> or <b>33</b> as MCT suspension.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Average of three male Sprague-Dawley rats, dosed IV with 1 mg/kg of compound <b>30</b> or <b>33</b> in 10% DMSO/50% PEG400/40% PBS or dosed PO with 5 mg/kg of compound <b>30</b> or <b>33</b> as MCT suspension. nc: not calculated.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Average of three male beagle dogs, dosed IV with <b>33</b> in 0.5 mg/kg in 15% EtOH and 60% PEG400 in water and orally dosed with <b>33</b> at 1 mg/kg as MCT suspension.</p></div></div></div><div class="NLM_p">To determine if the PK and potencies of our compounds were sufficient to demonstrate analgesia in vivo, <b>30</b> and <b>33</b> were evaluated in transgenic mice<a onclick="showRef(event, 'cit21c ref37'); return false;" href="javascript:void(0);" class="ref cit21c ref37">(21c,37)</a> that express a human variant of Na<sub>V</sub>1.7 that results in IEM (mutation I848T).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Aconitine-induced pain in these mice provides a novel way to quantify engagement of hNa<sub>V</sub>1.7 in vivo and facilitates the characterization of selective inhibitors that, most often, show species specificity for rodent orthologs. This assay reports the number of nociceptor responses (shaking and licking) in response to the sodium channel activator aconitine. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, <b>30</b> and <b>33</b> demonstrated dose-related inhibition of aconitine-induced nociceptive behaviors, matched by dose-dependent increases in plasma concentrations. Consistent with its significantly higher functional potency against Na<sub>V</sub>1.7, <b>33</b> was much more potent in this study, demonstrating >75% analgesic efficacy starting at a plasma concentration of approximately 3.1 μM (which corresponds to an unbound plasma concentration of <i>C</i><sub>pu</sub> = 3 nM, approximately 5-fold the hNa<sub>V</sub>1.7 IC<sub>50</sub>) (0.3 mg/kg, oral dose). At these very low efficacious free plasma concentrations, we did not expect to see significant inhibition of other Na<sub>V</sub> isoforms. Plasma concentrations of <b>33</b> for the 3 and 10 mg/kg groups were measured as 25 and 79 μM, respectively. The brain concentrations were 1.9 and 6.2 μM, respectively, which provided a low brain-to-plasma ratio of approximately 0.08. We were gratified to see this remarkable efficacy for <b>30</b> and <b>33</b> despite their high plasma protein binding. The significantly higher efficacy of <b>33</b> over <b>30</b> was rationalized by its 5-fold higher potency in the functional assay for the inhibition of hNa<sub>V</sub>1.7. In vivo effects of <b>33</b> were further assessed in a formalin-induced pain model in mice,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> an assay that has been used to evaluate analgesic effects for many sodium channel blockers.<a onclick="showRef(event, 'ref23 cit25b ref40'); return false;" href="javascript:void(0);" class="ref ref23 cit25b ref40">(23,25b,40)</a> This pain model utilizes formalin as a pain-inducing agent and generates a biphasic pain response. The initial response (phase I), occurring within 5–10 min after injection of formalin, indicates an acute localized irritation (partially due to activation of TRPA1 channels<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>), whereas a delayed response (phase II) that begins 10–15 min after injection indicates neurogenic inflammation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As illustrated in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <b>33</b> produced significant response reduction in phase II of the formalin assay at a PO dose of 10 mg/kg. The plasma concentration of <b>33</b> was measured at the end of the study (approximately 3 h after oral dosing) to be 50 μM. Despite the modest selectivity for the inhibition of hNa<sub>V</sub>1.7 over hNa<sub>V</sub>1.1 and hNa<sub>V</sub>1.2, <b>33</b> was well tolerated in mice, as there were no clinical observations over the course of this study. We also evaluated <b>30</b> and <b>33</b> for the inhibition of mNa<sub>V</sub>1.8 in TTX-resistant channels in mouse dorsal root ganglion neurons and found minimal inhibition (IC<sub>50</sub> > 10 μM), indicating that their efficacy was not caused by the inhibition of this isoform.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>30</b> on aconitine-induced pain in humanized IEM transgenic mice. Each bar represents the mean of at least four animals. The error bars represent standard errors of the mean. **** <i>p</i> < 0.0001 vs vehicle group. Statistical significance of results was calculated by two-way analysis of variance (ANOVA) using Prism version 7 (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0007.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>33</b> on aconitine-induced pain in humanized IEM transgenic mice. Each bar represents the mean of at least four animals, except the 0.3 and 1 mg/kg groups (three animals for each group at these doses). The error bars represent standard errors of the mean. **** <i>p</i> < 0.0001 and *** <i>p</i> < 0.005 vs vehicle group for nociceptive events. Statistical significance of results was calculated by two-way ANOVA using Prism version 7 (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0008.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Dose–response effect of <b>33</b> in the mouse formalin model. (A) Time course of inhibition of formalin-evoked pain behavior. Each point represents the mean number of times that a mouse (<i>n</i> = 4) shook or licked its injected paw over a 5 min period. (B) Quantification of the response to formalin binned into two different phases: phase I (0–10 min after formalin injection) and phase II (11–40 min after formalin injection). Each bar represents the mean of four animals. The error bars represent standard errors of the mean. *** <i>p</i> = 0.0021 vs vehicle group. Statistical significance of results was calculated by two-way ANOVA using prism version 7 software (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic routes to prepare acyl sulfonamides <b>7</b>–<b>33</b> are outlined in <a class="ref internalNav" href="#sch1" aria-label="scheme 1">scheme 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch8" aria-label="8">8</a>. For syntheses of analogues <b>7</b>–<b>14</b>, <b>16</b>, <b>21</b>–<b>23</b>, and <b>25</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), a simple and efficient nucleophilic aromatic substitution of intermediates <b>37</b>, <b>38</b>, and <b>39</b> with an appropriate alcohol was applied. This method was general, and a wide range of alcohols could be used in a library fashion to prepare the desired molecules <b>7</b>–<b>14</b>, <b>16</b>, <b>21</b>–<b>23</b>, and <b>25</b>.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Compounds <b>7</b>–<b>14</b>, <b>16</b>, <b>21</b>–<b>23</b>, and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) for <b>37</b> and <b>38</b>: MeSO<sub>2</sub>NH<sub>2</sub>, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI), 4-dimethylaminopyridine (DMAP), CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 58–96%; for <b>39</b>: MeSO<sub>2</sub>NH<sub>2</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 54%; (b) R<sup>1</sup>OH, <i>t-</i>BuOK, DMSO, rt, 9–58%.</p></p></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) adamantan-1-ylmethyl methanesulfonate, K<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 65 °C, 71%; (b) MeSO<sub>2</sub>NH<sub>2</sub>, Mo(CO)<sub>6</sub>, Pd(OAc)<sub>2</sub>, Xantphos, Et<sub>3</sub>N, 1,4-dioxane, 100 °C, microwave irradiation, 45 min, 10%.</p></p></figure><div class="NLM_p">Analogue <b>15</b> was synthesized in a two-step sequence from phenol <b>40</b>, which was alkylated to give intermediate <b>41</b>. Compound <b>15</b> was prepared from <b>41</b> via introduction of the acyl sulfonamide group by a palladium-catalyzed carbonylation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Compound <b>17</b> was prepared from <b>42</b> as detailed in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, involving a nucleophilic aromatic substitution and an acyl sulfonamide formation in the presence of EDCI and DMAP. The synthesis of analogue <b>18</b> involved the esterification of <b>34</b>, nucleophilic aromatic substitution of <b>44</b> with (adamantan-1-yl)methanol yielding the predominantly para-regioisomer in 62% yield, Suzuki–Miyaura cross-coupling reaction<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> of <b>45</b> with vinylboronic acid pinacol ester, hydrolysis of <b>46</b> with TFA, hydrogenation of <b>47</b>, and finally acyl sulfonamide formation of acid <b>48</b> with methanesulfonamide (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). For analogue <b>19</b>, a method analogous to that used for <b>18</b> was applied. In this preparation, vinylboronic acid pinacol ester was replaced by 2-isopropenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantane methanol, <i>t-</i>BuOK, DMSO, rt to 50 °C, 17%; (b) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 27%.</p></p></figure><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>tert</i>-butyl dicarbonate, DMAP, <i>tert</i>-butanol, 50 °C, 99%; (b) (adamantan-1-yl)methanol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 62%; (c) vinylboronic acid pinacol ester, tris(dibenzylideneacetone)dipalladium(0) (Pd<sub>2</sub>(dba)<sub>3</sub>), <i>t-</i>Bu<sub>3</sub>P·HBF<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C, 92%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 97%; (e) Pd–C, H<sub>2</sub>, EtOAc, rt, 74%; (f) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 69%.</p></p></figure><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-isopropenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>t-</i>Bu<sub>3</sub>P·HBF<sub>4,</sub> Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C, 64%; (b) Pd–C, H<sub>2</sub>, EtOAc, rt, 94%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 84%; (d) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 33%.</p></p></figure><div class="NLM_p">The syntheses of <b>20</b> and <b>26</b>–<b>32</b> started from an aromatic nucleophilic substitution of <b>44</b> with an appropriate alcohol in the same manner as described in the preparation of <b>45</b>. Compounds <b>45</b> and <b>52</b>–<b>56</b> were then subjected to the Suzuki–Miyaura cross-coupling reaction<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> with cyclopropylboronic acid to provide the corresponding cyclopropyl intermediates <b>57</b>–<b>62</b>. After treatment with TFA, the resulting acids <b>63</b>–<b>68</b> were coupled with alkylsulfonamide to afford the desired acyl sulfonamides <b>20</b> and <b>26</b>–<b>32</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Analogue <b>24</b> was directly prepared from <b>23</b> in a one-step transformation using the Suzuki–Miyaura cross-coupling reaction<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Compound <b>33</b> was synthesized in multiple steps from intermediate <b>44</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). In this preparation, the dioxolane protecting group in <b>70</b> was selectively removed with TFA in a mixture of THF and H<sub>2</sub>O without affecting the <i>tert</i>-butyl ester group. The Simmons–Smith cyclopropanation of <b>72</b> proceeded smoothly with the use of chloroiodomethane and diethylzinc<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> to afford the key intermediate <b>73</b>.</div><figure id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Compounds <b>20</b> and <b>26</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 43–95%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 86–99%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 50–86%; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40–70%.</p></p></figure><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 43–95%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 86–99%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 50–86%; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40–70%.</p></p></figure><figure id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0016.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (8-methyl-1,4-dioxaspiro[4.5]decan-8-yl)methanol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 54%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 83%; (c) trifluoroacetic acid (TFA), H<sub>2</sub>O, tetrahydrofuran (THF), rt, 90%; (e) MePPh<sub>3</sub>Br, LiHMDS, THF, −20 °C to rt, 82%; (e) ClCH<sub>2</sub>I, Et<sub>2</sub>Zn, ClCH<sub>2</sub>CH<sub>2</sub>Cl, 0 °C, 93%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90%; (g) cyclopropanesulfonamide, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 41%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This paper details the discovery of <b>33</b>, a highly potent and selective Na<sub>V</sub>1.7 inhibitor that displayed favorable PK in rodents, acceptable subtype selectivity over other Na<sub>V</sub> isoforms, and efficacy in in vivo models of pain as well as hNa<sub>V</sub>1.7 target engagement models. Starting with an analysis of the physicochemical property profiles of previously reported aryl- and acyl sulfonamides, followed by library syntheses, we identified lead molecule (<b>7</b>). Guided by induced fit docking into our recently published X-ray cocrystal structure of VSD4 of Na<sub>V</sub>1.7, we simplified the adamantane to a cyclohexane in compound <b>26</b> and conducted metabolite ID studies to guide further designs. Significant improvements in metabolic stability were achieved by identifying the primary metabolites of <b>26</b> and utilizing these data to systematically modify the structures to address proposed liabilities. These efforts culminated in the identification of <b>33</b>, a highly potent and efficacious tool molecule. Finally, we also disclosed CEREP screening data and inhibition data against TTX-resistant currents in mouse DRGs, which provided clear evidence that the in vivo activity of compound <b>33</b> was primarily caused by its inhibition of Na<sub>V</sub>1.7 channels.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General</h3><div class="NLM_p">Chemicals, reagents, and solvents were purchased from commercial sources and either used as supplied or purified using reported methods. Final compounds reported herein exhibited spectral data consistent with their proposed structure by nuclear magnetic resonance spectra (<sup>1</sup>H NMR and <sup>13</sup>C NMR) and mass spectra data. NMR spectra were recorded on a Bruker Avance 300 spectrometer with chemical shifts (δ) reported in parts per million relative to the residual signal of the deuterated solvent. <sup>1</sup>H NMR data are tabulated in the following order: multiplicity (s, singlet; d, doublet; t, triplet; m, multiplet; br, broad), coupling constants in hertz, and number of protons. Mass spectra were obtained using a Waters 2795/ZQ liquid chromatography (LC)/mass spectrometry (MS) system (Waters Corporation, Milford, MA). Final compounds were higher than 95% pure as determined by analytical high-performance liquid chromatography (HPLC) on Agilent 1200 systems (Agilent Technologies, Santa Clara, CA) using an EMD Chromolith SpeedROD RP-18e column (4.6 mm i.d. × 50 mm length) (Merck KGaA, Darmstadt, Germany). The mobile phase consisted of a gradient of component “A” (0.1% v/v aqueous trifluoroacetic acid) and component “B” (acetonitrile) at a flow rate of 1 mL/min. The gradient program used was as follows: initial conditions 5% B, hold at 5% B for 1 min, linear ramp from 5 to 95% B over 5 min, 100% B for 3 min, return to initial conditions for 1 min. Peaks were detected at a wavelength of 254 nm with an Agilent photodiode array detector. Melting points were determined on a Fisher-Johns melting point apparatus and were uncorrected. Chemical names were generated using ChemBioDraw version 16.0 (CambridgeSoft, Cambridge, MA).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(Adamantan-1-ylmethoxy)-5-chloro-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>7</b>)</h4><div class="NLM_p last">To a mixture of adamantan-1-ylmethanol (1.00 g, 6.0 mmol) and anhydrous DMSO (40 mL) was added potassium <i>t</i>-butoxide (1.68 g, 15.0 mmol) at room temperature. The resulting mixture was stirred at room temperature for 30 min followed by the addition of <b>37</b> (1.62 g, 6.0 mmol). The reaction mixture was again stirred at room temperature for 16 h, cooled to 0 °C, and quenched with hydrochloric acid (1 N, 30 mL), followed by extraction with ethyl acetate (200 mL). The organic layer was washed with water (2 × 40 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 10–60% ethyl acetate (containing 2% acetic acid) in hexanes to afford <b>7</b> as a colorless solid (1.17 g, 46%). mp 194–196 °C (EtOAc/hexanes) <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (s br, 1H), 7.77 (d, <i>J</i> = 7.5 Hz, 1H), 7.23 (d, <i>J</i> = 12.5 Hz, 1H), 3.72 (s, 2H), 3.35 (s, 3H), 1.99 (s br, 3H), 1.75–1.64 (m, 12H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.3 (d, <i>J</i> = 2.2 Hz), 159.8 (d, <i>J</i><sub>C–F</sub> = 255 Hz), 158.3 (d, <i>J</i><sub>C–F</sub> = 11 Hz), 130.6 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 116.8 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 113.6 (d, <i>J</i><sub>C–F</sub> = 14 Hz), 102.7 (d, <i>J</i><sub>C–F</sub> = 28 Hz), 79.1, 41.2, 38.5, 36.4, 33.4, 27.3. MS (electrospray (ES)−) <i>m</i>/<i>z</i>: 414.1, 416.1 (M – 1).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-Chloro-4-(cyclohexylmethoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>8</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>8</b> was prepared from <b>37</b> and cyclohexylmethanol as a colorless solid (0.11 g, 30%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.04 (s br, 1H), 7.73 (d, <i>J</i> = 7.5 Hz, 1H), 7.21 (d, <i>J</i> = 12.6 Hz, 1H), 3.93 (d, <i>J</i> = 5.9 Hz, 2H), 3.31 (s, 3H), 1.79–1.60 (m, 6H), 1.29–0.97 (m, 5H). MS (ES−) <i>m</i>/<i>z</i>: 362.1, 364.1 (M – 1).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-Chloro-2-fluoro-<i>N</i>-(methylsulfonyl)-4-((tetrahydro-2<i>H</i>-pyran-4-yl)methoxy)benzamide (<b>9</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>9</b> was prepared from <b>37</b> and (tetrahydro-2<i>H</i>-pyran-4-yl)methanol as a colorless solid (0.160 g, 15%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (s br, 1H), 7.78 (d, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 12.5 Hz, 1H), 4.03 (d, <i>J</i> = 6.4 Hz, 2H), 3.91–3.86 (m, 2H), 3.38–3.30 (m, 5H), 2.10–2.00 (m, 1H), 1.70–1.65 (m, 2H), 1.43–1.29 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 364.1, 366.1 (M – 1).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-Chloro-4-(2-cyclohexylethoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>10</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>10</b> was prepared from <b>37</b> and 2-cyclohexylethanol as a colorless solid (0.05 g, 14%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.05 (s, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.26 (d, <i>J</i> = 12.4 Hz, 1H), 4.17 (t, <i>J</i> = 6.6 Hz, 2H), 3.29 (s, 3H), 1.76–1.41 (m, 8H), 1.27–0.90 (m, 5H). MS (ES−) <i>m</i>/<i>z</i>: 376.1, 378.1 (M – 1).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Chloro-4-(cyclohexyloxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>11</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>11</b> was prepared from <b>37</b> and cyclohexanol as a colorless solid (0.03 g, 9%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.03 (s br, 1H), 7.73 (d, <i>J</i> = 7.6 Hz, 1H), 7.29 (d, <i>J</i> = 12.7 Hz, 1H), 4.64–4.57 (m, 1H), 3.31 (s, 3H), 1.88–1.82 (m, 2H), 1.69–1.64 (m, 2H), 1.54–1.27 (m, 6H). MS (ES−) <i>m</i>/<i>z</i>: 348.1, 350.1 (M – 1).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-Chloro-4-(cyclopentylmethoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>12</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>12</b> was prepared from <b>37</b> and cyclopentylmethanol as a colorless solid (0.14 g, 40%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.09 (s br, 1H), 7.77 (d, <i>J</i> = 7.5 Hz, 1H), 7.25 (d, <i>J</i> = 12.5 Hz, 1H), 4.04 (d, <i>J</i> = 6.8 Hz, 2H), 3.35 (s, 3H), 2.39–2.29 (m, 1H), 1.82–1.73 (m, 2H), 1.65–1.52 (m, 4H), 1.40–1.30 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 348.1, 350.1 (M – 1).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Chloro-4-(2-cyclopropylethoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>13</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>13</b> was prepared from <b>37</b> and 2-cyclopropylethan-1-ol as a colorless solid (0.26 g, 52%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (s br, 1H), 7.78 (d, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 12.5 Hz, 1H), 4.20 (t, <i>J</i> = 6.3 Hz, 2H), 3.35 (s, 3H), 1.70–1.63 (m, 2H), 0.87–0.79 (m, 1H), 0.47–0.41 (m, 2H), 0.17–0.12 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 334.1, 336.1 (M – 1).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(Adamantan-1-ylmethoxy)-3-chloro-<i>N</i>-(methylsulfonyl)benzamide (<b>14</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>14</b> was prepared from <b>38</b> and (adamantan-1-yl)methanol as a colorless solid (0.34 g, 52%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.07 (s br, 1H), 8.04–7.94 (m, 2H), 7.25 (d, <i>J</i> = 8.5 Hz, 1H), 3.72 (s, 2H), 3.36 (s, 3H), 1.99 (s br, 3H), 1.71–1.66 (m, 12H). MS (ES−) <i>m</i>/<i>z</i>: 396.1, 398.1 (M – 1).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-(Adamantan-1-ylmethoxy)-2,5-dichloro-<i>N</i>-(methylsulfonyl)benzamide (<b>15</b>)</h4><div class="NLM_p last">A mixture of <b>41</b> (0.16 g, 0.41 mmol), methanesulfonamide (0.12 g, 1.23 mmol), Mo(CO)<sub>6</sub>, (0.11 g, 0.41 mmol), and Et<sub>3</sub>N (0.23 mL, 1.64 mmol) in 1,4-dioxane was purged with nitrogen for 5 min, and Xantphos (0.35 g, 0.082 mmol) and Pd(OAc)<sub>2</sub> (0.01 g, 0.041 mmol) were added. The reaction mixture was heated at 100 °C for 45 min under microwave irradiation and then cooled to room temperature. The reaction was repeated twice on 0.82 mmol scale. The reaction mixtures were combined and concentrated <i>in</i> vacuo. The residue was diluted with EtOAc (40 mL) and saturated aqueous NH<sub>4</sub>Cl solution (10 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 10–40% EtOAc (containing 0.2% acetic acid) in hexanes to afford <b>15</b> as a colorless solid (0.09 g, 10%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.96 (s br, 1H), 7.99 (s, 1H), 6.91 (s, 1H), 3.60 (s, 2H), 3.42 (s, 3H), 2.09–2.01 (m, 3H), 1.83–1.64 (m, 12H). MS (ES−) <i>m</i>/<i>z</i>: 430.2 (M −1), 432.2 (M −1).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(Adamantan-1-ylmethoxy)-2,5-difluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>16</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>16</b> was prepared from <b>39</b> and adamantan-1-ylmethanol as a colorless solid (0.145 g, 36%): <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.01 (s, 1H), 7.53 (dd, <i>J</i> = 6.8, 11.3 Hz, 1H), 7.23 (dd, <i>J</i> = 6.8, 12.3 Hz, 1H), 3.68 (s, 2H), 3.31 (s, 3H), 1.95 (s, 3H), 1.71–1.58 (m, 12H). MS (ES−) <i>m</i>/<i>z</i>: 398.1 (M – 1).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-(Adamantan-1-ylmethoxy)-2-fluoro-5-methyl-<i>N</i>-(methylsulfonyl)benzamide (<b>17</b>)</h4><div class="NLM_p last">To a mixture of <b>43</b> (0.16 g, 0.50 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (25 mL) were added EDCI (0.22 g, 1.15 mmol), DMAP (0.14 g, 1.15 mmol), and MeSO<sub>2</sub>NH<sub>2</sub> (11.44 g, 119.0 mmol) at room temperature. After stirring at room temperature for 16 h, the reaction mixture was quenched by the addition of a 1 M HCl solution (5 mL) at 0 °C. The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was crystallized from EtOAc and hexanes to afford <b>17</b> as a colorless solid (0.06 g, 27%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s br, 1H), 7.48 (d, <i>J</i> = 8.3 Hz, 1H), 6.93 (d, <i>J</i> = 13.0 Hz, 1H), 3.62 (s, 2H), 3.33 (s, 3H), 2.15 (s, 3H), 1.99 (s br, 3H), 1.75–1.66 (m, 12H). MS (ES+) <i>m</i>/<i>z</i>: 396.2 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 394.2 (M – 1).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(Adamantan-1-ylmethoxy)-5-ethyl-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>18</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>18</b> was prepared from <b>48</b> and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (0.17 g, 69%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.87 (s br, 1H), 7.46 (d, <i>J</i> = 8.5 Hz, 1H), 6.94 (d, <i>J</i> = 13.1 Hz, 1H), 3.62 (s, 2H), 3.34 (s, 3H), 2.58 (q, <i>J</i> = 7.5 Hz, 2H), 1.99 (s br, 3H), 1.75–1.64 (m, 12H), 1.15 (t, <i>J</i> = 7.5 Hz, 3H). MS (ES+) <i>m</i>/<i>z</i>: 410.2 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 408.3 (M – 1).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-(Adamantan-1-ylmethoxy)-2-fluoro-5-isopropyl-<i>N</i>-(methylsulfonyl)benzamide (<b>19</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>19</b> was prepared from <b>51</b> and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (0.16 g, 33%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.73 (d, <i>J</i> = 16.5 Hz, 1H), 7.93 (d, <i>J</i> = 9.6 Hz, 1H), 6.57 (d, <i>J</i> = 14.7 Hz, 1H), 3.53 (s, 2H), 3.42 (s, 3H), 3.33–3.19 (m, 1H), 2.05 (s, 3H), 1.84–1.62 (m, 12H), 1.23 (d, <i>J</i> = 6.9 Hz). MS (ES−) <i>m</i>/<i>z</i>: 422.3 (M – 1).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(Adamantan-1-ylmethoxy)-5-cyclopropyl-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>20</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>20</b> was prepared from <b>63</b> and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (0.45 g, 70%). mp 158–159 °C (EtOAc/hexanes). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.72 (d, <i>J</i> = 16.2 Hz, 1H), 7.58 (d, <i>J</i> = 9.3 Hz, 1H), 6.56 (d, <i>J</i> = 14.7 Hz, 1H), 3.56 (s, 2H), 3.41 (s, 3H), 2.09–2.00 (m, 4H), 1.81–1.58 (m, 12H), 0.99–0.91 (m, 2H), 0.70–0.62 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 163.9 (d, <i>J</i><sub>C–F</sub> = 11 Hz), 160.5 (d, <i>J</i><sub>C–F</sub> = 246 Hz), 161.5 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 129.9 (d, <i>J</i><sub>C–F</sub> = 2 Hz), 128.2 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 108.6 (d, <i>J</i><sub>C–F</sub> = 10 Hz), 98.7 (d, <i>J</i><sub>C–F</sub> = 29 Hz), 78.9, 41.8, 39.3, 36.9, 33.8, 27.9, 9.3, 7.2. MS (ES+) <i>m</i>/<i>z</i>: 422.2 (M – 1); MS (ES−) <i>m</i>/<i>z</i>: 420.2 (M – 1).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-Chloro-2-fluoro-4-((3-hydroxyadamantan-1-yl)methoxy)-<i>N</i>-(methylsulfonyl)benzamide (<b>21</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>21</b> was prepared from <b>37</b> and 3-(hydroxymethyl)adamantan-1-ol as a colorless solid (0.25 g, 29%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.11 (s br, 1H), 7.76 (d, <i>J</i> = 6.6 Hz, 1H), 7.23 (d, <i>J</i> = 12.3 Hz, 1H), 4.36 (s br, 1H), 3.78 (s, 2H), 3.35 (s, 3H), 2.14 (s br, 2H), 1.68–1.39 (m, 12H). MS (ES−) <i>m</i>/<i>z</i>: 430.1, 432.1 (M – 1).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-Chloro-2-fluoro-4-((3-fluoroadamantan-1-yl)methoxy)-<i>N</i>-(methylsulfonyl)benzamide (<b>22</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>22</b> was prepared from <b>37</b> and (3-fluoroadamantan-1-yl)methanol as a colorless solid (0.37 g, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.12 (s br, 1H), 7.78 (d, <i>J</i> = 7.5 Hz, 1H), 7.24 (d, <i>J</i> = 12.4 Hz, 1H), 3.85 (s, 2H), 3.35 (s, 3H), 2.30 (s, 2H), 1.82–1.76 (m, 6H), 1.61–1.52 (m, 6H). MS (ES−) <i>m</i>/<i>z</i>: 432.1, 434.1 (M – 1).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Chloro-4-((4,4-difluoroadamantan-1-yl)methoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>23</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>23</b> was prepared from <b>37</b> and (4,4-difluoroadamantan-1-yl)methanol as a colorless solid (0.47 g, 42%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (s br, 1H), 8.06 (d, <i>J</i> = 8.4 Hz, 1H), 6.65 (d, <i>J</i> = 13.8 Hz, 1H), 3.61 (s, 2H), 3.39 (s, 3H), 2.28 (s br, 2H), 2.05–1.87 (m, 5H), 1.78–1.66 (m, 6H). MS (ES+) <i>m</i>/<i>z</i>: 452.1, 454.1 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 450.2, 452.2 (M – 1).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-Cyclopropyl-4-((4,4-difluoroadamantan-1-yl)methoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>24</b>)</h4><div class="NLM_p last">To a mixture of <b>23</b> (0.37 g, 0.81 mmol), cyclopropylboronic acid (0.21 g, 2.44 mmol), and K<sub>3</sub>PO<sub>4</sub> (1.72 g, 8.10 mmol) in toluene (30 mL) and water (1.5 mL) under a nitrogen atmosphere were added Cy<sub>3</sub>P·HBF<sub>4</sub> (0.06 g, 0.16 mmol) and Pd(OAc)<sub>2</sub> (0.02 g, 0.9 mmol). The reaction mixture was heated to 100 °C for 18 h and then cooled to ambient temperature. Aqueous hydrochloric acid (5%, 20 mL) was added, and the mixture was extracted with EtOAc (100 mL × 3); the combined organics were washed with brine, dried over anhydrous sodium sulfate, and concentrated in vacuo. Purification of the residue by column chromatography (10–30% gradient ethyl acetate in hexanes) afforded the title compound as a colorless solid (0.32 g, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (br s, 1H), 7.59 (d, <i>J</i> = 9.0 Hz, 1H), 6.53 (d, <i>J</i> = 14.1 Hz, 1H), 3.59 (s, 2H), 3.39 (s, 3H), 2.28 (br s, 2H), 2.08–1.92 (m, 6H), 1.53–1.51 (m, 6H), 0.97–0.89 (m, 2H), 0.66–0.60 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 456.2 (M – 1).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-Chloro-2-fluoro-<i>N</i>-(methylsulfonyl)-4-((3,5,7-trifluoroadamantan-1-yl)methoxy)benzamide (<b>25</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>7</b>, <b>25</b> was prepared from <b>37</b> and (3,5,7-trifluoroadamantan-1-yl)methanol as a colorless solid (0.04 g, 28%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (br s, 1H), 7.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 12.28 Hz, 1H), 4.00 (s, 2H), 3.22 (s, 3H), 2.26–2.15 (m, 3H), 2.07–1.97 (m, 3H), 1.82–1.74 (m, 6H). MS (ES−) <i>m</i>/<i>z</i> 468.21, 470.20 (M – 1).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-(Cyclohexylmethoxy)-5-cyclopropyl-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>26</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>26</b> was prepared from <b>64</b> and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (0.19 g, 40%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.71 (d, <i>J</i> = 16.5 Hz, 1H), 7.56 (d, <i>J</i> = 9.0 Hz, 1H), 6.56 (d, <i>J</i> = 14.7 Hz, 1H), 3.82 (d, <i>J</i> = 5.7 Hz, 2H), 3.41 (s, 3H), 2.11–2.01 (m, 1H), 1.96–1.68 (m, 6H), 1.39–1.04 (m, 5H), 0.98–0.90 (m, 2H), 0.69–0.63 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 368.3 (M – 1).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-Cyclopropyl-4-((4,4-difluorocyclohexyl)methoxy)-2-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>27</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>27</b> was prepared from <b>65</b> and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (0.04 g, 13%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.69 (d, <i>J</i> = 15.0 Hz, 1H), 7.57 (d, <i>J</i> = 9.0 Hz, 1H), 6.55 (d, <i>J</i> = 14.4 Hz, 1H), 3.88 (d, <i>J</i> = 9.0 Hz, 2H), 3.39 (s, 3H), 2.25–2.11 (m, 2H), 2.04–1.66 (m, 6H), 1.54–1.41 (m, 2H), 0.97–0.89 (m, 2H), 0.67–0.61 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 404.1 (M – 1).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-Cyclopropyl-<i>N</i>-(cyclopropylsulfonyl)-4-((4,4-difluorocyclohexyl)-methoxy)-2-fluorobenzamide (<b>28</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>28</b> was prepared from <b>65</b> and cyclopropanesulfonamide as a colorless solid (0.15 g, 46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.68 (d, <i>J</i> = 16.2 Hz, 1H), 7.59 (d, <i>J</i> = 9.0 Hz, 1H), 6.56 (d, <i>J</i> = 14.4 Hz, 1H), 3.89 (d, <i>J</i> = 6.0 Hz, 2H), 3.15–3.04 (m, 1H), 2.24–1.66 (m, 12H), 1.19–1.10 (m, 2H), 0.98–0.89 (m, 2H), 0.69–0.63 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 432.0 (M + 1).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-Cyclopropyl-4-((4,4-difluorocyclohexyl)-methoxy)-2-fluoro-<i>N</i>-((2-methoxyethyl)sulfonyl)benzamide (<b>29</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>29</b> was prepared from <b>65</b> and 2-methoxyethane-1-sulfonamide as a colorless solid (0.07 g, 26%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.62 (d, <i>J</i> = 15.9 Hz, 1H), 7.56 (d, <i>J</i> = 9.0 Hz, 1H), 6.55 (d, <i>J</i> = 14.4 Hz, 1H), 3.91–3.75 (m, 6H), 3.30 (s, 3H), 2.24–1.42 (m, 10H), 0.97–0.88 (m, 2H), 0.71–0.60 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 450.0 (M + 1).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-Cyclopropyl-<i>N</i>-(cyclopropylsulfonyl)-4-((4,4-difluoro-1-methylcyclohexyl)-methoxy)-2-fluorobenzamide (<b>30</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>30</b> was prepared from <b>66</b> and cyclopropanesulfonamide as a colorless solid (0.17 g, 61%). mp 134–135 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.6 6 (d, <i>J</i> = 16.2 Hz, 1H), 7.61 (d, <i>J</i> = 9.0 Hz, 1H), 6.55 (d, <i>J</i> = 14.4 Hz, 1H), 3.74 (s, 2H), 3.14–3.03 (m, 1H), 2.05–1.73 (m, 7H), 1.66–1.59 (m, 2H), 1.48–1.41 (m, 2H), 1.20–1.10 (m, 5H), 0.97–0.89 (m, 2H), 0.68–0.59 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 163.3 (d, <i>J</i><sub>C–F</sub> = 11 Hz), 161.1 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 160.4 (d, <i>J</i><sub>C–F</sub> = 247 Hz), 129.9 (d, <i>J</i><sub>C–F</sub> = 2 Hz), 128.8 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 123.3 (t, <i>J</i><sub>C–F</sub> = 241 Hz), 109.4 (d, <i>J</i><sub>C–F</sub> = 10 Hz), 98.9, 98.5, 33.7, 31.5, 30.7 (dd, <i>J</i><sub>C–F</sub> = 6.93, 2.82 Hz), 29.6 (t, <i>J</i><sub>C–F</sub> = 24.3 Hz), 21.2, 9.4, 7.1, 6.4. MS (ES+) <i>m</i>/<i>z</i>: 446.1 (M + 1). Anal. Calcd for C<sub>21</sub>H<sub>26</sub>F<sub>3</sub>NO<sub>4</sub>S: C, 56.62; H, 5.88; N, 3.14. Found: C, 56.80; H, 5.89; N, 3.15.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-Cyclopropyl-<i>N</i>-(cyclopropylsulfonyl)-4-((1-ethyl-4,4-difluorocyclohexyl)methoxy)-2-fluorobenzamide (<b>31</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>31</b> was prepared from <b>67</b> and cyclopropanesulfonamide as a colorless solid (0.17 g, 37%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.68 (d, <i>J</i> = 16.2 Hz, 1H), 7.64 (d, <i>J</i> = 9.0 Hz, 1H), 6.59 (d, <i>J</i> = 14.4 Hz, 1H), 3.79 (s, 2H), 3.15–3.05 (m, 1H), 2.04–1.86 (m, 5H), 1.81–1.57 (m, 6H), 1.50–1.41 (m, 2H), 1.19–1.10 (m, 2H), 0.98–0.84 (m, 5H), 0.69–0.61 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 458.3 (M – 1).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-Cyclopropyl-<i>N</i>-(cyclopropylsulfonyl)-2-fluoro-4-((1-methyl-4-(trifluoromethyl)cyclohexyl)methoxy)benzamide (<b>32</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>32</b> was prepared from <b>68</b> and cyclopropanesulfonamide as a colorless solid (0.11 g, 61%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s br, 1H), 7.15 (d, <i>J</i> = 8.3 Hz, 1H), 7.09 (d, <i>J</i> = 13.1 Hz, 1H), 3.93 (s, 2H), 3.12–3.03 (m, 1H), 2.30–2.20 (m, 1H), 2.05–1.96 (m, 1H), 1.87–1.83 (m, 2H), 1.73–1.68 (m, 2H), 1.54–1.41 (m, 2H), 1.34–1.24 (m, 2H), 1.13–1.08 (m, 4H), 1.05 (s, 3H), 0.92–0.85 (m, 2H), 0.69–0.63 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 478.1 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 476.2 (M – 1).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-Cyclopropyl-<i>N</i>-(cyclopropylsulfonyl)-2-fluoro-4-((6-methylspiro[2.5]octan-6-yl)methoxy)benzamide (<b>33</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>17</b>, compound <b>33</b> was prepared from <b>74</b> and cyclopropanesulfonamide as a colorless solid (0.05 g, 41%). mp 134–135 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.70 (d, <i>J</i> = 16.3 Hz, 1H), 7.62 (d, <i>J</i> = 9.1 Hz, 1H), 6.59 (d, <i>J</i> = 14.5 Hz, 1H), 3.76 (s, 2H), 3.16–3.06 (m, 1H), 2.09–1.95 (m, 1H), 1.69–1.40 (m, 7H), 1.28–1.02 (m, 7H), 0.98–0.79 (m, 3H), 0.69–0.62 (m, 2H), 0.32–0.18 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 163.9 (d, <i>J</i><sub>C–F</sub><i>=</i> 11 Hz), 162.2, 161.2 (d, <i>J</i><sub>C–F</sub><i>=</i> 3 Hz), 158.9, 130.0 (d, <i>J</i><sub>C–F</sub><i>=</i> 3 Hz), 128.6 (d, <i>J</i><sub>C–F</sub><i>=</i> 3 Hz), 108.9 (d, <i>J</i><sub>C–F</sub><i>=</i> 10 Hz), 98.7 (d, <i>J</i><sub>C–F</sub><i>=</i> 29 Hz), 34.4, 33.5, 31.5, 30.9, 22.2, 18.7, 11.9, 11.9, 9.4, 7.1, 6.4. MS (ES+) <i>m</i>/<i>z</i>: 436.2 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 434.2 (M – 1). Anal. Calcd for C<sub>23</sub>H<sub>30</sub>FNO<sub>4</sub>S·0.2H<sub>2</sub>O: C, 62.91; H, 6.98; N, 3.19. Found: C, 62.73; H, 7.11; N, 3.20.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-Chloro-2,4-difluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>37</b>)</h4><div class="NLM_p last">To a solution of 5-chloro-2,4-difluorobenzoic acid (<b>34</b>) (15.0 g, 77.9 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (250 mL) were added EDCI (22.6 g, 117.8 mmol), DMAP (21.6 g, 176.8 mmol), and MeSO<sub>2</sub>NH<sub>2</sub> (11.4 g, 119.0 mmol) at room temperature. After stirring at room temperature for 16 h, the reaction mixture was quenched by the addition of 1 M HCl solution (50 mL). The organic layer was separated and washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was crystallized from EtOAc and hexanes (1:4, by volume) to give <b>37</b> as a colorless solid (12.3 g, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (s br, 1H), 8.02–7.97 (m, 1H), 7.76–7.70 (m, 1H), 3.37 (s, 3H). MS (ES−) <i>m</i>/<i>z</i>: 268.1, 270.1 (M – 1).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-Chloro-4-fluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>38</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of compound <b>37</b>, <b>38</b> was prepared from 5-chloro-4-difluorobenzoic acid (<b>35</b>) and MeSO<sub>2</sub>NH<sub>2</sub> as a colorless solid (13.8 g, 96%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.27 (s br, 1H), 8.21–8.18 (m, 1H), 8.00–7.95 (m, 1H), 7.62–7.56 (m, 1H), 3.38 (s, 3H).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2,4,5-Trifluoro-<i>N</i>-(methylsulfonyl)benzamide (<b>39</b>)</h4><div class="NLM_p last">To a solution of MeSO<sub>2</sub>NH<sub>2</sub> (0.49 g, 5.14 mmol) and Et<sub>3</sub>N (4.3 mL, 30.8 mmol) in anhydrous CH<sub>3</sub>CN (15 mL) was added 2,4,5-trifluorobenzoyl chloride (<b>36</b>) (1.00 g, 5.14 mmol). After stirring at room temperature for 16 h, the reaction mixture was quenched by the addition of 1 M HCl (20 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was crystallized from EtOAc and hexanes to give <b>39</b> as a light-brown solid (0.7 g, 54%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.76 (d, <i>J</i> = 14.2 Hz, 1H), 8.00–7.92 (m, 1H), 7.15–7.06 (m, 1H), 3.43 (s, 3H). MS (ES−) <i>m</i>/<i>z</i>: 252.0 (M – 1).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-((4-Bromo-2,5-dichlorophenoxy)methyl)adamantine (<b>41</b>)</h4><div class="NLM_p last">To a mixture of 4-bromo-2,5-dichlorophenol (<b>40</b>) (1.35 g, 5.58 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.85 g, 6.14 mmol) in DMF (10 mL) was added adamantan-1-ylmethyl methanesulfonate (1.50 g, 6.14 mmol) at room temperature. After stirring at 65 and 125 °C for 16 and 48 h, respectively, the reaction mixture was cooled to room temperature, diluted with water (40 mL), and extracted with EtOAc (2 × 50 mL). The combined organic extract was washed with brine (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 5–10% EtOAc in hexanes to afford <b>41</b> as a colorless solid (1.70 g, 71%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.57 (s, 1H), 6. 96 (s, 1H), 3.51 (s, 2H), 2.05–1.97 (m, 3H), 1.81–1.61 (m, 12H).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(Adamantan-1-ylmethoxy)-2-fluoro-5-methylbenzoic acid (<b>43</b>)</h4><div class="NLM_p last">To a solution of 1-adamantane methanol (2.40 g, 14.4 mmol) in anhydrous DMSO (20 mL) was added <i>t-</i>BuOK (4.86 g, 43.3 mmol). After stirring at room temperature for 30 min, 5-methyl-2,4-difluorobenzoic acid (<b>42</b>) (2.50 g, 14.40 mmol) was added to the reaction mixture and stirred at 50 °C for 72 h. The reaction mixture was cooled to room temperature and acidified to pH 1 with an ice-cold 1 M HCl solution, followed by the addition of saturated NH<sub>4</sub>Cl solution (100 mL). The solid was collected by filtration and washed with H<sub>2</sub>O. The crude product was crystallized from EtOAc and hexanes to afford <b>43</b> as a colorless solid (0.77 g, 17%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.70 (s br, 1H), 7.64 (d, <i>J</i> = 8.6 Hz, 1H), 6.86 (d, <i>J</i> = 13.2 Hz, 1H), 3.60 (s, 2H), 2.14 (s, 3H), 1.99 (s br, 3H), 1.74–1.63 (m, 12H). MS (ES+) <i>m</i>/<i>z</i>: 437.2 (M + 1).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl-5-chloro-2,4-difluorobenzoate (<b>44</b>)</h4><div class="NLM_p last">To a solution of <b>34</b> (10.0 g, 51.93 mmol) and DMAP (0.02 g, 0.16 mmol) in <i>t</i>-BuOH (60 mL) was added di-<i>tert</i>-butyl dicarbonate (23.35 g, 106.98 mmol). The reaction mixture was heated at 50 °C for 16 h and concentrated in vacuo. The residue was diluted with EtOAc (200 mL); washed with 1 M HCl (50 mL), water, and brine; dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>; and filtered. The filtrate was concentrated in vacuo to give <b>44</b> as a pale yellow oil (12.9 g, 99%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.94 (t, <i>J</i> = 7.8 Hz, 1H), 6.95 (t, <i>J</i> = 9.4 Hz, 1H), 1.59 (s, 9H).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>tert-</i>Butyl-4-(adamantan-1-ylmethoxy)-5-chloro-2-fluorobenzoate (<b>45</b>)</h4><div class="NLM_p last">To a mixture of 1-adamantane methanol (25.8 g, 0.155 mol) and <b>44</b> (50.0 g, 0.201 mol) in DMSO (250 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (109 g, 0.309 mol). The reaction mixture was heated at 70 °C for 20 h, then cooled to room temperature, filtered through a pad of celite, and washed with EtOAc (600 mL). The filtrate was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo. The residue was triturated in methanol (300 mL) and filtered to afford <b>45</b> as a pale yellow solid (37.8 g, 62%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 6.59 (d, <i>J</i> = 12.3 Hz, 1H), 3.53 (s, 2H), 2.01 (s, 3H), 1.78–1.61 (m, 12H), 1.55 (s, 9H).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl-4-(adamantan-1-ylmethoxy)-2-fluoro-5-vinylbenzoate (<b>46</b>)</h4><div class="NLM_p last">To a mixture of <b>45</b> (2.00 g, 5.06 mmol), vinylboronic acid pinacol ester (1.56 g, 10.1 mmol), and Na<sub>2</sub>CO<sub>3</sub> (1.61 g, 15.2 mmol) in 1,4-dioxane (20 mL) and water (5 mL) were added <i>t-</i>Bu<sub>3</sub>P·HBF<sub>4</sub> (0.15 g, 0.51 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (0.023 g, 0.025 mmol) under a nitrogen atmosphere. The reaction mixture was heated to 100 °C for 24 h and then cooled to room temperature. Water (50 mL) was added and the mixture was extracted with EtOAc (3 × 100 mL). The combined organic extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified over column chromatography eluted with 30% CH<sub>2</sub>Cl<sub>2</sub> in hexanes to give <b>46</b> as a pale yellow solid (1.80 g, 92%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.95 (d, <i>J</i> = 9.0 Hz, 1H), 6.98–6.86 (m, 1H), 6.52 (d, <i>J</i> = 12.0 Hz, 1H), 5.76 (d, <i>J</i> = 18.0 Hz, 1H), 5.26 (d, <i>J</i> = 9.0 Hz, 1H), 3.51 (s, 2H), 1.78–1.62 (m, 12H), 1.58–1.52 (m, 3H), 1.22 (s, 9H). MS (ES+) <i>m</i>/<i>z</i>: 387.2 (M + 1).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(Adamantan-1-ylmethoxy)-2-fluoro-5-vinylbenzoic Acid (<b>47</b>)</h4><div class="NLM_p last">To a solution of <b>46</b> (1.80 g, 4.65 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added TFA (10 mL). The reaction mixture was stirred at room temperature for 16 h and then concentrated in vacuo. The residue was triturated in hexanes (50 mL), and the solid was collected by filtration to give <b>47</b> as a pale yellow solid (1.50 g, 97%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.94 (s br, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 1H), 6.96–6.81 (m, 2H), 5.84–5.78 (m, 1H), 5.32–5.28 (m, 1H), 3.62 (s, 2H), 1.95 (s, 3H), 1.70–1.60 (m, 12H). MS (ES+) <i>m</i>/<i>z</i>: 331.2 (M + 1); MS (ES−) <i>m</i>/<i>z</i>: 329.2 (M – 1).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(Adamantan-1-ylmethoxy)-5-ethyl-2-fluorobenzoic Acid (<b>48</b>)</h4><div class="NLM_p last">A mixture of <b>47</b> (1.00 g, 3.03 mmol) in EtOAc (50 mL) was hydrogenated over 10% palladium on activated carbon (0.10 g) with atmospheric hydrogen at room temperature for 42 h. The mixture was filtered through a pad of celite and washed with EtOAc (50 mL). The filtrate was concentrated in vacuo, and the residue was recrystallized from EtOAc and hexanes to afford <b>48</b> as a colorless solid (0.75 g, 74%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (s br, 1H), 7.63 (d, <i>J</i> = 8.6 Hz, 1H), 6.87 (d, <i>J</i> = 13.2 Hz, 1H), 3.61 (s, 2H), 5.57 (d, <i>J</i> = 7.5 Hz, 2H), 1.99 (s, 3H), 1.75–1.63 (m, 12H), 1.14 (t, <i>J</i> = 7.5 Hz, 3H). MS (ES+) <i>m</i>/<i>z</i>: 333.2 (M + 1).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl-4-(adamantan-1-ylmethoxy)-2-fluoro-5-(prop-1-en-2-yl)benzoate (<b>49</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>46</b>, compound <b>49</b> was prepared from <b>45</b> and 2-isopropenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane as a colorless solid (1.94 g, 64%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 8.7 Hz, 1H), 6.54 (d, <i>J</i> = 13.2 Hz, 1H), 5.17–5.13 (m, 1H), 5.10–5.07 (m, 1H), 3.50 (s, 2H), 2.15 (s, br, 3H), 2.02 (s br, 3H), 1.81–1.62 (m, 12H), 1.58 (s, 9H). MS (ES+) <i>m</i>/<i>z</i>: 401.2 (M + 1).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl-4-(adamantan-1-ylmethoxy)-2-fluoro-5-isopropylbenzoate (<b>50</b>)</h4><div class="NLM_p last">A mixture of <b>49</b> (1.94 g, 4.84 mmol) in EtOAc (50 mL) was hydrogenated over 10% palladium on activated carbon (0.19 g) with atmospheric hydrogen at room temperature for 16 h, filtered through a pad of celite, and concentrated in vacuo to afford <b>50</b> as a pale yellow oil (1.84 g, 94%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 8.7 Hz, 1H), 6.50 (d, <i>J</i> = 12.9 Hz, 1H), 3.49 (s, 2H), 3.30–3.18 (m, 1H), 2.04 (s br, 3H), 1.83–1.64 (m, 12H), 1.58 (s, 9H), 1.22 (d, <i>J</i> = 6.9 Hz, 1H). MS (ES+) <i>m</i>/<i>z</i>: 403.3 (M + 1).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(Adamantan-1-ylmethoxy)-2-fluoro-5-isopropylbenzoic Acid (<b>51</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>51</b> was prepared from <b>50</b> as a colorless solid (1.31 g, 84 %). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (s br, 1H), 7.61 (d, <i>J</i> = 8.7 Hz, 1H), 6.84 (d, <i>J</i> = 13.2 Hz, 1H), 3.58 (s, 2H), 3.22–3.10 (m, 1H), 1.96 (s, 3H), 1.75–1.59 (m, 12H), 1.15 (d, <i>J</i> = 6.9 Hz, 6H). MS (ES+) <i>m</i>/<i>z</i>: 347.2 (M + 1).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl-5-chloro-4-(cyclohexylmethoxy)-2-fluorobenzoate (<b>52</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>52</b> was prepared from <b>44</b> and cyclohexylmethanol as a colorless oil (15.37 g, 43%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.86 (d, <i>J</i> = 7.5 Hz, 1H), 6.61 (d, <i>J</i> = 12.0 Hz, 1H), 3.81 (d, <i>J</i> = 6.0 Hz, 2H), 1.90–1.68 (m, 6H), 1.57 (s, 9H), 1.39–1.04 (m, 5H).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl-5-cyclopropyl-4-((4,4-difluoro-cyclohexyl)methoxy)-2-fluorobenzoate (<b>53</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>53</b> was prepared from <b>44</b> and (4,4-difluorocyclohexyl)methanol as a pale yellow oil (5.9 g, 80%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 7.8 Hz, 1H), 6.62 (d, <i>J</i> = 12.0 Hz, 1H), 3.88 (d, <i>J</i> = 6.0 Hz, 2H), 2.23–1.92 (m, 7H), 1.57 (m, 9H), 1.50–1.42 (m, 2H).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl-5-chloro-4-((4,4-difluoro-1-methylcyclohexyl)methoxy)-2-fluorobenzoate (<b>54</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>54</b> was prepared from <b>44</b> and (4,4-difluoro-1-methylcyclohexyl)methanol as a colorless oil (3.69 g, 51%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 6.62 (d, <i>J</i> = 12.0 Hz, 1H), 3.74 (s, 2H), 2.06–1.55 (m, 17H), 1.16 (s, 3H). MS (ES+) <i>m</i>/<i>z</i>: 393.1 (M + 1).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>tert</i>-Butyl-5-chloro-4-((1-ethyl-4,4-difluorocyclohexyl)methoxy)-2-fluorobenzoate (<b>55</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>55</b> was prepared from <b>44</b> and (4,4-difluoro-1-ethylcyclohexyl)methanol as a colorless oil (5.97 g, 77%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 7.8 Hz, 1H), 6.63 (d, <i>J</i> = 11.7 Hz, 1H), 3.78 (s, 2H), 2.02–1.86 (m, 4H), 1.74–1.67 (m, 4H), 1.59–1.57 (m, 11H), 0.87 (t, <i>J</i> = 7.51 Hz, 3H). MS (ES+) <i>m</i>/<i>z</i>: 351.2 (M – 56).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>tert</i>-Butyl-5-chloro-2-fluoro-4-((1-methyl-4-(trifluoromethyl)cyclohexyl)methoxy)benzoate (<b>56</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>56</b> was prepared from <b>44</b> and (1-methyl-4-(trifluoromethyl)cyclohexyl)methanol as a colorless oil (6.20 g, 95%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (d, <i>J</i> = 7.7 Hz, 1H), 6.65 (d, <i>J</i> = 12.0 Hz, 1H), 3.85 (s, 2H), 1.96–1.93 (m, 2H), 1.85–1.79 (m, 2H), 1.58 (s, 9H), 1.53–1.39 (m, 3H), 1.34–1.23 (m, 2H), 1.11 (s, 3H).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>tert</i>-Butyl-4-(adamantan-1-ylmethoxy)-5-cyclopropyl-2-fluorobenzoate (<b>57</b>)</h4><div class="NLM_p last">To a mixture of <b>45</b> (15.8 g, 40.0 mmol), cyclopropylboronic acid (5.16 g, 60.0 mmol), and K<sub>3</sub>PO<sub>4</sub> (38.2 g, 180.0 mmol) in toluene (160 mL) and H<sub>2</sub>O (8 mL) under a nitrogen atmosphere were added Cy<sub>3</sub>P·HBF<sub>4</sub> (1.47 g, 3.99 mmol) and Pd(OAc)<sub>2</sub> (0.45 g, 2.00 mmol). The reaction mixture was heated to 100 °C for 18 h and then cooled to room temperature. H<sub>2</sub>O (100 mL) was added, and the mixture was extracted with EtOAc (3 × 100 mL); the combined organic extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtrated. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with 5% ethyl acetate in hexanes to afford <b>57</b> as a colorless solid (13.8 g, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.37 (d, <i>J</i> = 8.4 Hz, 1H), 6.47 (d, <i>J</i> = 12.9 Hz, 1H), 3.49 (s, 2H), 2.05–1.95 (m, 4H), 1.78–1.61 (m, 12H), 1.55 (s, 9H), 0.91–0.84 (m, 2H), 0.64–0.58 (m, 2H).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>tert</i>-Butyl-4-(cyclohexylmethoxy)-5-cyclopropyl-2-fluorobenzoate (<b>58</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>57</b>, compound <b>58</b> was prepared from <b>52</b> as a colorless oil (13.73 g, 88%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 12.9 Hz, 1H), 3.78 (d, <i>J</i> = 5.7 Hz, 2H), 2.07–1.98 (m, 1H), 1.92–1.69 (m, 6H), 1.56 (s, 9H), 1.39–1.02 (m, 5H), 0.93–0.85 (m, 2H), 0.67–0.61 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 387.2 (M + 39).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>tert</i>-Butyl-5-cyclopropyl-4-((4,4-difluorocyclohexyl)methoxy)-2-fluorobenzoate (<b>59</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>57</b>, compound <b>59</b> was prepared from <b>53</b> and cyclopropylboronic acid as a pale yellow oil (5.37 g, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 6.49 (d, <i>J</i> = 12.6 Hz, 1H), 3.85 (d, <i>J</i> = 5.7 Hz, 2H), 2.24–1.91 (m, 8H), 1.59–1.47 (m, 11H), 0.94–0.84 (m, 2H), 0.70–0.58 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 383.0 (M – 1).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>tert</i>-Butyl-5-cyclopropyl-4-((4,4-difluoro-1-methylcyclohexyl)-methoxy)-2-fluorobenzoate (<b>60</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>57</b>, compound <b>60</b> was prepared from <b>54</b> and cyclopropylboronic acid as a colorless oil (3.69 g, 99%). <sup>1</sup>H NMR (300 MHz,CDCl<sub>3</sub>) δ 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 12.6 Hz, 1H), 3.72 (s, 2H), 2.06–1.73 (m, 8H), 1.65–1.62 (m, 1H), 1.57 (s, 9H), 1.15 (s, 3H), 0.94–0.85 (m, 2H), 0.66–0.59 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 399.2 (M + 1).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>tert</i>-Butyl-5-cyclopropyl-4-((1-ethyl-4,4-difluorocyclohexyl)methoxy)-2-fluorobenzoate (<b>61</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>57</b>, compound <b>61</b> was prepared from <b>55</b> and cyclopropylboronic acid as a colorless oil (5.66 g, 94%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 12.6 Hz, 1H), 3.74 (s, 2H), 2.02–1.86 (m, 5H), 1.82–1.60 (m, 6H), 1.55 (s, 9H), 0.92–0.82 (m, 5H), 0.65–0.56 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 413.1 (M + 1).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>tert-</i>Butyl 5-cyclopropyl-2-fluoro-4-((1-methyl-4-(trifluoromethyl)cyclohexyl)methoxy)benzoate (<b>62</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>62</b> was prepared from <b>56</b> and cyclopropylboronic acid as a pale yellow oil (1.66 g, 96%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (d, <i>J</i> = 12.6 Hz, 1H), 3.81 (s, 2H), 2.00–1.95 (m, 3H), 1.84–1.79 (m, 2H), 1.57 (s, 9H), 1.55–1.41 (m, 3H), 1.33–1.22 (m, 2H), 1.11 (s, 3H), 0.91–0.85 (m, 2H), 0.64–0.59 (m, 2H).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-(Adamantan-1-ylmethoxy)-5-cyclopropyl-2-fluorobenzoic Acid (<b>63</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>63</b> was prepared from <b>57</b> as a colorless solid (10.1 g, 85%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s br, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (d, <i>J</i> = 13.2 Hz, 1H), 3.59 (s, 2H), 2.04–1.92 (m, 4H), 1.71–1.58 (m, 12H), 0.91–0.83 (m, 2H), 0.59–0.52 (m, 2H).</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(Cyclohexylmethoxy)-5-cyclopropyl-2-fluorobenzoic Acid (<b>64</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>64</b> was prepared from <b>58</b> as a colorless solid (6.64 g, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.79 (s br, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 6.88 (d, <i>J</i> = 13.2 Hz, 1H), 3.88 (d, <i>J</i> = 5.7 Hz, 2H), 2.06–1.96 (m, 1H), 1.86–1.62 (m, 6H), 1.34–1.02 (m, 5H), 0.93–0.85 (m, 2H), 0.62–0.55 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 291.3 (M – 1).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 5-Cyclopropyl-4-((4,4-difluorocyclohexyl)-methoxy)-2-fluorobenzoic Acid (<b>65</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>65</b> was prepared from <b>59</b> as a colorless solid (2.29 g, 50%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (s br, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 6.91 (d, <i>J</i> = 13.2 Hz, 1H), 3.96 (d, <i>J</i> = 6.0 Hz, 2H), 2.10–1.74 (m, 8H), 1.47–1.33 (m, 2H), 0.92–0.84 (m, 2H), 0.61–0.54 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 329.1 (M + 1).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 5-Cyclopropyl-4-((4,4-difluoro-1-methylcyclohexyl)methoxy)-2-fluorobenzoic Acid (<b>66</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>66</b> was prepared from <b>60</b> as a colorless solid (2.74 g, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 6.57 (d, <i>J</i> = 12.9 Hz, 1H), 3.75 (s, 2H), 2.08–1.75 (m, 7H), 1.66–1.55 (m, 2H), 1.16 (s, 3H), 0.97–0.88 (m, 2H), 0.68–0.61 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 343.2 (M + 1).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 5-Cyclopropyl-4-((1-ethyl-4,4-difluorocyclohexyl)methoxy)-2-fluorobenzoic Acid (<b>67</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>67</b> was prepared from <b>61</b> as a colorless solid (3.497 g, 72%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.31 (s br, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 1H), 6.57 (d, <i>J</i> = 12.6 Hz, 1H), 3.77 (s, 2H), 2.02–1.85 (m, 5H), 1.82–1.57 (m, 6H), 0.96–0.84 (m, 5H), 0.67–0.59 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 357.2 (M + 1).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-Cyclopropyl-2-fluoro-4-((1-methyl-4-(trifluoromethyl)cyclohexyl)methoxy)benzoic Acid (<b>68</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>47</b>, compound <b>68</b> was prepared from <b>62</b> as a colorless solid (1.30 g, 81%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.84 (s br, 1H), 7.33 (d, <i>J</i> = 8.5 Hz, 1H), 7.02 (d, <i>J</i> = 13.2 Hz, 1H), 3.92 (s, 2H), 2.26–2.20 (m, 1H), 2.04–1.95 (m, 1H), 1.87–1.83 (m, 2H), 1.72–1.67 (m, 2H), 1.54–1.41 (m, 2H), 1.34–1.23 (m, 2H), 1.05 (s, 3H), 0.91–0.85 (m, 2H), 0.60–0.55 (m, 2H). MS (ES−) <i>m</i>/<i>z</i>: 373.2 (M – 1).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>tert</i>-Butyl-5-chloro-2-fluoro-4-((8-methyl-1,4-dioxaspiro[4.5]decan-8-yl)methoxy)benzoate (<b>69</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>45</b>, compound <b>69</b> was prepared from <b>44</b> and (8-methyl-1,4-dioxaspiro[4.5]decan-8-yl)methanol as a colorless oil (5.13 g, 54%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.87 (d, <i>J</i> = 7.9 Hz, 1H), 6.62 (d, <i>J</i> = 12.3 Hz, 1H), 3.95 (s, 4H), 3.74 (s, 2H), 1.76–1.60 (m, 8H), 1.58 (s, 9H), 1.15 (s, 3H). MS (ES+) <i>m</i>/<i>z</i>: 359.1 (M – 55).</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>tert</i>-Butyl-5-cyclopropyl-2-fluoro-4-((8-methyl-1,4-dioxaspiro[4.5]decan-8-yl)methoxy)benzoate (<b>70</b>)</h4><div class="NLM_p last">Using a method analogous to the preparation of <b>57</b>, compound <b>70</b> was prepared from <b>69</b> and cyclopropylboronic acid as a colorless oil (2.59 g, 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 6.50 (d, <i>J</i> = 12.7 Hz, 1H), 3.95 (s, 4H), 3.71 (s, 2H), 2.05–1.94 (m, 1H), 1.77–1.60 (m, 8H), 1.57 (s, 9H), 1.14 (s, 3H), 0.93–0.85 (m, 2H), 0.65–0.59 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 365.2 (M – 55).</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>tert</i>-Butyl-5-cyclopropyl-2-fluoro-4-((1-methyl-4-oxocyclohexyl)methoxy)benzoate (<b>71</b>)</h4><div class="NLM_p last">To a solution of <b>70</b> (2.59 g, 6.16 mmol) in THF (6 mL) and H<sub>2</sub>O (4.3 mL) was added TFA (2.2 mL). After stirring at room temperature for 18 h, the reaction was quenched by the addition of a 2 M aqueous NaOH solution (15 mL) and then extracted with EtOAc (3 × 50 mL). The combined organic extract was washed with H<sub>2</sub>O and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 0–15% EtOAc in hexanes to afford <b>71</b> as a colorless oil (2.09 g, 90%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 6.53 (d, <i>J</i> = 12.5 Hz, 1H), 3.82 (s, 2H), 2.56–2.36 (m, 4H), 2.05–1.78 (m, 5H), 1.57 (s, 9H), 1.30 (s, 3H), 0.92–0.86 (m, 2H), 0.65–0.60 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 321.2 (M – 55).</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>tert</i>-Butyl-5-cyclopropyl-2-fluoro-4-((1-methyl-4-methylenecyclohexyl)methoxy)benzoate (<b>72</b>)</h4><div class="NLM_p last">To a cooled (−20 °C) suspension of methyltriphenylphosphonium bromide (1.44 g, 4.02 mmol) in THF (12 mL) was added LiHMDS (1.0 M solution in THF, 4.0 mL, 4.00 mmol). After stirring at −20 °C for 90 min, a solution of <b>71</b> (1.00 g, 2.68 mmol) in THF (6 mL) was added. The reaction mixture was slowly warmed to room temperature, stirred for 12 h, quenched by the addition of saturated aqueous NH<sub>4</sub>Cl solution (20 mL), and diluted with ethyl acetate (100 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (3 × 30 mL). The combined organic extract was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 0–5% EtOAc in hexanes to afford <b>72</b> as a colorless oil (0.83 g, 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 6.51 (d, <i>J</i> = 12.7 Hz, 1H), 4.65 (s, 2H), 3.71 (s, 2H), 2.30–2.15 (m, 4H), 2.05–1.93 (m, 1H), 1.68–1.50 (m, 13H), 1.15 (s, 3H), 0.93–0.86 (m, 2H), 0.66–0.60 (m, 2H). MS (ES+) <i>m</i>/<i>z</i>: 319.1 (M – 55).</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>tert</i>-Butyl-5-cyclopropyl-2-fluoro-4-((6-methylspiro[2.5]octan-6-yl)methoxy)benzoate (<b>73</b>)</h4><div class="NLM_p last">To a cooled (0 °C) solution of <b>72</b> (0.30 g, 0.80 mmol) and chloroiodomethane (0.21 mL, 2.65 mmol) in 1,2-dichloroethane (2 mL) was added diethylzinc (1.0 M solution in hexanes, 1.33 mL, 1.33 mmol). After stirring at 0 °C for 2 h, the reaction was quenched by the addition of a 1 N HCl solution (5 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic extract was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography eluted with a gradient of 0–5% EtOAc in hexanes to afford <b>73</b> as a colorless oil (0.29 g, 93%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 8.5 Hz, 1H), 6.52 (d, <i>J</i> = 12.8 Hz, 1H), 3.72 (s, 2H), 2.09–1.94 (m, 1H), 1.73–1.42 (m, 14H), 1.19–1.03 (m, 5H), 0.97–0.84 (m, 3H), 0.70–0.59 (m, 2H), 0.33–0.16 (m, 4H). MS (ES+) <i>m</i>/<i>z</i>: 333.2 (M – 55).</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 5-Cyclopropyl-2-fluoro-4-((6-methylspiro[2.5]octan-6-yl)methoxy)benzoic Acid (<b>74</b>)</h4><div class="NLM_p last">To a cooled (0 °C) solution of <b>73</b> (0.28 g, 0.71 mmol) and anisole (0.11 mL, 1.07 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added TFA (0.75 mL, 9.61 mmol). After stirring for 4 h at 0 °C, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and washed with H<sub>2</sub>O (5 × 10 mL) until the last wash was neutral as monitored by pH paper. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> sulfate and filtered. The filtrate was concentrated in vacuo to afford <b>74</b> as a colorless solid (0.21 g, 90%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.48 (d, <i>J</i> = 8.5 Hz, 1H), 6.55 (d, <i>J</i> = 13.0 Hz, 1H), 3.71 (s, 2H), 2.08–1.90 (m, 1H), 1.78–1.38 (m, 6H), 1.17–1.02 (m, 4H), 0.95–0.80 (m, 3H), 0.68–0.56 (m, 2H), 0.33–0.13 (m, 4H). MS (ES−) <i>m</i>/<i>z</i>: 331.3 (M – 1).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Molecular Modeling</h3><div class="NLM_p last">Induced fit docking of compound <b>7</b> to the hNa<sub>V</sub>1.7 VSD4 active site: using the X-ray structure of Na<sub>V</sub>1.7<sup>26</sup> as the source, chain B of the protein was first isolated and prepped using the Protein Preparation Wizard.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Compound <b>7</b> was docked into the VSD4 active site via induced fit docking<a onclick="showRef(event, 'cit46b ref47'); return false;" href="javascript:void(0);" class="ref cit46b ref47">(46b,47)</a> using default settings, which optimized side chains within 5 Å of the ligand in addition to docking. The centroid of the cocrystal structure ligand <b>GX-936</b> was used as the center of the grid box. A single receptor-ligand model was chosen from the resulting set through visual inspection. Compound <b>7</b> was then minimized in the active site.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Use of Animal Subjects</h3><div class="NLM_p last">All studies involving animals were either approved by the Animal Care Committee of Xenon Pharmaceuticals (Burnaby, BC, Canada) and performed in compliance with the Canadian Council on Animal Care guidelines (mouse efficacy and mouse PK studies) or approved by and conformed to the guidelines and principles set by the Institutional Animal Care and Use Committee of Genentech.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01621" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01621" class="ext-link">10.1021/acs.jmedchem.8b01621</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Description of in vitro biological assays, in vivo rodent pain assays, acute dissociation of mouse DRG neuron and patch clamp recording, CEREP screening data for compound <b>33</b>, <sup>1</sup>H NMR spectra of compounds <b>7–33</b>, HPLC purity data for compounds <b>7</b>, <b>20</b>, <b>26</b>, <b>30</b>, and <b>33</b>, and experimental procedure and small-molecule X-ray coordinates for compound <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv">jm8b01621_si_001.csv (3.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_002.pdf">jm8b01621_si_002.pdf (1.43 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01621" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel F. Ortwine</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#37584543405e5952195356595e525b77505259521954585a"><span class="__cf_email__" data-cfemail="91fee3e5e6f8fff4bff5f0fff8f4fdd1f6f4fff4bff2fefc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph M. Dehnhardt</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5213-6354" title="Orcid link">http://orcid.org/0000-0001-5213-6354</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b484f4e4345434a594f5f6b534e454445065b434a59464a"><span class="__cf_email__" data-cfemail="066562636e686e67746272467e636869682b766e67746b67">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaoyi Sun</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Jia</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alla Y. Zenova</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael S. Wilson</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sultan Chowdhury</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span>; 
    <span>Present Address:
                        Syrachem Sciences Inc., 7600 Glover Road, Langley, British Columbia V2Y 1Y1, Canada (S.C.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thilo Focken</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1993-2476" title="Orcid link">http://orcid.org/0000-0003-1993-2476</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Li</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shannon Decker</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael E. Grimwood</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Andrez</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan Hemeon</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Sheng</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span>; 
    <span>Present Address:
                        Inception Sciences Canada, 887 Great Northern Way, Suite 210, Vancouver, British Columbia V5T 4T5, Canada (T.S.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chien-An Chen</span> - <span class="hlFld-Affiliation affiliation">ChemPartner, Building No. 5, 998 Halei Road,
Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span>; 
    <span>Present Address:
                        WuXi AppTec Co., Ltd., 288 FuTe Zhong Road, Shanghai 200131, P. R. China (C.-A.C.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy White</span> - <span class="hlFld-Affiliation affiliation">ChemPartner, Building No. 5, 998 Halei Road,
Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, P. R. China</span>; 
    <span>Present Address:
                        College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109-1065, United States (A.W.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Hackos</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lunbin Deng</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Girish Bankar</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuldip Khakh</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elaine Chang</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainbow Kwan</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophia Lin</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Nelkenbrecher</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin D. Sellers</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4194-1240" title="Orcid link">http://orcid.org/0000-0002-4194-1240</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio G. DiPasquale</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae Chang</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jodie Pang</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis Sojo</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Lindgren</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Waldbrook</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiwei Xie</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clint Young</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James P. Johnson</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. Lee Robinette</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles J. Cohen</span> - <span class="hlFld-Affiliation affiliation">Xenon
Pharmaceuticals Inc., 200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian S. Safina</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8134-9949" title="Orcid link">http://orcid.org/0000-0001-8134-9949</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Sutherlin</span> - <span class="hlFld-Affiliation affiliation">Genentech
Inc., 1 DNA Way, South San Francisco, California 94080-4990, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6367-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Eric Kam for assistance in the preparation of compounds <b>9</b>, <b>12</b>, and <b>13</b>; Noah Stuart and Sam Goodchild for additional EP data; and Rhena Yoo for assistance in ligand binding assay test. They also thank Bruce Roth, Tarek S. Mansour, Renata M. Oballa, and the Xenon-Genentech JRC for their leadership and support. In addition, they thank James Empfield and Steven Wesolowski for helpful revisions of this manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">CIP</td><td class="NLM_def"><p class="first last">congenital insensitivity to pain</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal concentration</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term">CL<sub>hep</sub></td><td class="NLM_def"><p class="first last">hepatic clearance</p></td></tr><tr><td class="NLM_term">cLogP</td><td class="NLM_def"><p class="first last">calculated logarithm of partition coefficient</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochromes P450</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EP</td><td class="NLM_def"><p class="first last">electrophysiology</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">IEM</td><td class="NLM_def"><p class="first last">inherited erythromelalgia</p></td></tr><tr><td class="NLM_term">LBA</td><td class="NLM_def"><p class="first last">ligand binding assay</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">0.5% w/w methylcellulose and 0.2% v/v Tween-80 in water</p></td></tr><tr><td class="NLM_term">MDCKI</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell line I</p></td></tr><tr><td class="NLM_term">MDRI</td><td class="NLM_def"><p class="first last">multidrug-resistant protein I, also refer to P-glycoprotein</p></td></tr><tr><td class="NLM_term">MetID</td><td class="NLM_def"><p class="first last">metabolite identification</p></td></tr><tr><td class="NLM_term">mLogD</td><td class="NLM_def"><p class="first last">measured distribution coefficient at pH 7.2</p></td></tr><tr><td class="NLM_term">Na<sub>V</sub>1.7</td><td class="NLM_def"><p class="first last">voltage-gated sodium channel type 7</p></td></tr><tr><td class="NLM_term">Na<sub>V</sub>1.5</td><td class="NLM_def"><p class="first last">voltage-gated sodium channel type 5</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SCN9A</td><td class="NLM_def"><p class="first last">gene encoding the sodium channel NaV1.7</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">terminal half-life</p></td></tr><tr><td class="NLM_term">VSD4</td><td class="NLM_def"><p class="first last">voltage sensing domain 4</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulroy, M. F.</span></span> <span> </span><span class="NLM_article-title">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span>. <i>Reg. Anesth. Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1053/rapm.2002.37127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1053%2Frapm.2002.37127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=12430104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=556-561&author=M.+F.+Mulroy&title=Systemic+toxicity+and+cardiotoxicity+from+local+anesthetics%3A+incidence+and+preventive+measures&doi=10.1053%2Frapm.2002.37127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span></div><div class="casAuthors">Mulroy, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Regional Anesthesia and Pain Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-561</span>CODEN:
                <span class="NLM_cas:coden">RAPMFX</span>;
        ISSN:<span class="NLM_cas:issn">1098-7339</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Central nervous system toxicity from unintentionally high blood levels has been a significant concern and risk with local anesthetics since their discovery.  Cardiotoxicity assocd. with toxic blood levels of long-acting local anesthetics has heightened concern about systemic blood levels in the last 20 yr.  This review will discuss the apparent incidence of systemic toxicity, the situations in which it occurs, some of the other risks of regional anesthesia, and appropriate safety steps to reduce the frequency of both systemic reactions and cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMkLHgF6vjrVg90H21EOLACvtfcHk0ljnN8LOEGckkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D&md5=6ddb4d2bbba7485049e85a3f8df71038</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1053%2Frapm.2002.37127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Frapm.2002.37127%26sid%3Dliteratum%253Aachs%26aulast%3DMulroy%26aufirst%3DM.%2BF.%26atitle%3DSystemic%2520toxicity%2520and%2520cardiotoxicity%2520from%2520local%2520anesthetics%253A%2520incidence%2520and%2520preventive%2520measures%26jtitle%3DReg.%2520Anesth.%2520Pain%2520Med.%26date%3D2002%26volume%3D27%26spage%3D556%26epage%3D561%26doi%3D10.1053%2Frapm.2002.37127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walia, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Y. N.</span></span> <span> </span><span class="NLM_article-title">Side effects of antiepileptics – a review</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1533-2500.2004.04304.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1533-2500.2004.04304.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17173601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=194-203&author=K.+S.+Waliaauthor=E.+A.+Khanauthor=D.+H.+Koauthor=S.+S.+Razaauthor=Y.+N.+Khan&title=Side+effects+of+antiepileptics+%E2%80%93+a+review&doi=10.1111%2Fj.1533-2500.2004.04304.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Side effects of antiepileptics--a review</span></div><div class="casAuthors">Walia Kulbir S; Khan Elizabeth A; Ko Dong H; Raza Shariq S; Khan Yasin N</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-203</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Older generation antiepileptic drugs like Phenobarbital (Luminal), carbamazepine (Tegretol), phenytoin (Dilantin), and valproic acid (Depakote) have several shortcomings such as suboptimal response rates, significant adverse effects, several drug interactions, and a narrow therapeutic index.  New antiepileptic drugs have been developed in the last decade to overcome some of these problems.  These newer generation antiepileptics like felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), tiagabine (Gabitril), topiramate (Topamax), and zonisamide (Zonegran) have better tolerability profiles, low interaction potential, and significantly less enzyme inducing or inhibiting properties.  As the use of antiepileptic drugs has expanded to include treatment of neuropathic pain, newer side effects have been reported.  In addition to the common side effects of antiepileptic drugs, like dizziness, drowsiness, and mental slowing; other side effects like weight gain, metabolic acidosis, nephrolithiasis, angle closure glaucoma, skin rash, hepatotoxicity, colitis, and movement and behavioral disorders, to name a few, have been brought to our attention.  This review is an attempt to highlight the features and incidences of some of these side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq8w-gtiU7_bYtC3U5jeOifW6udTcc2ebEPNIXSFdLKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D&md5=0bd5221a573a26194b0ea14116d9ce7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1533-2500.2004.04304.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1533-2500.2004.04304.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalia%26aufirst%3DK.%2BS.%26aulast%3DKhan%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DD.%2BH.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKhan%26aufirst%3DY.%2BN.%26atitle%3DSide%2520effects%2520of%2520antiepileptics%2520%25E2%2580%2593%2520a%2520review%26jtitle%3DPain%2520Pract.%26date%3D2004%26volume%3D4%26spage%3D194%26epage%3D203%26doi%3D10.1111%2Fj.1533-2500.2004.04304.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattachacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span> <span> </span><span class="NLM_article-title">Sodium channel blockers for the treatment of neuropathic pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/j.nurt.2009.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.nurt.2009.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19789071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=663-678&author=A.+Bhattachacharyaauthor=A.+D.+Wickendenauthor=S.+R.+Chaplan&title=Sodium+channel+blockers+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.nurt.2009.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachacharya%26aufirst%3DA.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26atitle%3DSodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D663%26epage%3D678%26doi%3D10.1016%2Fj.nurt.2009.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">From genes to pain: Na<sub>V</sub>1.7 and human pain disorders</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2007.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.tins.2007.08.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=555-563&author=S.+D.+Dib-Hajjauthor=T.+R.+Cumminsauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=From+genes+to+pain%3A+NaV1.7+and+human+pain+disorders&doi=10.1016%2Fj.tins.2007.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2007.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2007.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DFrom%2520genes%2520to%2520pain%253A%2520NaV1.7%2520and%2520human%2520pain%2520disorders%26jtitle%3DTrends%2520Neurosci.%26date%3D2007%26volume%3D30%26spage%3D555%26epage%3D563%26doi%3D10.1016%2Fj.tins.2007.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lhDUr8Y7hSV2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamponi, G. W.</span></span> <span> </span><span class="NLM_article-title">Regulating excitability of peripheral afferents: emerging ion channel targets</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1038/nn.3602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnn.3602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=24473263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlemtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=153-163&author=S.+G.+Waxmanauthor=G.+W.+Zamponi&title=Regulating+excitability+of+peripheral+afferents%3A+emerging+ion+channel+targets&doi=10.1038%2Fnn.3602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating excitability of peripheral afferents: emerging ion channel targets</span></div><div class="casAuthors">Waxman, Stephen G.; Zamponi, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The transmission and processing of pain signals relies critically on the activities of ion channels that are expressed in afferent pain fibers.  This includes voltage-gated channels, as well as background (or leak) channels that collectively regulate resting membrane potential and action potential firing properties.  Dysregulated ion channel expression in response to nerve injury and inflammation results in enhanced neuronal excitability that underlies chronic neuropathic and inflammatory pain.  Pharmacol. modulators of ion channels, particularly those that target channels on peripheral neurons, are being pursued as possible analgesics.  Over the past few years, a no. of different types of ion channels have been implicated in afferent pain signaling.  Here we give an overview of recent advances on sodium, calcium, potassium and chloride channels that are emerging as esp. attractive targets for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b-g0NGYOYrVg90H21EOLACvtfcHk0liLskFYA9SFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlemtbo%253D&md5=bc89fb490f383cdbca7ed272213d4494</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnn.3602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3602%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DZamponi%26aufirst%3DG.%2BW.%26atitle%3DRegulating%2520excitability%2520of%2520peripheral%2520afferents%253A%2520emerging%2520ion%2520channel%2520targets%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D153%26epage%3D163%26doi%3D10.1038%2Fnn.3602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasako, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaklander, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span> <span> </span><span class="NLM_article-title">Congenital insensitivity to pain: an update</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(02)00482-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2FS0304-3959%2802%2900482-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=12583863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fntlygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2003&pages=213-219&author=E.+M.+Nagasakoauthor=A.+L.+Oaklanderauthor=R.+H.+Dworkin&title=Congenital+insensitivity+to+pain%3A+an+update&doi=10.1016%2FS0304-3959%2802%2900482-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Congenital insensitivity to pain: an update</span></div><div class="casAuthors">Nagasako Elna M; Oaklander Anne Louise; Dworkin Robert H</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-9</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBp-x8XzwmS-_Q9URG6Dx8fW6udTcc2earVE28j3AwULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fntlygug%253D%253D&md5=9f0657d750e7a7fb2a8178a11f1113a6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2802%2900482-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252802%252900482-7%26sid%3Dliteratum%253Aachs%26aulast%3DNagasako%26aufirst%3DE.%2BM.%26aulast%3DOaklander%26aufirst%3DA.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26atitle%3DCongenital%2520insensitivity%2520to%2520pain%253A%2520an%2520update%26jtitle%3DPain%26date%3D2003%26volume%3D101%26spage%3D213%26epage%3D219%26doi%3D10.1016%2FS0304-3959%2802%2900482-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicolasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0liLskFYA9SFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oves, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ovesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eakaW8bCM8_nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DOves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellgren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morinville, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynoschek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupp, J. J.</span></span> <span> </span><span class="NLM_article-title">A stop codon mutation in SCN9A causes lack of pain sensation</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2114</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddm160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1093%2Fhmg%2Fddm160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17597096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2114-2121&author=S.+Ahmadauthor=L.+Dahllundauthor=A.+B.+Erikssonauthor=D.+Hellgrenauthor=U.+Karlssonauthor=P.-E.+Lundauthor=I.+A.+Meijerauthor=L.+Meuryauthor=T.+Millsauthor=A.+Moodyauthor=A.+Morinvilleauthor=J.+Mortenauthor=D.+O%E2%80%99Donnellauthor=C.+Raynoschekauthor=H.+Salterauthor=G.+A.+Rouleauauthor=J.+J.+Krupp&title=A+stop+codon+mutation+in+SCN9A+causes+lack+of+pain+sensation&doi=10.1093%2Fhmg%2Fddm160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A stop codon mutation in SCN9A causes lack of pain sensation</span></div><div class="casAuthors">Ahmad, Sultan; Dahllund, Leif; Eriksson, Anders B.; Hellgren, Dennis; Karlsson, Urban; Lund, Per-Eric; Meijer, Inge A.; Meury, Luc; Mills, Tracy; Moody, Adrian; Morinville, Anne; Morten, John; O'Donnell, Dajan; Raynoschek, Carina; Salter, Hugh; Rouleau, Guy A.; Krupp, Johannes J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2114-2121</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The general lack of pain experience is a rare occurrence in humans, and the mol. causes for this phenotype are not well understood.  Here we have studied a Canadian family from Newfoundland with members who exhibit a congenital inability to experience pain.  We have mapped the locus to a 13.7 Mb region on chromosome 2q (2q24.3-2q31.1).  Screening of candidate genes in this region identified a protein-truncating mutation in SCN9A, which encodes for the voltage-gated sodium channel Nav1.7.  The mutation is a C-A transversion at nucleotide 984 transforming the codon for tyrosine 328 to a stop codon.  The predicted product lacks all pore-forming regions of Nav1.7.  Indeed, expression of this altered gene in a cell line did not produce functional responses, nor did it cause compensatory effects on endogenous voltage-gated sodium currents when expressed in ND7/23 cells.  Because a homozygous knockout of Nav1.7 in mice has been shown to be lethal, we explored why a deficiency of Nav1.7 is non-lethal in humans.  Expression studies in monkey, human, mouse and rat tissue indicated species-differences in the Nav1.7 expression profile.  Whereas in rodents the channel was strongly expressed in hypothalamic nuclei, only weak mRNA levels were detected in this area in primates.  Furthermore, primate pituitary and adrenal glands were devoid of signal, whereas these two glands were mRNA-pos. in rodents.  This species difference may explain the non-lethality of the obsd. mutation in humans.  Our data further establish Nav1.7 as a crit. element of peripheral nociception in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-UExUOmeYrVg90H21EOLACvtfcHk0lj0ki7S0RMMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D&md5=4800e0aee1230c46ada3e29e551b1833</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm160%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDahllund%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DHellgren%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DU.%26aulast%3DLund%26aufirst%3DP.-E.%26aulast%3DMeijer%26aufirst%3DI.%2BA.%26aulast%3DMeury%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DT.%26aulast%3DMoody%26aufirst%3DA.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DMorten%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DRaynoschek%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DRouleau%26aufirst%3DG.%2BA.%26aulast%3DKrupp%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520stop%2520codon%2520mutation%2520in%2520SCN9A%2520causes%2520lack%2520of%2520pain%2520sensation%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D2114%26epage%3D2121%26doi%3D10.1093%2Fhmg%2Fddm160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellgren, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebuchennykh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasly, J.</span></span> <span> </span><span class="NLM_article-title">Two novel SCN9A mutations causing insensitivity to pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.pain.2009.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19304393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=155-158&author=K.+B.+Nilsenauthor=A.+K.+Nicholasauthor=C.+G.+Woodsauthor=S.+I.+Mellgrenauthor=M.+Nebuchennykhauthor=J.+Aasly&title=Two+novel+SCN9A+mutations+causing+insensitivity+to+pain&doi=10.1016%2Fj.pain.2009.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel SCN9A mutations causing insensitivity to pain</span></div><div class="casAuthors">Nilsen, K. B.; Nicholas, A. K.; Woods, C. G.; Mellgren, S. I.; Nebuchennykh, M.; Aasly, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-158</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The sensation of pain is important and there may be serious consequences if it is missing.  Recently, the genetic basis for a channelopathy characterised by a congenital inability to experience pain has been described and channelopathy-assocd. insensitivity to pain has been proposed as a suitable name for this condition.  Different mutations in the SCN9A gene causing loss of function of the voltage-gated sodium channel Nav1.7 have been reported in patients with this rare disease.  Here we describe a woman with insensitivity to pain with two novel mutations in the SCN9A gene, coding for the Nav1.7 channel.  We also discuss the finding of anosmia which apparently is a common feature in these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCKc-xMMonrVg90H21EOLACvtfcHk0lj0ki7S0RMMPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2msrg%253D&md5=ab329cd3892ba364968c99ef503ee0e4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DK.%2BB.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DMellgren%26aufirst%3DS.%2BI.%26aulast%3DNebuchennykh%26aufirst%3DM.%26aulast%3DAasly%26aufirst%3DJ.%26atitle%3DTwo%2520novel%2520SCN9A%2520mutations%2520causing%2520insensitivity%2520to%2520pain%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D155%26epage%3D158%26doi%3D10.1016%2Fj.pain.2009.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheynin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholasm, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubovic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baralle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraige, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvari, R.</span></span> <span> </span><span class="NLM_article-title">Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">E1670</span>– <span class="NLM_lpage">E1686</span>, <span class="refDoi"> DOI: 10.1002/humu.21325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fhumu.21325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=20635406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=E1670-E1686&author=J.+J.+Coxauthor=J.+Sheyninauthor=Z.+Shorerauthor=F.+Reimannauthor=A.+K.+Nicholasmauthor=L.+Zubovicauthor=M.+Baralleauthor=E.+Wraigeauthor=E.+Manorauthor=J.+Levyauthor=C.+G.+Woodsauthor=R.+Parvari&title=Congenital+insensitivity+to+pain%3A+novel+SCN9A+missense+and+in-frame+deletion+mutations&doi=10.1002%2Fhumu.21325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations</span></div><div class="casAuthors">Cox, James J.; Sheynin, Jony; Shorer, Zamir; Reimann, Frank; Nicholas, Adeline K.; Zubovic, Lorena; Baralle, Marco; Wraige, Elizabeth; Manor, Esther; Levy, Jacov; Woods, C. Geoffrey; Parvari, Ruti</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1670-e1686</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">SCN9A encodes the voltage-gated sodium channel Nav1.7, a protein highly expressed in pain-sensing neurons.  Mutations in SCN9A cause three human pain disorders: bi-allelic loss of function mutations result in Channelopathy-assocd. Insensitivity to Pain (CIP), whereas activating mutations cause severe episodic pain in Paroxysmal Extreme Pain Disorder (PEPD) and Primary Erythermalgia (PE).  To date, all mutations in SCN9A that cause a complete inability to experience pain are protein truncating and presumably lead to no protein being produced.  Here, we describe the identification and functional characterization of two novel non-truncating mutations in families with CIP: a homozygously-inherited missense mutation found in a consanguineous Israeli Bedouin family (Nav1.7-R896Q) and a five amino acid in-frame deletion found in a sporadic compd. heterozygote (Nav1.7-ΔR1370-L1374).  Both of these mutations map to the pore region of the Nav1.7 sodium channel.  Using transient transfection of PC12 cells we found a significant redn. in membrane localization of the mutant protein compared to the wild type.  Furthermore, voltage clamp expts. of mutant-transfected HEK293 cells show a complete loss of function of the sodium channel, consistent with the absence of pain phenotype.  In summary, this study has identified crit. amino acids needed for the normal subcellular localization and function of Nav1.7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrOjG6MZDj4rVg90H21EOLACvtfcHk0lgWezH-FQtEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqtLrL&md5=59caf383a04ef957ca0c0aa74e7d753b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhumu.21325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.21325%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DSheynin%26aufirst%3DJ.%26aulast%3DShorer%26aufirst%3DZ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholasm%26aufirst%3DA.%2BK.%26aulast%3DZubovic%26aufirst%3DL.%26aulast%3DBaralle%26aufirst%3DM.%26aulast%3DWraige%26aufirst%3DE.%26aulast%3DManor%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DParvari%26aufirst%3DR.%26atitle%3DCongenital%2520insensitivity%2520to%2520pain%253A%2520novel%2520SCN9A%2520missense%2520and%2520in-frame%2520deletion%2520mutations%26jtitle%3DHum.%2520Mutat.%26date%3D2010%26volume%3D31%26spage%3DE1670%26epage%3DE1686%26doi%3D10.1002%2Fhumu.21325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanova-Mihaylova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S. M.</span></span> <span> </span><span class="NLM_article-title">SCN9A-associated congenital insensitivity to pain and anosmia in an Irish patient</span>. <i>J. Peripher. Nerv. Syst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1111/jns.12123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fjns.12123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26292973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC287ltVWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=86-87&author=P.+Bogdanova-Mihaylovaauthor=M.+D.+Alexanderauthor=R.+P.+J.+Murphyauthor=S.+M.+Murphy&title=SCN9A-associated+congenital+insensitivity+to+pain+and+anosmia+in+an+Irish+patient&doi=10.1111%2Fjns.12123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A-associated congenital insensitivity to pain and anosmia in an Irish patient</span></div><div class="casAuthors">Bogdanova-Mihaylova Petya; Murphy Raymond P J; Murphy Sinead M; Alexander Michael D; Murphy Sinead M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the peripheral nervous system : JPNS</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTNt9w0am7_iA3UY9EwTNrfW6udTcc2ebLbjAEiHV-zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ltVWitg%253D%253D&md5=3e91ae04a0da63eeab0de470d39c04c5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fjns.12123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjns.12123%26sid%3Dliteratum%253Aachs%26aulast%3DBogdanova-Mihaylova%26aufirst%3DP.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DMurphy%26aufirst%3DR.%2BP.%2BJ.%26aulast%3DMurphy%26aufirst%3DS.%2BM.%26atitle%3DSCN9A-associated%2520congenital%2520insensitivity%2520to%2520pain%2520and%2520anosmia%2520in%2520an%2520Irish%2520patient%26jtitle%3DJ.%2520Peripher.%2520Nerv.%2520Syst.%26date%3D2015%26volume%3D20%26spage%3D86%26epage%3D87%26doi%3D10.1111%2Fjns.12123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breedveld, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heutink, P.</span></span> <span> </span><span class="NLM_article-title">The primary erythemyalgia-susceptibility gene is located on chromosome 2q31-32</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1282</span>, <span class="refDoi"> DOI: 10.1086/320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1086%2F320107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=11283792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvF2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2001&pages=1277-1282&author=J.+P.+Drenthauthor=W.+H.+Finleyauthor=G.+L.+Breedveldauthor=L.+Testersauthor=J.+J.+Michielsauthor=G.+Guilletauthor=A.+Taiebauthor=R.+L.+Kirbyauthor=P.+Heutink&title=The+primary+erythemyalgia-susceptibility+gene+is+located+on+chromosome+2q31-32&doi=10.1086%2F320107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32</span></div><div class="casAuthors">Drenth, Joost P. H.; Finley, Wayne H.; Breedveld, Guido J.; Testers, Leon; Michiels, Jan J.; Guillet, G.; Taieb, Alain; Kirby, R. Lee; Heutink, Peter</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1277-1282</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm, and painful hands and/or feet.  The symptoms are generally refractory to treatment and persist throughout life.  5 Kindreds with multiple cases of primary erythermalgia were identified, and the largest was subjected to a genomewide search.  We detected strong evidence for linkage of the primary erythermalgia locus to markers from chromosome 2q.  The highest LOD score (Z) was obtained with D2S2330 (Zmax = 6.51).  Anal. of recombination events identified D2S2370 and D2S1776 as flanking markers, on chromosome 2q31-32.  This defines a crit. interval of 7.94 cM that harbors the primary erythermalgia gene.  Affected members within the addnl. families also shared a common haplotype on chromosome 2q31-32, supporting our linkage results.  Identification of the primary erythermalgia gene will allow a better clin. classification of this pleomorphic group of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIafRc7tMRbVg90H21EOLACvtfcHk0lgWezH-FQtEmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvF2nu7o%253D&md5=80afefeb67ffe1ac4f0a00d438e24608</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1086%2F320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F320107%26sid%3Dliteratum%253Aachs%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DFinley%26aufirst%3DW.%2BH.%26aulast%3DBreedveld%26aufirst%3DG.%2BL.%26aulast%3DTesters%26aufirst%3DL.%26aulast%3DMichiels%26aufirst%3DJ.%2BJ.%26aulast%3DGuillet%26aufirst%3DG.%26aulast%3DTaieb%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DR.%2BL.%26aulast%3DHeutink%26aufirst%3DP.%26atitle%3DThe%2520primary%2520erythemyalgia-susceptibility%2520gene%2520is%2520located%2520on%2520chromosome%25202q31-32%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D68%26spage%3D1277%26epage%3D1282%26doi%3D10.1086%2F320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xe, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>SCN9A</i>, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xeauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lh3nQfMHZkHsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXe%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisama, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function mutation in Na<sub>V</sub>1.7 in familial erythromelalgia induces bursting of sensory neurons</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1093/brain/awh514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1093%2Fbrain%2Fawh514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=15958509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1847-1854&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=F.+M.+Hisamaauthor=S.+Novellaauthor=L.+Tyrrellauthor=L.+Marshallauthor=S.+G.+Waxman&title=Gain-of-function+mutation+in+NaV1.7+in+familial+erythromelalgia+induces+bursting+of+sensory+neurons&doi=10.1093%2Fbrain%2Fawh514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons</span></div><div class="casAuthors">Dib-Hajj S D; Rush A M; Cummins T R; Hisama F M; Novella S; Tyrrell L; Marshall L; Waxman S G</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1847-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Erythromelalgia is an autosomal dominant disorder characterized by burning pain in response to warm stimuli or moderate exercise.  We describe a novel mutation in a family with erythromelalgia in SCN9A, the gene that encodes the Na(v)1.7 sodium channel.  Na(v)1.7 produces threshold currents and is selectively expressed within sensory neurons including nociceptors.  We demonstrate that this mutation, which produces a hyperpolarizing shift in activation and a depolarizing shift in steady-state inactivation, lowers thresholds for single action potentials and high frequency firing in dorsal root ganglion neurons.  Erythromelalgia is the first inherited pain disorder in which it is possible to link a mutation with an abnormality in ion channel function and with altered firing of pain signalling neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfGPgL4LrC-0VfW6udTcc2ea82aDp4qJxr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D&md5=6befcde7de47dd574901a333c2f14909</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh514%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DHisama%26aufirst%3DF.%2BM.%26aulast%3DNovella%26aufirst%3DS.%26aulast%3DTyrrell%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DGain-of-function%2520mutation%2520in%2520NaV1.7%2520in%2520familial%2520erythromelalgia%2520induces%2520bursting%2520of%2520sensory%2520neurons%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1847%26epage%3D1854%26doi%3D10.1093%2Fbrain%2Fawh514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Mutation in the sodium channel Na<sub>V</sub>1.7 underlie inherited erythromelalgia</span>. <i>Drug Discovery Today: Dis. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.ddmec.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.ddmec.2006.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=343-350&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=S.+G.+Waxman&title=Mutation+in+the+sodium+channel+NaV1.7+underlie+inherited+erythromelalgia&doi=10.1016%2Fj.ddmec.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMutation%2520in%2520the%2520sodium%2520channel%2520NaV1.7%2520underlie%2520inherited%2520erythromelalgia%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2006%26volume%3D3%26spage%3D343%26epage%3D350%26doi%3D10.1016%2Fj.ddmec.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title"><i>SCN9A</i> mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lg4BrvvXVfeWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+Na%CE%BD1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0lg4BrvvXVfeWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520Na%25CE%25BD1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asghari-Roodsari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. L.</span></span> <span> </span><span class="NLM_article-title">Cardiac sodium channelopathies</span>. <i>Pflugers Arch.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1007/s00424-009-0761-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs00424-009-0761-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=20091048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC3cvps1Kgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2010&pages=223-237&author=A.+S.+Aminauthor=A.+Asghari-Roodsariauthor=H.+L.+Tan&title=Cardiac+sodium+channelopathies&doi=10.1007%2Fs00424-009-0761-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac sodium channelopathies</span></div><div class="casAuthors">Amin Ahmad S; Asghari-Roodsari Alaleh; Tan Hanno L</div><div class="citationInfo"><span class="NLM_cas:title">Pflugers Archiv : European journal of physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cardiac sodium channel are protein complexes that are expressed in the sarcolemma of cardiomyocytes to carry a large inward depolarizing current (INa) during phase 0 of the cardiac action potential.  The importance of INa for normal cardiac electrical activity is reflected by the high incidence of arrhythmias in cardiac sodium channelopathies, i.e., arrhythmogenic diseases in patients with mutations in SCN5A, the gene responsible for the pore-forming ion-conducting alpha-subunit, or in genes that encode the ancillary beta-subunits or regulatory proteins of the cardiac sodium channel.  While clinical and genetic studies have laid the foundation for our understanding of cardiac sodium channelopathies by establishing links between arrhythmogenic diseases and mutations in genes that encode various subunits of the cardiac sodium channel, biophysical studies (particularly in heterologous expression systems and transgenic mouse models) have provided insights into the mechanisms by which INa dysfunction causes disease in such channelopathies.  It is now recognized that mutations that increase INa delay cardiac repolarization, prolong action potential duration, and cause long QT syndrome, while mutations that reduce INa decrease cardiac excitability, reduce electrical conduction velocity, and induce Brugada syndrome, progressive cardiac conduction disease, sick sinus syndrome, or combinations thereof.  Recently, mutation-induced INa dysfunction was also linked to dilated cardiomyopathy, atrial fibrillation, and sudden infant death syndrome.  This review describes the structure and function of the cardiac sodium channel and its various subunits, summarizes major cardiac sodium channelopathies and the current knowledge concerning their genetic background and underlying molecular mechanisms, and discusses recent advances in the discovery of mutation-specific therapies in the management of these channelopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3D1Kd32EnTX6CEoQgWY10fW6udTcc2ebyNH3ym4cn3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvps1Kgug%253D%253D&md5=cad45f34d71373258332117f8c9af527</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0761-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0761-0%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BS.%26aulast%3DAsghari-Roodsari%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DH.%2BL.%26atitle%3DCardiac%2520sodium%2520channelopathies%26jtitle%3DPflugers%2520Arch.%26date%3D2010%26volume%3D460%26spage%3D223%26epage%3D237%26doi%3D10.1007%2Fs00424-009-0761-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage-gated sodium channels with small molecules</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=22945552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage-gated+sodium+channels+with+small+molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules</span></div><div class="casAuthors">Nardi, Antonio; Damann, Nils; Hertrampf, Torsten; Kless, Achim</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1712-1740</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blockade of voltage-gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathol. firing patterns that occur in conditions as diverse as chronic pain, epilepsy, and arrhythmias.  Herein we review the state of the art in marketed sodium channel inhibitors, including a brief compendium of their binding sites and of the cellular and mol. biol. of sodium channels.  Despite the preferential action of this drug class toward over-excited cells, which significantly limits potential undesired side effects on other cells, the need to develop a second generation of sodium channel inhibitors to overcome their crit. clin. shortcomings is apparent.  Current approaches in drug discovery to deliver novel and truly innovative sodium channel inhibitors is next presented by surveying the most recent medicinal chem. breakthroughs in the field of small mols. and developments in automated patch-clamp platforms.  Various strategies aimed at identifying small mols. that target either particular isoforms of sodium channels involved in specific diseases or anomalous sodium channel currents, irresp. of the isoform by which they have been generated, are critically discussed and revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25xI9xQpdebVg90H21EOLACvtfcHk0lg4BrvvXVfeWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN&md5=a4072539ac2084d994eb4a2143844d3c</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage-gated%2520sodium%2520channels%2520with%2520small%2520molecules%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lgltZ1S2F_qGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lgltZ1S2F_qGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+Structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lgltZ1S2F_qGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lhh17G8zuZ0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0ljdvdmdEjyNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surujbally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of the Na<sub>V</sub>1.7 blocker PF-05089771 in a randomized, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1476</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000001227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1097%2Fj.pain.0000000000001227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29578944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=1465-1476&author=A.+McDonnellauthor=S.+Collinsauthor=Z.+Aliauthor=L.+Iavaroneauthor=R.+Surujballyauthor=S.+Kirbyauthor=R.+P.+Butt&title=Efficacy+of+the+NaV1.7+blocker+PF-05089771+in+a+randomized%2C+placebo-controlled%2C+double-blind+clinical+study+in+subjects+with+painful+diabetic+peripheral+neuropathy&doi=10.1097%2Fj.pain.0000000000001227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span></div><div class="casAuthors">McDonnell, Aoibhinn; Collins, Susie; Ali, Zahid; Iavarone, Laura; Surujbally, Raulin; Kirby, Simon; Butt, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1465-1476</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The effect of PF-05089771, a selective, peripherally restricted Nav1.7 sodium channel blocker on pain due to diabetic peripheral neuropathy was investigated in a randomised, placebo and active-controlled parallel group clin. trial (NCT02215252).  A 1-wk placebo-run in the period was followed by a 4-wk treatment period and a 1-wk placebo run-out/taper-down period.  Single-blind placebo was administered throughout run-in and run-out periods.  Subjects were randomised to receive either PF-05089771 150 mg twice daily, pregabalin 150 mg twice daily, or placebo during the 4-wk treatment period.  One hundred thirty-five subjects were randomised.  The primary endpoint was the av. pain score derived from subjects' Numerical Rating Scale scores over the past 7 days of week 4 of the double-blind treatment period.  Predefined efficacy criteria for the trial were the effect of PF-05089771 being >0.5 units better than placebo at interim anal. after completion of the first part of the study.  Although a trend for a redn. in the weekly av. pain score in the PF-05089771 treatment group was obsd., this was not statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.41 (90% credible interval: -1.00 to 0.17).  The effect of PF-05089771 was smaller than that seen with pregabalin, which was statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.53 (90% credible interval: -0.91 to -0.20).  As predefined efficacy criteria were not met, the study did not proceed to the second part.  PF-05089771 was well tolerated.  Possible reasons for the modest efficacy obsd. with PF-05089771 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiEsCT64-q7Vg90H21EOLACvtfcHk0ljdvdmdEjyNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM&md5=61d83a34d992b85b828cea56f0a4f7b9</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000001227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000001227%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DSurujbally%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DR.%2BP.%26atitle%3DEfficacy%2520of%2520the%2520NaV1.7%2520blocker%2520PF-05089771%2520in%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520clinical%2520study%2520in%2520subjects%2520with%2520painful%2520diabetic%2520peripheral%2520neuropathy%26jtitle%3DPain%26date%3D2018%26volume%3D159%26spage%3D1465%26epage%3D1476%26doi%3D10.1097%2Fj.pain.0000000000001227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0ljdvdmdEjyNZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=77-82&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D77%26epage%3D82%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.</span></span> <span> </span><span class="NLM_article-title">Design of conformationally constrained acyl sulfonamide isosteres: Identification of <i>N</i>-([1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methane-sulfonamides as potent and selective <i>h</i>Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4810</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01826</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01826" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4810-4831&author=T.+Fockenauthor=S.+Chowdhuryauthor=A.+Zenovaauthor=M.+Grimwoodauthor=C.+Chabotauthor=T.+Shengauthor=I.+Hemeonauthor=S.+Deckerauthor=M.+Wilsonauthor=P.+Bichlerauthor=Q.+Jiaauthor=S.+Sunauthor=C.+Youngauthor=S.+Linauthor=S.+J.+Goodchildauthor=N.+G.+Shuartauthor=E.+Changauthor=Z.+Xieauthor=B.+Liauthor=K.+Khakhauthor=G.+Bankarauthor=M.+Waldbrookauthor=R.+Kwanauthor=K.+Nelkenbrecherauthor=P.+K.+Tariauthor=N.+Chahalauthor=L.+Sojoauthor=L.+Robinetteauthor=A.+Whiteauthor=C.+Chenauthor=Y.+Zhangauthor=J.+Pangauthor=J.+H.+Changauthor=D.+Hackosauthor=J.+P.+Johnsonauthor=C.+J.+Cohenauthor=D.+Ortwineauthor=D.+Sutherlinauthor=C.+Dehnhardtauthor=B.+Safina&title=Design+of+conformationally+constrained+acyl+sulfonamide+isosteres%3A+Identification+of+N-%28%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridin-3-yl%29methane-sulfonamides+as+potent+and+selective+hNaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.7b01826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Focken, Thilo; Chowdhury, Sultan; Zenova, Alla; Grimwood, Michael E.; Chabot, Christine; Sheng, Tao; Hemeon, Ivan; Decker, Shannon M.; Wilson, Michael; Bichler, Paul; Jia, Qi; Sun, Shaoyi; Young, Clint; Lin, Sophia; Goodchild, Samuel J.; Shuart, Noah G.; Chang, Elaine; Xie, Zhiwei; Li, Bowen; Khakh, Kuldip; Bankar, Girish; Waldbrook, Matthew; Kwan, Rainbow; Nelkenbrecher, Karen; Karimi Tari, Parisa; Chahal, Navjot; Sojo, Luis; Robinette, C. Lee; White, Andrew D.; Chen, Chien-An; Zhang, Yi; Pang, Jodie; Chang, Jae H.; Hackos, David H.; Johnson, J. P.; Cohen, Charles J.; Ortwine, Daniel F.; Sutherlin, Daniel P.; Dehnhardt, Christoph M.; Safina, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4810-4831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception.  In recent years, a no. of aryl and acyl sulfonamides have been reported as potent inhibitors of NaV1.7, with high selectivity over the cardiac isoform NaV1.5.  Herein, we report on the discovery of a novel series of N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as selective NaV1.7 inhibitors.  Starting with the crystal structure of an acyl sulfonamide, we rationalized that cyclization to form a fused heterocycle would improve physicochem. properties, in particular lipophilicity.  Our design strategy focused on optimization of potency for block of NaV1.7 and human metabolic stability.  Lead compds. I (R1 = cPr, R2 = Me), I (R1 = cPr, R2 = cPr) (GNE-131), and II showed excellent potency, good in vitro metabolic stability, and low in vivo clearance in mouse, rat, and dog.  Compd. I (R1 = cPr, R2 = cPr) also displayed excellent efficacy in a transgenic mouse model of induced pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXjwguDi_ClbVg90H21EOLACvtfcHk0liqBjJa0tkosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWit78%253D&md5=90523ea6500363ed8efd4112d644f3b6</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%2BG.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DTari%26aufirst%3DP.%2BK.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DRobinette%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DSafina%26aufirst%3DB.%26atitle%3DDesign%2520of%2520conformationally%2520constrained%2520acyl%2520sulfonamide%2520isosteres%253A%2520Identification%2520of%2520N-%2528%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methane-sulfonamides%2520as%2520potent%2520and%2520selective%2520hNaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4810%26epage%3D4831%26doi%3D10.1021%2Facs.jmedchem.7b01826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E.
F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.%0AF.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0liqBjJa0tkosg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lhwfN6PwBJ1pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lhwfN6PwBJ1pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+Activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0liT4bzFvINfYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: Tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.+J.+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+Tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0liT4bzFvINfYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520Tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0liphb5GgUxCCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of non-zwitterionic aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+non-zwitterionic+aryl+sulfonamides+as+NaV1.7+inhibitors+with+efficacy+in+preclinical+behavioral+models+and+translational+measures+of+nociceptive+neuron+activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0liphb5GgUxCCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520non-zwitterionic%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%2520with%2520efficacy%2520in%2520preclinical%2520behavioral%2520models%2520and%2520translational%2520measures%2520of%2520nociceptive%2520neuron%2520activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, <i>N</i>-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0lg6DR7VTNH_tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in <i>vivo</i> efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0lg6DR7VTNH_tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as hNa<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0lgJk0VOCHVHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNa<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0lgJk0VOCHVHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukundl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriverl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aac5464</span> <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=S.+Ahujaauthor=S.+Mukundlauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverlauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukundl%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriverl%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span>; <span class="NLM_string-name">Laufer-Sweiler, M. C.</span>; <span class="NLM_string-name">Markworth, C. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Reister, S. M.</span>; <span class="NLM_string-name">Sasaki, K.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span>; <span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT International Application <span class="NLM_patent">WO2010079443</span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Beaudoin&author=M.+C.+Laufer-Sweiler&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=S.+M.+Reister&author=K.+Sasaki&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaudoin%26aufirst%3DS.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span>; <span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012004706</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012004714</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Greener&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreener%26aufirst%3DB.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Ryckmans, T.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Benzenesulfonamides Useful As Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012004743</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=M.+J.+de+Groot&author=B.+E.+Marron&author=D.+J.+Rawson&author=T.+Ryckmans&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&title=Benzenesulfonamides+Useful+As+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DBenzenesulfonamides%2520Useful%2520As%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Gaulier, S. M.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Sulfonamide Derivatives Useful as Voltage Gated Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012007861</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+de+Groot&author=S.+M.+Gaulier&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=P.+M.+Perez&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=N-Sulfonamide+Derivatives+Useful+as+Voltage+Gated+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DN-Sulfonamide%2520Derivatives%2520Useful%2520as%2520Voltage%2520Gated%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007868</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007869</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007877</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=R.+A.+Lewthwaite&author=P.+M.+Perez&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives as Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span>. PCT International Application <span class="NLM_patent">WO2012007883</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+de+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=P.+M.+Perez&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&title=Sulfonamide+Derivatives+as+NaV1.7+Inhibitors+for+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DSulfonamide%2520Derivatives%2520as%2520NaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Indazole Derivatives as Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012095781</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=M.+J.+de+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=Indazole+Derivatives+as+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DIndazole%2520Derivatives%2520as%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT International Application <span class="NLM_patent">WO2013088315</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives and use Thereof as VGSC Inhibitors</span>. <span class="NLM_patent">WO2013093688</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+I.+Storer&author=N.+A.+Swain&title=Sulfonamide+Derivatives+and+use+Thereof+as+VGSC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26atitle%3DSulfonamide%2520Derivatives%2520and%2520use%2520Thereof%2520as%2520VGSC%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Galan, S. R. G.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Aminosulfonyl Benzamides</span>. PCT International Application <span class="NLM_patent">WO2013102826</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+D.+Brown&author=S.+R.+G.+Galan&author=D.+S.+Millan&author=D.+J.+Rawson&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&title=N-Aminosulfonyl+Benzamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DN-Aminosulfonyl%2520Benzamides%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Both series displayed the same average LLE of 2.5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lj2IOvuF6XBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability–are too many aromatic rings a liability in drug design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1011</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%93are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lj2IOvuF6XBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2593are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span> <span> </span><span class="NLM_article-title">Prediction of aqueous solubility of organic compounds by topological descriptors</span>. <i>QSAR Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1002/qsar.200330822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fqsar.200330822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWgsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=821-829&author=A.+Yanauthor=J.+Gasteiger&title=Prediction+of+aqueous+solubility+of+organic+compounds+by+topological+descriptors&doi=10.1002%2Fqsar.200330822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of aqueous solubility of organic compounds by topological descriptors</span></div><div class="casAuthors">Yan, Aixia; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">QSAR & Combinatorial Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">821-829</span>CODEN:
                <span class="NLM_cas:coden">QCSSAU</span>;
        ISSN:<span class="NLM_cas:issn">1611-020X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two quant. models for the prediction of aq. soly. of 1293 org. compds. were generated by a Multilinear Regression (MLR) anal., and a Backpropagation (BPG) neural network.  The mols. were represented by 18 topol. descriptors.  The physicochem. relation between soly. and the descriptors for different individual classes of monofunctional group compds. such as hydrocarbons, ethers, halocarbons, alcs., aldehydes and ketones, acids, esters, and amines was studied.  The 1293 compds. were divided into a training set of 741 compds. and a test set of 552 compds. based on a Kohonen's self-organizing neural network map.  The models obtained show a good predictive power: for the test set, a correlation coeff. of 0.97 and a std. deviation of 0.52 were achieved by the backpropagation neural network approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjxmnjMpbJ7Vg90H21EOLACvtfcHk0lj2IOvuF6XBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWgsbjM&md5=a787dd158657ac4f404947077197b215</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fqsar.200330822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.200330822%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DA.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DPrediction%2520of%2520aqueous%2520solubility%2520of%2520organic%2520compounds%2520by%2520topological%2520descriptors%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2003%26volume%3D22%26spage%3D821%26epage%3D829%26doi%3D10.1002%2Fqsar.200330822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The holding potential was chosen to produce optimal potent block. Drug effects at physiological relevant voltages would be half as potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C</span>; <span class="NLM_string-name">Chowdhury, S.</span>; <span class="NLM_string-name">Decker, S.</span>; <span class="NLM_string-name">Dehnhardt, C. M.</span>; <span class="NLM_string-name">Focken, T.</span>; <span class="NLM_string-name">Grimwood, M. E.</span>; <span class="NLM_string-name">Hemeon, I. W.</span>; <span class="NLM_string-name">Jia, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Ortwine, D. F.</span>; <span class="NLM_string-name">Safina, B. S.</span>; <span class="NLM_string-name">Sheng, T.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Wilson, M. S.</span>; <span class="NLM_string-name">Zenova, A. Y.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Substituted Benzamides and Their Use in the Treatment of Pain</span>. PCT International Application <span class="NLM_patent">WO2013177224A1</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-C+Andrez&author=S.+Chowdhury&author=S.+Decker&author=C.+M.+Dehnhardt&author=T.+Focken&author=M.+E.+Grimwood&author=I.+W.+Hemeon&author=Q.+Jia&author=J.+Li&author=D.+F.+Ortwine&author=B.+S.+Safina&author=T.+Sheng&author=S.+Sun&author=D.+P.+Sutherlin&author=M.+S.+Wilson&author=A.+Y.+Zenova&title=N-Substituted+Benzamides+and+Their+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrez%26aufirst%3DJ.-C%26atitle%3DN-Substituted%2520Benzamides%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5560</span>– <span class="NLM_lpage">5564</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.%0AW.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span> <span> </span><span class="NLM_article-title">Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1016/s0065-7743(10)45023-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fs0065-7743%2810%2945023-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.%0AP.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+ligand+lipophilicity+efficiency+in+addressing+drug+safety+risks&doi=10.1016%2Fs0065-7743%2810%2945023-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1016%2Fs0065-7743%2810%2945023-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0065-7743%252810%252945023-x%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520ligand%2520lipophilicity%2520efficiency%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391%26doi%3D10.1016%2Fs0065-7743%2810%2945023-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lg2n-r69V1yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lg2n-r69V1yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kümmerle, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, C. A. M.</span></span> <span> </span><span class="NLM_article-title">The methylation effect in medicinal chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">5215</span>– <span class="NLM_lpage">5246</span>, <span class="refDoi"> DOI: 10.1021/cr200060g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200060g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5215-5246&author=E.%0AJ.+Barreiroauthor=A.+E.+K%C3%BCmmerleauthor=C.+A.+M.+Fraga&title=The+methylation+effect+in+medicinal+chemistry&doi=10.1021%2Fcr200060g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">The Methylation Effect in Medicinal Chemistry</span></div><div class="casAuthors">Barreiro, Eliezer J.; Kummerle, Arthur E.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5215-5246</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this review, we aimed to highlight the importance of the simple Me group as a very useful structural modification in the rational design of bioactive compds. and drugs.  We selected different examples from distinct classes of org. compds. with several pharmacol. properties in order to illustrate that an apparent subtle mol. modification can strongly alter the biol. profile of a drug.  The Me effect alter both biol. phases of a drug, represented by its pharmacodynamic and pharmacokinetc profile, due to the modifications introduced in the stereoeletronic properties.  In fact, it was illustrated that distinct metabolic behavior or receptor affinity could be modified by the Me effect.  Among the examples included many other important ones could be used, such as the importance of the Me in modified the bioprofile of Ph ethanolamines with differentiation in the mol. recognition pattern among different adrenergic receptor subtypes.  The introduction of an simple extra Me connected to the N-alkylpiperidine moiety present in PDE5 inhibitor raisng the discovery of me-too drug vardenafil for erectile dysfunction.  In fact, the correct use of this strategy for mol. modification and design of drugs or drug-candidate compds. may be useful from both a pharmacokinetic and a pharmacodynamic point of view, representing an important tool for the medicinal chemist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx5w0XiOyJ7bVg90H21EOLACvtfcHk0lh0ujQN_6v71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChsrk%253D&md5=1cfdacf68ea53408c0f671a1dffb6d3a</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Fcr200060g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200060g%26sid%3Dliteratum%253Aachs%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DK%25C3%25BCmmerle%26aufirst%3DA.%2BE.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DThe%2520methylation%2520effect%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5215%26epage%3D5246%26doi%3D10.1021%2Fcr200060g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schönherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new C–H methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12256</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&author=H.+Sch%C3%B6nherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C%E2%80%93H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span></div><div class="casAuthors">Schonherr Heike; Cernak Tim</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12256-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The methyl group is one of the most commonly occurring carbon fragments in small-molecule drugs.  This simplest alkyl fragment appears in more than 67 % of the top-selling drugs of 2011 and can modulate both the biological and physical properties of a molecule.  This Review focuses on so-called magic methyl effects on binding potency, where the seemingly mundane change of C H to C Me improves the IC50  value of a drug candidate more than 100-fold.  This discussion is followed by a survey of recent advances in synthetic chemistry that allow the direct methylation of C(sp(2) ) H and C(sp(3) ) H bonds.  It is our hope that the relevance of the meager methyl group to drug discovery as presented herein will inspire reports on new C H methylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyoLZDDgvsMh0LsK7uFuY7fW6udTcc2eYSnTCKbat3Jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D&md5=ef08f80e55b2c530b49e4306da024902</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C%25E2%2580%2593H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dourado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective Na<sub>V</sub>1.7 antagonists with long residence time show improved efficacy against inflammatory and neuropathic pain</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3145</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.08.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.celrep.2018.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=30231997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3133-3145&author=G.+Bankarauthor=S.+Howardauthor=K.+Nelkenbrecherauthor=M.+Waldbrookauthor=M.+Douradoauthor=S.+J.+Goodchildauthor=N.+Shuartauthor=S.+Linauthor=C.+Youngauthor=Z.+Xieauthor=K.+Khakhauthor=E.+Changauthor=L.+E.+Sojoauthor=A.+Lindgrenauthor=S.+Chowdhuryauthor=S.+Deckerauthor=M.+Grimwoodauthor=J.+C.+Andrezauthor=C.+M.+Dehnhardtauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=D.+H.+Hackosauthor=C.+L.+Robinetteauthor=C.+J.+Cohen&title=Selective+NaV1.7+antagonists+with+long+residence+time+show+improved+efficacy+against+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.celrep.2018.08.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain</span></div><div class="casAuthors">Bankar, Girish; Goodchild, Samuel J.; Howard, Sarah; Nelkenbrecher, Karen; Waldbrook, Matthew; Dourado, Michelle; Shuart, Noah G.; Lin, Sophia; Young, Clint; Xie, Zhiwei; Khakh, Kuldip; Chang, Elaine; Sojo, Luis E.; Lindgren, Andrea; Chowdhury, Sultan; Decker, Shannon; Grimwood, Michael; Andrez, Jean-Christophe; Dehnhardt, Christoph M.; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, James P. Jr.; Hackos, David H.; Robinette, C. Lee; Cohen, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3133-3145</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Selective block of NaV1.7 promises to produce non-narcotic analgesic activity without motor or cognitive impairment.  Several NaV1.7-selective blockers have been reported, but efficacy in animal pain models required high multiples of the IC50 for channel block.  Here, we report a target engagement assay using transgenic mice that has enabled the development of a second generation of selective Nav1.7 inhibitors that show robust analgesic activity in inflammatory and neuropathic pain models at low multiples of the IC50.  Like earlier arylsulfonamides, these newer acylsulfonamides target a binding site on the surface of voltage sensor domain 4 to achieve high selectivity among sodium channel isoforms and steeply state-dependent block.  The improved efficacy correlates with very slow dissocn. from the target channel.  Chronic dosing increases compd. potency about 10-fold, possibly due to reversal of sensitization arising during chronic injury, and provides efficacy that persists long after the compd. has cleared from plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ByCcGmC1abVg90H21EOLACvtfcHk0lh0ujQN_6v71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnur3J&md5=f84e48e3e176446f3134d04dae1ac605</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DDourado%26aufirst%3DM.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DAndrez%26aufirst%3DJ.%2BC.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520NaV1.7%2520antagonists%2520with%2520long%2520residence%2520time%2520show%2520improved%2520efficacy%2520against%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D24%26spage%3D3133%26epage%3D3145%26doi%3D10.1016%2Fj.celrep.2018.08.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osoegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frengen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catanese, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P.</span></span> <span> </span><span class="NLM_article-title">An improved approach for construction of bacterial artificial chromosome libraries</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1006/geno.1998.5423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1006%2Fgeno.1998.5423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9740665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1998&pages=1-8&author=K.+Osoegawaauthor=P.+Y.+Woonauthor=B.+Zhaoauthor=E.+Frengenauthor=M.+Tatenoauthor=J.+J.+Cataneseauthor=P.+de+Jong&title=An+improved+approach+for+construction+of+bacterial+artificial+chromosome+libraries&doi=10.1006%2Fgeno.1998.5423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An improved approach for construction of bacterial artificial chromosome libraries</span></div><div class="casAuthors">Osoegawa, Kazutoyo; Woon, Peng Yeong; Zhao, Baohui; Frengen, Eirik; Tateno, Minako; Catanese, Joseph J.; De Jong, Pieter J.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Presented here are improved methodologies that enable the generation of highly redundant bacterial artificial chromosome/P1-derived artificial chromosome libraries, with larger and relatively uniform insert sizes.  Improvements in vector prepn. and enhanced ligation conditions reduce the no. of background nonrecombinant clones.  Preelectrophoresis of immobilized high-mol.-wt. DNA removes inhibitors of the cloning process, while sizing DNA fragments twice within a single gel effectively eliminates small restriction fragments, thus increasing the av. insert size of the clones.  The size-fractionated DNA fragments are recovered by electroelution rather than the more common melting of gel slices with subsequent β-agarase treatment.  Concn.of the ligation products yields a 6- to 12-fold redn. in the no. of electroporations required in prepg. a library of desirable size.  These improved methods have been applied to prep. PAC and BAC libraries from the human murine, rat, canine, and baboon genomes with av. insert sizes ranging between 160 and 235 kb.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEr_poMXX_bVg90H21EOLACvtfcHk0lhLS-IJhbvCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlamtr4%253D&md5=dc3022e1fe5b366db7ceac27b2d36c59</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1998.5423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1998.5423%26sid%3Dliteratum%253Aachs%26aulast%3DOsoegawa%26aufirst%3DK.%26aulast%3DWoon%26aufirst%3DP.%2BY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DFrengen%26aufirst%3DE.%26aulast%3DTateno%26aufirst%3DM.%26aulast%3DCatanese%26aufirst%3DJ.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DP.%26atitle%3DAn%2520improved%2520approach%2520for%2520construction%2520of%2520bacterial%2520artificial%2520chromosome%2520libraries%26jtitle%3DGenomics%26date%3D1998%26volume%3D52%26spage%3D1%26epage%3D8%26doi%3D10.1006%2Fgeno.1998.5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-177&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine%2C+and+brain+stem+stimulation+in+rats+and+cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lhLS-IJhbvCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%252C%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D177%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCumber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathbun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkmus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, M. C.</span></span> <span> </span><span class="NLM_article-title">An automated flinch detecting system for use in the formalin nociceptive. bioassay</span>. <i>J. Appl. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">2386</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1152/jappl.2001.90.6.2386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1152%2Fjappl.2001.90.6.2386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=2386-2402&author=T.+L.+Yakshauthor=G.+Ozakiauthor=D.+McCumberauthor=M.+Rathbunauthor=C.+Svenssonauthor=S.+Malkmusauthor=M.+C.+Yaksh&title=An+automated+flinch+detecting+system+for+use+in+the+formalin+nociceptive.+bioassay&doi=10.1152%2Fjappl.2001.90.6.2386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1152%2Fjappl.2001.90.6.2386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjappl.2001.90.6.2386%26sid%3Dliteratum%253Aachs%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26aulast%3DOzaki%26aufirst%3DG.%26aulast%3DMcCumber%26aufirst%3DD.%26aulast%3DRathbun%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DMalkmus%26aufirst%3DS.%26aulast%3DYaksh%26aufirst%3DM.%2BC.%26atitle%3DAn%2520automated%2520flinch%2520detecting%2520system%2520for%2520use%2520in%2520the%2520formalin%2520nociceptive.%2520bioassay%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2001%26volume%3D90%26spage%3D2386%26epage%3D2402%26doi%3D10.1152%2Fjappl.2001.90.6.2386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(96)03285-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2FS0304-3959%2896%2903285-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9060019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=101-110&author=C.+Abbadieauthor=B.+K.+Taylorauthor=M.+A.+Petersonauthor=A.+I.+Basbaum&title=differential+contribution+of+the+two+phases+of+the+formalin+test+to+the+pattern+of+c-fos+expression+in+the+rat+spinal+cord%3A+studies+with+remifentanil+and+lidocain&doi=10.1016%2FS0304-3959%2896%2903285-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine</span></div><div class="casAuthors">Abbadie, Catherine; Taylor, Bradley K.; Peterson, M. Alex; Basbaum, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Injection of formalin in the rat hindpaw produces two phases of nociceptive behavior.  Although it is generally agreed that the first phase results from direct chem. activation of nociceptive primary afferent fibers, the factors that contribute to the second phase are not established.  In the present study, we monitored the expression of the c-fos protein to evaluate whether the pattern of activity of dorsal horn neurons differs as a result of ongoing afferent activity during the two phases.  To selectively block the first or second phase, we resp. used remifentanil, a potent and short acting opiate agonist, and QX-314, a quaternary deriv. of lidocaine, which does not cross the blood brain barrier.  We also evaluated the effect of eliminating nociceptive behavior in both phases using both remifentanil and lidocaine or a combination of local anesthetics, bupivacaine and quaternary lidocaine.  In all groups, formalin (5%, 50 μl) was injected s.c. into the plantar surface of the hindpaw.  To assess the nociceptive behavior produced by formalin, we monitored the no. of flinches.  Injection of remifentanil during the first phase completely blocked the first phase formalin-evoked nociceptive behavior, and had no effect on the second phase.  Injection of lidocaine during the interphase completely blocked second phase nociceptive behavior.  As expected, when remifentanil was administered during the first phase and lidocaine during the second phase, all formalin-evoked nociceptive behavior was blocked.  The same was true for rats that received injections of bupivacaine and lidocaine during phases 1 and 2, resp.  In laminae I-II of the L4-L5 segment, the magnitude of the decrease in Fos expression was comparable for remifentanil (26.5%) and lidocaine (27.3%); the decrease was greater when both remifentanil and lidocaine were administered (50.5%), and even greater when bupivacaine and lidocaine were used (74.2%).  In laminae V-VI, remifentanil, by itself, decreased c-fos expression by 39.4%; for lidocaine alone, the decrease was 58.4%.  We did not observe further significant decreases when both remifentanil and lidocaine, or bupivacaine and lidocaine were injected (69.7% and 74.6%, resp.).  Our results not only provide strong evidence that activity during the second phase is necessary for maintaining the maximal expression of c-fos in the spinal cord, but also reveal significant regional differences in the central patterns of activity generated during the two phases.  These results also confirm our previous reports that c-fos expression is not eliminated when the behavioral manifestation of the noxious stimulus is completely blocked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbT2_N8WyT_bVg90H21EOLACvtfcHk0lgR47Ju7CwD1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFSgsrk%253D&md5=41de7a4652ae9b558504e4d9d280795f</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2896%2903285-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252896%252903285-X%26sid%3Dliteratum%253Aachs%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DB.%2BK.%26aulast%3DPeterson%26aufirst%3DM.%2BA.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3Ddifferential%2520contribution%2520of%2520the%2520two%2520phases%2520of%2520the%2520formalin%2520test%2520to%2520the%2520pattern%2520of%2520c-fos%2520expression%2520in%2520the%2520rat%2520spinal%2520cord%253A%2520studies%2520with%2520remifentanil%2520and%2520lidocain%26jtitle%3DPain%26date%3D1997%26volume%3D69%26spage%3D101%26epage%3D110%26doi%3D10.1016%2FS0304-3959%2896%2903285-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Priest, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middletion, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiseter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmalhofer, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span> <span> </span><span class="NLM_article-title">A disubstituted succinamide is a Potent sodium channel blocker with efficacy in a rat pain model</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">9866</span>– <span class="NLM_lpage">9876</span>, <span class="refDoi"> DOI: 10.1021/bi0493259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0493259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFahsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9866-9876&author=B.+T.+Priestauthor=M.+L.+Garciaauthor=R.+E.+Middletionauthor=R.+M.+Brochuauthor=S.+Clarkauthor=G.+Daiauthor=I.+E.+Dickauthor=J.+P.+Felixauthor=C.+J.+Liuauthor=B.+Reiseterauthor=W.+A.+Schmalhoferauthor=P.+Shaoauthor=Y.+S.+Tangauthor=M.+Z.+Chouauthor=M.+G.+Kohlerauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Williamsauthor=C.+J.+Cohenauthor=W.+J.+Martinauthor=P.+T.+Meinkeauthor=W.+H.+Parsonsauthor=K.+A.+Waffordauthor=G.+J.+Kaczorowski&title=A+disubstituted+succinamide+is+a+Potent+sodium+channel+blocker+with+efficacy+in+a+rat+pain+model&doi=10.1021%2Fbi0493259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">A Disubstituted Succinamide Is a Potent Sodium Channel Blocker with Efficacy in a Rat Pain Model</span></div><div class="casAuthors">Priest, Birgit T.; Garcia, Maria L.; Middleton, Richard E.; Brochu, Richard M.; Clark, Samantha; Dai, Ge; Dick, Ivy E.; Felix, John P.; Liu, Chou J.; Reiseter, Brita S.; Schmalhofer, William A.; Shao, Pengcheng P.; Tang, Yui S.; Chou, Margaret Z.; Kohler, Martin G.; Smith, McHardy M.; Warren, Vivien A.; Williams, Brande S.; Cohen, Charles J.; Martin, William J.; Meinke, Peter T.; Parsons, William H.; Wafford, Keith A.; Kaczorowski, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9866-9876</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium channel blockers are used clin. to treat a no. of neuropathic pain conditions, but more potent and selective agents should improve on the therapeutic index of currently used drugs.  In a high-throughput functional assay, a novel sodium channel (NaV) blocker, N-{[2'-(aminosulfonyl)biphenyl-4-yl]methyl}-N'-(2,2'-bithien-5-ylmethyl)succinamide (BPBTS), was discovered.  BPBTS is 2 orders of magnitude more potent than anticonvulsant and antiarrhythmic sodium channel blockers currently used to treat neuropathic pain.  Resembling block by these agents, block of NaV1.2, NaV1.5, and NaV1.7 by BPBTS was voltage- and use-dependent.  BPBTS appeared to bind preferentially to open and inactivated states and caused a dose-dependent hyperpolarizing shift in the steady-state availability curves for all sodium channel subtypes tested.  The affinity of BPBTS for the resting and inactivated states of NaV1.2 was 1.2 and 0.14 μM, resp.  BPBTS blocked NaV1.7 and NaV1.2 with similar potency, whereas block of NaV1.5 was slightly more potent.  The slow tetrodotoxin-resistant Na+ current in small-diam. DRG neurons was also potently blocked by BPBTS.  [3H]BPBTS bound with high affinity to a single class of sites present in rat brain synaptosomal membranes (Kd = 6.1 nM), and in membranes derived from HEK cells stably expressing NaV1.5 (Kd = 0.9 nM).  BPBTS dose-dependently attenuated nociceptive behavior in the formalin test, a rat model of tonic pain.  On the basis of these findings, BPBTS represents a structurally novel and potent sodium channel blocker that may be used as a template for the development of analgesic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUHRgORU0r7Vg90H21EOLACvtfcHk0lgR47Ju7CwD1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFahsbY%253D&md5=1244a358dc7ee38a1fa61a0270fad4e7</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fbi0493259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0493259%26sid%3Dliteratum%253Aachs%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMiddletion%26aufirst%3DR.%2BE.%26aulast%3DBrochu%26aufirst%3DR.%2BM.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DDick%26aufirst%3DI.%2BE.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DC.%2BJ.%26aulast%3DReiseter%26aufirst%3DB.%26aulast%3DSchmalhofer%26aufirst%3DW.%2BA.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%2BS.%26aulast%3DChou%26aufirst%3DM.%2BZ.%26aulast%3DKohler%26aufirst%3DM.%2BG.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DWilliams%26aufirst%3DB.%2BS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26atitle%3DA%2520disubstituted%2520succinamide%2520is%2520a%2520Potent%2520sodium%2520channel%2520blocker%2520with%2520efficacy%2520in%2520a%2520rat%2520pain%2520model%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9866%26epage%3D9876%26doi%3D10.1021%2Fbi0493259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingfan Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hierl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janosky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilenkin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Identification of potent, state-dependent inhibitors of Na<sub>V</sub>1.7 with oral efficacy in the formalin model of persistent pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4427</span>– <span class="NLM_lpage">4445</span>, <span class="refDoi"> DOI: 10.1021/jm200018k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200018k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4427-4445&author=H.+Bregmanauthor=L.+Berryauthor=J.+L.+Buchananauthor=A.+Chenauthor=B.+Bingfan+Duauthor=E.+Fericauthor=M.+Hierlauthor=L.+Huangauthor=D.+Immkeauthor=B.+Janoskyauthor=D.+Johnsonauthor=X.+Liauthor=J.+Liguttiauthor=D.+Liuauthor=A.+Malmbergauthor=D.+Matsonauthor=J.+McDermottauthor=P.+Miuauthor=H.+N.+Nguyenauthor=V.+F.+Patelauthor=D.+Waldonauthor=B.+Wilenkinauthor=X.+Zhengauthor=A.+Zouauthor=S.+I.+McDonoughauthor=E.+F.+DiMauro&title=Identification+of+potent%2C+state-dependent+inhibitors+of+NaV1.7+with+oral+efficacy+in+the+formalin+model+of+persistent+pain&doi=10.1021%2Fjm200018k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm200018k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200018k%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBingfan%2BDu%26aufirst%3DB.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DHierl%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DImmke%26aufirst%3DD.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMalmberg%26aufirst%3DA.%26aulast%3DMatson%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMiu%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DWaldon%26aufirst%3DD.%26aulast%3DWilenkin%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DIdentification%2520of%2520potent%252C%2520state-dependent%2520inhibitors%2520of%2520NaV1.7%2520with%2520oral%2520efficacy%2520in%2520the%2520formalin%2520model%2520of%2520persistent%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4427%26epage%3D4445%26doi%3D10.1021%2Fjm200018k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Macsari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besidski, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csjernyik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yngve, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åhlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venyike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakeman, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, P. I.</span></span> <span> </span><span class="NLM_article-title">3-Oxoisoindoline-1-carboxamides: Potent, state-dependent blockers of voltage-gated sodium channel Na<sub>V</sub>1.7 with efficacy in rat pain models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6866</span>– <span class="NLM_lpage">6880</span>, <span class="refDoi"> DOI: 10.1021/jm300623u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300623u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2ju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6866-6880&author=I.+Macsariauthor=Y.+Besidskiauthor=G.+Csjernyikauthor=L.+I.+Nilssonauthor=L.+Sandbergauthor=U.+Yngveauthor=K.+%C3%85hlinauthor=T.+Buetersauthor=A.+B.+Erikssonauthor=P.-E.+Lundauthor=E.+Venyikeauthor=S.+Oertherauthor=K.+H.+Blakemanauthor=L.+Luoauthor=P.+I.+Arvidsson&title=3-Oxoisoindoline-1-carboxamides%3A+Potent%2C+state-dependent+blockers+of+voltage-gated+sodium+channel+NaV1.7+with+efficacy+in+rat+pain+models&doi=10.1021%2Fjm300623u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40cR"><div class="casContent"><span class="casTitleNuber">40c</span><div class="casTitle"><span class="NLM_cas:atitle">3-Oxoisoindoline-1-carboxamides: Potent, State-Dependent Blockers of Voltage-Gated Sodium Channel NaV1.7 with Efficacy in Rat Pain Models</span></div><div class="casAuthors">Macsari, Istvan; Besidski, Yevgeni; Csjernyik, Gabor; Nilsson, Linda I.; Sandberg, Lars; Yngve, Ulrika; Aahlin, Kristofer; Bueters, Tjerk; Eriksson, Anders B.; Lund, Per-Eric; Venyike, Elisabet; Oerther, Sandra; Hygge Blakeman, Karin; Luo, Lei; Arvidsson, Per I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6866-6880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 is believed to be a crit. mediator of pain sensation based on clin. genetic studies and pharmacol. results.  Clin. utility of nonselective sodium channel blockers is limited due to serious adverse drug effects.  Here, we present the optimization, structure-activity relationships, and in vitro and in vivo characterization of a novel series of NaV1.7 inhibitors based on the oxoisoindoline core.  Extensive studies with focus on optimization of NaV1.7 potency, selectivity over NaV1.5, and metabolic stability properties produced several interesting oxoisoindoline carboxamides (16A, 26B, 28, 51, 60, and 62) that were further characterized.  The oxoisoindoline carboxamides interacted with the local anesthetics binding site.  In spite of this, several compds. showed functional selectivity vs. NaV1.5 of more than 100-fold.  This appeared to be a combination of subtype and state-dependent selectivity.  Compd. 28 showed concn.-dependent inhibition of nerve injury-induced ectopic in an ex vivo DRG prepn. from SNL rats.  Compds. 16A and 26B demonstrated concn.-dependent efficacy in preclin. behavioral pain models.  The oxoisoindoline carboxamides series described here may be valuable for further investigations for pain therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHVyRjfbFVzrVg90H21EOLACvtfcHk0liKfZZTlIUixQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2ju7g%253D&md5=c4ffe7eeec76079250c073f764f2b7f5</span></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1021%2Fjm300623u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300623u%26sid%3Dliteratum%253Aachs%26aulast%3DMacsari%26aufirst%3DI.%26aulast%3DBesidski%26aufirst%3DY.%26aulast%3DCsjernyik%26aufirst%3DG.%26aulast%3DNilsson%26aufirst%3DL.%2BI.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DYngve%26aufirst%3DU.%26aulast%3D%25C3%2585hlin%26aufirst%3DK.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DLund%26aufirst%3DP.-E.%26aulast%3DVenyike%26aufirst%3DE.%26aulast%3DOerther%26aufirst%3DS.%26aulast%3DBlakeman%26aufirst%3DK.%2BH.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DArvidsson%26aufirst%3DP.%2BI.%26atitle%3D3-Oxoisoindoline-1-carboxamides%253A%2520Potent%252C%2520state-dependent%2520blockers%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%2520with%2520efficacy%2520in%2520rat%2520pain%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6866%26epage%3D6880%26doi%3D10.1021%2Fjm300623u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csjernyik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macsari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nylöf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skogholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venyike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besidski, Y.</span></span> <span> </span><span class="NLM_article-title">Structure and activity relationship in the (S)-<i>N</i>-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5624</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2012.06.105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5618-5624&author=I.+Kersauthor=G.+Csjernyikauthor=I.+Macsariauthor=M.+Nyl%C3%B6fauthor=L.+Sandbergauthor=K.+Skogholmauthor=T.+Buetersauthor=A.+B.+Erikssonauthor=S.+Oertherauthor=P.+Lundauthor=E.+Venyikeauthor=J.+Nystr%C3%B6mauthor=Y.+Besidski&title=Structure+and+activity+relationship+in+the+%28S%29-N-chroman-3-ylcarboxamide+series+of+voltage-gated+sodium+channel+blockers&doi=10.1016%2Fj.bmcl.2012.06.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.105%26sid%3Dliteratum%253Aachs%26aulast%3DKers%26aufirst%3DI.%26aulast%3DCsjernyik%26aufirst%3DG.%26aulast%3DMacsari%26aufirst%3DI.%26aulast%3DNyl%25C3%25B6f%26aufirst%3DM.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DSkogholm%26aufirst%3DK.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DOerther%26aufirst%3DS.%26aulast%3DLund%26aufirst%3DP.%26aulast%3DVenyike%26aufirst%3DE.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBesidski%26aufirst%3DY.%26atitle%3DStructure%2520and%2520activity%2520relationship%2520in%2520the%2520%2528S%2529-N-chroman-3-ylcarboxamide%2520series%2520of%2520voltage-gated%2520sodium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5618%26epage%3D5624%26doi%3D10.1016%2Fj.bmcl.2012.06.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel-Brehm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deranian, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span> <span> </span><span class="NLM_article-title">TRPA1 mediates formalin-induced pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">13525</span>– <span class="NLM_lpage">13530</span>, <span class="refDoi"> DOI: 10.1073/pnas.0705924104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1073%2Fpnas.0705924104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17686976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1eqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13525-13530&author=C.+R.+McNamaraauthor=J.+Mandel-Brehmauthor=D.+M.+Bautistaauthor=J.+Siemensauthor=K.+L.+Deranianauthor=M.+Zhao&title=TRPA1+mediates+formalin-induced+pain&doi=10.1073%2Fpnas.0705924104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">TRPA1 mediates formalin-induced pain</span></div><div class="casAuthors">McNamara, Colleen R.; Mandel-Brehm, Josh; Bautista, Diana M.; Siemens, Jan; Deranian, Kari L.; Zhao, Michael; Hayward, Neil J.; Chong, Jayhong A.; Julius, David; Moran, Magdalene M.; Fanger, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13525-13530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The formalin model is widely used for evaluating the effects of analgesic compds. in lab. animals.  Injection of formalin into the hind paw induces a biphasic pain response; the first phase is thought to result from direct activation of primary afferent sensory neurons, whereas the second phase has been proposed to reflect the combined effects of afferent input and central sensitization in the dorsal horn.  Here we show that formalin excites sensory neurons by directly activating transient receptor potential ion channel TRPA1, a cation channel that plays an important role in inflammatory pain.  Formalin induced robust calcium influx in cells expressing cloned or native TRPA1 channels, and these responses were attenuated by a previously undescribed TRPA1-selective antagonist.  Moreover, sensory neurons from TRPA1-deficient mice lacked formalin sensitivity.  At the behavioral level, pharmacol. blockade or genetic ablation of TRPA1 produced marked attenuation of the characteristic flinching, licking, and lifting responses resulting from intraplantar injection of formalin.  Our results show that TRPA1 is the principal site of formalin's pain-producing action in vivo, and that activation of this excitatory channel underlies the physiol. and behavioral responses assocd. with this model of pain hypersensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgRKOZy2rNILVg90H21EOLACvtfcHk0lhBfekPFisjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1eqsL8%253D&md5=2482d7b071a4eb6c3131d3d95ea05ae2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705924104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705924104%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BR.%26aulast%3DMandel-Brehm%26aufirst%3DJ.%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DSiemens%26aufirst%3DJ.%26aulast%3DDeranian%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DM.%26atitle%3DTRPA1%2520mediates%2520formalin-induced%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D13525%26epage%3D13530%26doi%3D10.1073%2Fpnas.0705924104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eZ6HrfHbXl3OLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Easy-to-execute carbonylations: microwave synthesis of acyl sulfonamides using Mo(CO)<sub>6</sub> as a solid carbon monoxide source</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/jo050080v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050080v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=3094-3098&author=X.+Wuauthor=R.+Ronnauthor=T.+Gossasauthor=M.+Larhed&title=Easy-to-execute+carbonylations%3A+microwave+synthesis+of+acyl+sulfonamides+using+Mo%28CO%296+as+a+solid+carbon+monoxide+source&doi=10.1021%2Fjo050080v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiongyu; Roenn, Robert; Gossas, Thomas; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3094-3098</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a robust palladium-catalyzed amidocarbonylation protocol for the prepn. of arom. acyl sulfonamides utilizing high-d. microwave heating is described.  This synthetic approach employs Mo(CO)6 as a convenient CO-releasing reagent and allows for the direct prepn. of acyl sulfonamides from both aryl iodides and aryl bromides.  The reactions can be performed under air, employing only 15 min of microwave irradn., to produce acyl sulfonamide derivs. in good to excellent yields.  To illustrate the usefulness of this method, we reported the synthesis of a novel hepatitis C virus NS3 protease inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp281_WOJXTW7Vg90H21EOLACvtfcHk0lhBfekPFisjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D&md5=443608fb9917b8194efc9fb778a2aede</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo050080v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050080v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DEasy-to-execute%2520carbonylations%253A%2520microwave%2520synthesis%2520of%2520acyl%2520sulfonamides%2520using%2520Mo%2528CO%25296%2520as%2520a%2520solid%2520carbon%2520monoxide%2520source%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D3094%26epage%3D3098%26doi%3D10.1021%2Fjo050080v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lhBfekPFisjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3Dpalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denmark, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span> <span> </span><span class="NLM_article-title">A comparison of (chloromethyl)- and (iodomethyl)zinc cyclopropanation reagents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6974</span>– <span class="NLM_lpage">6981</span>, <span class="refDoi"> DOI: 10.1021/jo00025a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00025a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK3MXmsl2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=6974-6981&author=S.+E.+Denmarkauthor=J.+P.+Edwards&title=A+comparison+of+%28chloromethyl%29-+and+%28iodomethyl%29zinc+cyclopropanation+reagents&doi=10.1021%2Fjo00025a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of (chloromethyl)- and (iodomethyl)zinc cyclopropanation reagents</span></div><div class="casAuthors">Denmark, Scott E.; Edwards, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6974-81</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A study comparing the rate of cyclopropanation of a range of olefins with (chloromethyl)- and (iodomethyl)zinc reagents is described.  The (chloromethyl)zinc reagent derived from diethylzinc and chloroiodomethane is generally more reactive than the (iodomethyl)zinc analog.  The use of 1,2-dichloroethane as the solvent for these reactions was a crucial factor necessary to achieve clean, rapid, high-yielding cyclopropanations.  The well-known directing effect of proximal oxygen substituents on the stereochem. outcome of Simmons-Smith cyclopropanations held for the (chloromethyl)zinc reagent as well.  The diethylzinc/chloroiodoethane reagent system in 1,2-dichloroethane should prove to be a valuable alternative to traditional (iodomethyl)zinc-based cyclopropanation reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9nyu8ULBXjrVg90H21EOLACvtfcHk0liQRZIxbH0nmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsl2jsrk%253D&md5=26396a744ad5ce598f60a4f3ab537768</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00025a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00025a007%26sid%3Dliteratum%253Aachs%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comparison%2520of%2520%2528chloromethyl%2529-%2520and%2520%2528iodomethyl%2529zinc%2520cyclopropanation%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D6974%26epage%3D6981%26doi%3D10.1021%2Fjo00025a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+Parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eZQMq7x4CSCqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520Parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note">b<p class="last">Schrödinger Release 2014-1: Schrödinger Suite 2017-4. Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY, 2017.</p></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearlstein, R. A.</span></span> <span> </span><span class="NLM_article-title">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3160</span>– <span class="NLM_lpage">3173</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmc.2005.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=16413785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3160-3173&author=R.+Faridauthor=T.+Dayauthor=R.+A.+Friesnerauthor=R.+A.+Pearlstein&title=New+insights+about+HERG+blockade+obtained+from+protein+modeling%2C+potential+energy+mapping%2C+and+docking+studies&doi=10.1016%2Fj.bmc.2005.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span></div><div class="casAuthors">Farid, Ramy; Day, Tyler; Friesner, Richard A.; Pearlstein, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3160-3173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We created a homol. model of the homo-tetrameric pore domain of HERG using the crystal structure of the bacterial potassium channel, KvAP, as a template.  We docked a set of known blockers with well-characterized effects on channel function into the lumen of the pore between the selectivity filter and extracellular entrance using a novel docking and refinement procedure incorporating Glide and Prime.  Key arom. groups of the blockers are predicted to form multiple simultaneous ring stacking and hydrophobic interactions among the eight arom. residues lining the pore.  Furthermore, each blocker can achieve these interactions via multiple docking configurations.  To further interpret the docking results, we mapped hydrophobic and hydrophilic potentials within the lumen of each refined docked complex.  Hydrophilic iso-potential contours define a 'propeller-shaped' vol. at the selectivity filter entrance.  Hydrophobic contours define a hollow 'crown-shaped' vol. located above the 'propeller', whose hydrophobic 'rim' extends along the pore axis between Tyr652 and Phe656.  Blockers adopt conformations/binding orientations that closely mimic the shapes and properties of these contours.  Blocker basic groups are localized in the hydrophilic 'propeller', forming electrostatic interactions with Ser624 rather than a generally accepted π-cation interaction with Tyr652.  Terfenadine, cisapride, sertindole, ibutilide, and clofilium adopt similar docked poses, in which their N-substituents bridge radially across the hollow interior of the 'crown' (analogous to the hub and spokes of a wheel), and project arom./hydrophobic portions into the hydrophobic 'rim'.  MK-499 docks with its longitudinal axis parallel to the axis of the pore and crown', and its hydrophobic groups buried within the hydrophobic 'rim'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1RsiljwGxrVg90H21EOLACvtfcHk0liQRZIxbH0nmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D&md5=8df638aa78d2d35337bb82d8a94357c4</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26atitle%3DNew%2520insights%2520about%2520HERG%2520blockade%2520obtained%2520from%2520protein%2520modeling%252C%2520potential%2520energy%2520mapping%252C%2520and%2520docking%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3160%26epage%3D3173%26doi%3D10.1016%2Fj.bmc.2005.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lj9wOYIliW39g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Use of an induced fit receptor structure in virtual screening</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2005.00327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1747-0285.2005.00327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=16492153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=83-84&author=W.+Shermanauthor=H.+S.+Beardauthor=R.+Farid&title=Use+of+an+induced+fit+receptor+structure+in+virtual+screening&doi=10.1111%2Fj.1747-0285.2005.00327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47cR"><div class="casContent"><span class="casTitleNuber">47c</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an induced fit receptor structure in virtual screening</span></div><div class="casAuthors">Sherman, Woody; Beard, Hege S.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-84</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The automated induced fit docking protocol was used to generate the DFG-out conformation from a p38 MAP kinase activation loop starting from a DFG-in structure (1a9u) and the ligand from 1kv1 (BMU).  In a virtual screening study of 25K decoy ligands and 46 known actives, using an ensemble consisting of the induced fit docking structure (DFG-out) and the 1a9u crystal structure (DFG-in), 14 actives were identified in the top 1% of the database, including BMU and BIRB 796.  3 Actives were identified when 1a9u was used alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PRgtFzy8u7Vg90H21EOLACvtfcHk0lj9wOYIliW39g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D&md5=efe9900aacaaea6af805c1cbdb350c73</span></div><a href="/servlet/linkout?suffix=cit47c&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00327.x%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DUse%2520of%2520an%2520induced%2520fit%2520receptor%2520structure%2520in%2520virtual%2520screening%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D83%26epage%3D84%26doi%3D10.1111%2Fj.1747-0285.2005.00327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20a','cit20b','cit20c','cit20d'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22a','cit22b','cit22c','cit22d','cit22e'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c','cit27d','cit27e','cit27f','cit27g','cit27h','cit27i','cit27j','cit27k','cit27l','cit27m'],'ref28':[],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36a','cit36b'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b','cit39c'],'ref40':['cit40a','cit40b','cit40c','cit40d'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46a'],'ref47':['cit47a','cit47b','cit47c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Anthony J. Roecker, Mark E. Layton, Joseph E. Pero, Michael J. Kelly, III, Thomas J. Greshock, Richard L. Kraus, Yuxing Li, Rebecca Klein, Michelle Clements, Christopher Daley, Aneta Jovanovska, Jeanine E. Ballard, Deping Wang, Fuqiang Zhao, Andrew P. J. Brunskill, Xuanjia Peng, Xiu Wang, Haiyan Sun, Andrea K. Houghton, <span class="NLM_string-name hlFld-ContribAuthor">Christopher S. Burgey</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 1038-1049. <a href="https://doi.org/10.1021/acsmedchemlett.1c00218" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BArylsulfonamide%252BNav1.7%252BInhibitors%25253A%252BIVIVC%25252C%252BMPO%252BMethods%25252C%252Band%252BOptimization%252Bof%252BSelectivity%252BProfile%26aulast%3DRoecker%26aufirst%3DAnthony%2BJ.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D26052021%26date%3D01062021%26volume%3D12%26issue%3D6%26spage%3D1038%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brian S. Safina, Steven J. McKerrall, Shaoyi Sun, Chien-An Chen, Sultan Chowdhury, Qi Jia, Jun Li, Alla Y. Zenova, Jean-Christophe Andrez, Girish Bankar, Philippe Bergeron, Jae H. Chang, Elaine Chang, Jun Chen, Richard Dean, Shannon M. Decker, Antonio DiPasquale, Thilo Focken, Ivan Hemeon, Kuldip Khakh, Amy Kim, Rainbow Kwan, Andrea Lindgren, Sophia Lin, Jonathan Maher, Janette Mezeyova, Dinah Misner, Karen Nelkenbrecher, Jodie Pang, Rebecca Reese, Shannon D. Shields, Luis Sojo, Tao Sheng, Henry Verschoof, Matthew Waldbrook, Michael S. Wilson, Zhiwei Xie, Clint Young, Tanja S. Zabka, David H. Hackos, Daniel F. Ortwine, Andrew D. White, J.P. Johnson, Jr., C. Lee Robinette, Christoph M. Dehnhardt, Charles J. Cohen, <span class="NLM_string-name hlFld-ContribAuthor">Daniel P. Sutherlin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 2953-2966. <a href="https://doi.org/10.1021/acs.jmedchem.1c00049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAcyl-sulfonamide%252BNav1.7%252BInhibitors%252BGDC-0276%252Band%252BGDC-0310%26aulast%3DSafina%26aufirst%3DBrian%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11012021%26date%3D08032021%26volume%3D64%26issue%3D6%26spage%3D2953%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tsuyoshi Shinozuka, Hiroyuki Kobayashi, Sayaka Suzuki, Kyosuke Tanaka, Narayan Karanjule, Noriyuki Hayashi, Toshifumi Tsuda, Eri Tokumaru, Masahiro Inoue, Kiyono Ueda, Hiroko Kimoto, Yuki Domon, Sakiko Takahashi, Kazufumi Kubota, Tomihisa Yokoyama, Akiko Shimizugawa, Ryuta Koishi, Chie Fujiwara, Daigo Asano, Tomoko Sakakura, Kiyoshi Takasuna, Yasuyuki Abe, Toshiyuki Watanabe, <span class="NLM_string-name hlFld-ContribAuthor">Yutaka Kitano</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10204-10220. <a href="https://doi.org/10.1021/acs.jmedchem.0c00259" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00259%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDS-1971a%25252C%252Ba%252BPotent%25252C%252BSelective%252BNaV1.7%252BInhibitor%26aulast%3DShinozuka%26aufirst%3DTsuyoshi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12022020%26date%3D26052020%26date%3D11052020%26volume%3D63%26issue%3D18%26spage%3D10204%26epage%3D10220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vidya Ramdas, Rashmi Talwar, Vijay Kanoje, Rajesh M. Loriya, Moloy Banerjee, Pradeep Patil, Advait Arun Joshi, Laxmikant Datrange, Amit Kumar Das, Deepak Sahebrao Walke, Vaibhav Kalhapure, Talha Khan, Ganesh Gote, Usha Dhayagude, Shreyas Deshpande, Javed Shaikh, Ganesh Chaure, Ravindra R. Pal, Santosh Parkale, Sachin Suravase, Smita Bhoskar, Rajesh V. Gupta, Anil Kalia, Rajesh Yeshodharan, Mahammad Azhar, Jagadeesh Daler, Vinod Mali, Geetika Sharma, Amitesh Kishore, Rupali Vyawahare, Gautam Agarwal, Himani Pareek, Sagar Budhe, Arun Nayak, Dnyaneshwar Warude, Praveen Kumar Gupta, Parag Joshi, Sneha Joshi, Sagar Darekar, Dilip Pandey, Akshaya Wagh, Prashant B. Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Shashikant Pawar, Mahip Verma, Minakshi Singh, Sudipto Das, Jayasagar Gundu, Kumar Nemmani, Mark G. Bock, Sharad Sharma, Dhananjay Bakhle, Rajender Kumar Kamboj, <span class="NLM_string-name hlFld-ContribAuthor">Venkata P. Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6107-6133. <a href="https://doi.org/10.1021/acs.jmedchem.0c00361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BState-Dependent%252BNaV1.7%252BInhibitors%252Bwith%252BRobust%252BOral%252BEfficacy%252Bin%252BPain%252BModels%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BOptimization%252Bof%252BChroman%252Band%252BIndane%252BAryl%252BSulfonamides%26aulast%3DRamdas%26aufirst%3DVidya%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D19052020%26date%3D05052020%26volume%3D63%26issue%3D11%26spage%3D6107%26epage%3D6133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rohan R. Merchant, Simon B. Lang, Tingting Yu, Shuilian Zhao, Zhiqi Qi, Takao Suzuki, <span class="NLM_string-name hlFld-ContribAuthor">Jianming Bao</span>. </span><span class="cited-content_cbyCitation_article-title">A General One-Pot Protocol for Hindered N-Alkyl Azaheterocycles from Tertiary Carboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4180-4184. <a href="https://doi.org/10.1021/acs.orglett.0c01254" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01254%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BGeneral%252BOne-Pot%252BProtocol%252Bfor%252BHindered%252BN-Alkyl%252BAzaheterocycles%252Bfrom%252BTertiary%252BCarboxylic%252BAcids%26aulast%3DMerchant%26aufirst%3DRohan%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08042020%26date%3D08052020%26volume%3D22%26issue%3D11%26spage%3D4180%26epage%3D4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig, J. Du Bois, <span class="NLM_string-name hlFld-ContribAuthor">John C. Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (19)
                                     , 8695-8710. <a href="https://doi.org/10.1021/acs.jmedchem.8b01906" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChallenges%252Band%252BOpportunities%252Bfor%252BTherapeutics%252BTargeting%252Bthe%252BVoltage-Gated%252BSodium%252BChannel%252BIsoform%252BNaV1.7%26aulast%3DMulcahy%26aufirst%3DJohn%2BV.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04122018%26date%3D07052019%26date%3D23042019%26volume%3D62%26issue%3D19%26spage%3D8695%26epage%3D8710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven J. McKerrall, Teresa Nguyen, Kwong Wah Lai, Philippe Bergeron, Lunbin Deng, Antonio DiPasquale, Jae H. Chang, Jun Chen, Tania Chernov-Rogan, David H. Hackos, Jonathan Maher, Daniel F. Ortwine, Jodie Pang, Jian Payandeh, William R. Proctor, Shannon D. Shields, Jennifer Vogt, Pengfei Ji, Wenfeng Liu, Elisa Ballini, Lilia Schumann, Glauco Tarozzo, Girish Bankar, Sultan Chowdhury, Abid Hasan, J. P. Johnson, Jr., Kuldip Khakh, Sophia Lin, Charles J. Cohen, Christoph M. Dehnhardt, Brian S. Safina, <span class="NLM_string-name hlFld-ContribAuthor">Daniel P. Sutherlin</span>. </span><span class="cited-content_cbyCitation_article-title">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4091-4109. <a href="https://doi.org/10.1021/acs.jmedchem.9b00141" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-%252Band%252BLigand-Based%252BDiscovery%252Bof%252BChromane%252BArylsulfonamide%252BNav1.7%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BPain%26aulast%3DMcKerrall%26aufirst%3DSteven%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23012019%26date%3D16042019%26date%3D03042019%26volume%3D62%26issue%3D8%26spage%3D4091%26epage%3D4109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Andreas    Stumpf    </span><span class="hlFld-ContribAuthor "> Daniel    Sutherlin    </span><span class="hlFld-ContribAuthor "> Christoph M.    Dehnhardt    </span><span class="hlFld-ContribAuthor "> Rémy    Angelaud </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of the Nav1.7 Inhibitor GDC-0276 and Development of an Efficient Large-Scale Synthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 107-123. <a href="https://doi.org/10.1021/bk-2019-1332.ch005" title="DOI URL">https://doi.org/10.1021/bk-2019-1332.ch005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2019-1332.ch005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2019-1332.ch005%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252Bthe%252BNav1.7%252BInhibitor%252BGDC-0276%252Band%252BDevelopment%252Bof%252Ban%252BEfficient%252BLarge-Scale%252BSynthesis%26aulast%3DStumpf%26aufirst%3DAndreas%26date%3D2019%26date%3D2019%26spage%3D107%26epage%3D123%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B2%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2019%26date%3D2019%26volume%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sameep  Sonvane</span>, <span class="hlFld-ContribAuthor ">Prafulla  Choudhari</span>, <span class="hlFld-ContribAuthor ">Omprakash  Bhusnuare</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              analysis of polyphenols and flavonoids for design of human Nav1.7 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (12)
                                     , 4472-4479. <a href="https://doi.org/10.1080/07391102.2020.1777902" title="DOI URL">https://doi.org/10.1080/07391102.2020.1777902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1777902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1777902%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Banalysis%252Bof%252Bpolyphenols%252Band%252Bflavonoids%252Bfor%252Bdesign%252Bof%252Bhuman%252BNav1.7%252Binhibitors%26aulast%3DSonvane%26aufirst%3DSameep%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D12%26spage%3D4472%26epage%3D4479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">He-ling  Niu</span>, <span class="hlFld-ContribAuthor ">Ya-ni  Liu</span>, <span class="hlFld-ContribAuthor ">Deng-qi  Xue</span>, <span class="hlFld-ContribAuthor ">Li-ying  Dong</span>, <span class="hlFld-ContribAuthor ">Hui-jie  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Yi-lin  Zheng</span>, <span class="hlFld-ContribAuthor ">An-ruo  Zou</span>, <span class="hlFld-ContribAuthor ">Li-ming  Shao</span>, <span class="hlFld-ContribAuthor ">KeWei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>42 </em>
                                    (8)
                                     , 1235-1247. <a href="https://doi.org/10.1038/s41401-021-00682-9" title="DOI URL">https://doi.org/10.1038/s41401-021-00682-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-021-00682-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-021-00682-9%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DInhibition%252Bof%252BNav1.7%252Bchannel%252Bby%252Ba%252Bnovel%252Bblocker%252BQLS-81%252Bfor%252Balleviation%252Bof%252Bneuropathic%252Bpain%26aulast%3DNiu%26aufirst%3DHe-ling%26date%3D2021%26date%3D2021%26volume%3D42%26issue%3D8%26spage%3D1235%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sigrid  Noreng</span>, <span class="hlFld-ContribAuthor ">Tianbo  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Payandeh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Pharmacology of Voltage-Gated Sodium Channels. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2021,</strong> <em>433 </em>
                                    (17)
                                     , 166967. <a href="https://doi.org/10.1016/j.jmb.2021.166967" title="DOI URL">https://doi.org/10.1016/j.jmb.2021.166967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2021.166967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2021.166967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructural%252BPharmacology%252Bof%252BVoltage-Gated%252BSodium%252BChannels%26aulast%3DNoreng%26aufirst%3DSigrid%26date%3D2021%26volume%3D433%26issue%3D17%26spage%3D166967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sooyeon  Jo</span>, <span class="hlFld-ContribAuthor ">Bruce P.  Bean</span>. </span><span class="cited-content_cbyCitation_article-title">Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2020,</strong> <em>97 </em>
                                    (6)
                                     , 377-383. <a href="https://doi.org/10.1124/mol.119.118380" title="DOI URL">https://doi.org/10.1124/mol.119.118380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.118380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.118380%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DLidocaine%252BBinding%252BEnhances%252BInhibition%252Bof%252BNav1.7%252BChannels%252Bby%252Bthe%252BSulfonamide%252BPF-05089771%26aulast%3DJo%26aufirst%3DSooyeon%26date%3D2020%26date%3D2020%26volume%3D97%26issue%3D6%26spage%3D377%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yue-ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Yue-ting  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Gu</span>, <span class="hlFld-ContribAuthor ">Zhao-bing  Gao</span>, <span class="hlFld-ContribAuthor ">Fa-jun  Nan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (3)
                                     , 293-302. <a href="https://doi.org/10.1038/s41401-019-0267-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0267-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0267-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0267-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Baryl%252Bsulfonamide-selective%252BNav1.7%252Binhibitors%252Bwith%252Ba%252Bhighly%252Bhydrophobic%252Bethanoanthracene%252Bcore%26aulast%3DWang%26aufirst%3DJin-tao%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D3%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De-jiang  Kong</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Han-xun  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-xing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Mao-sheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 107132. <a href="https://doi.org/10.1016/j.compbiolchem.2019.107132" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2019.107132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2019.107132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2019.107132%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bdeterminants%252Bfor%252Bligand%252Bbinding%252Bat%252BNav1.4%252Band%252BNav1.7%252Bchannels%25253A%252BExperimental%252Baffinity%252Bresults%252Banalyzed%252Bby%252Bmolecular%252Bmodeling%26aulast%3DKong%26aufirst%3DDe-jiang%26date%3D2019%26volume%3D83%26spage%3D107132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-mei  Li</span>, <span class="hlFld-ContribAuthor ">Li-xia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?. </span><span class="cited-content_cbyCitation_journal-name">Current Medical Science</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 863-873. <a href="https://doi.org/10.1007/s11596-019-2117-0" title="DOI URL">https://doi.org/10.1007/s11596-019-2117-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11596-019-2117-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11596-019-2117-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medical%2520Science%26atitle%3DVoltage-gated%252BSodium%252BChannels%252Band%252BBlockers%25253A%252BAn%252BOverview%252Band%252BWhere%252BWill%252BThey%252BGo%25253F%26aulast%3DLi%26aufirst%3DZhi-mei%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D863%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumika  Karaki</span>, <span class="hlFld-ContribAuthor ">Sho  Umemoto</span>, <span class="hlFld-ContribAuthor ">Karin  Ashizawa</span>, <span class="hlFld-ContribAuthor ">Tomoya  Oki</span>, <span class="hlFld-ContribAuthor ">Noriko  Sato</span>, <span class="hlFld-ContribAuthor ">Takumi  Ogino</span>, <span class="hlFld-ContribAuthor ">Naoto  Ishibashi</span>, <span class="hlFld-ContribAuthor ">Ryoto  Someya</span>, <span class="hlFld-ContribAuthor ">Kanako  Miyano</span>, <span class="hlFld-ContribAuthor ">Shigeto  Hirayama</span>, <span class="hlFld-ContribAuthor ">Yasuhito  Uezono</span>, <span class="hlFld-ContribAuthor ">Hideaki  Fujii</span>. </span><span class="cited-content_cbyCitation_article-title">A New Lead Identification Strategy: Screening an sp
              3
              ‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (21)
                                     , 1840-1848. <a href="https://doi.org/10.1002/cmdc.201900398" title="DOI URL">https://doi.org/10.1002/cmdc.201900398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900398%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BNew%252BLead%252BIdentification%252BStrategy%25253A%252BScreening%252Ban%252Bsp%252B3%252B%2525E2%252580%252590rich%252Band%252BLead%2525E2%252580%252590like%252BCompound%252BLibrary%252BComposed%252Bof%252B7%2525E2%252580%252590Azanorbornane%252BDerivatives%26aulast%3DKaraki%26aufirst%3DFumika%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D21%26spage%3D1840%26epage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Ding</span>, <span class="hlFld-ContribAuthor ">Tianhu  Wang</span>, <span class="hlFld-ContribAuthor ">Shanzhi  Mou</span>, <span class="hlFld-ContribAuthor ">Huiyong  Sun</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Voltage-gated sodium channels: structures, functions, and molecular modeling. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (7)
                                     , 1389-1397. <a href="https://doi.org/10.1016/j.drudis.2019.05.014" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DVoltage-gated%252Bsodium%252Bchannels%25253A%252Bstructures%25252C%252Bfunctions%25252C%252Band%252Bmolecular%252Bmodeling%26aulast%3DXu%26aufirst%3DLei%26date%3D2019%26volume%3D24%26issue%3D7%26spage%3D1389%26epage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected subtype-selective Na<sub>V</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acyl sulfonamides generally occupy a more favorable physicochemical property space (average cLogP of 3.0 vs 4.1 and MW of 400 vs 490 for acyl vs aryl sulfonamides) for achieving oral bioavailability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Induced fit docking of <b>7</b> into VSD4 of the hNa<sub>V</sub>1.7 receptor, shown in cyan. The active site cavity and helices are from the induced fit version. Key residues and distances are shown. The cocrystal structure of <b>GX-936</b> and VSD4 of Na<sub>V</sub>1.7<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK0">5EK0</a>) is superimposed and shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small-molecule crystal structure of the sodium salt of <b>7</b> (crystals grown in 50% MeOH solution), with sodium ions complexed to the charged oxygen atom shown as orange spheres. Two molecules of methanol are also shown. For details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of the major metabolic pathway of <b>26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>30</b> on aconitine-induced pain in humanized IEM transgenic mice. Each bar represents the mean of at least four animals. The error bars represent standard errors of the mean. **** <i>p</i> < 0.0001 vs vehicle group. Statistical significance of results was calculated by two-way analysis of variance (ANOVA) using Prism version 7 (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0007.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>33</b> on aconitine-induced pain in humanized IEM transgenic mice. Each bar represents the mean of at least four animals, except the 0.3 and 1 mg/kg groups (three animals for each group at these doses). The error bars represent standard errors of the mean. **** <i>p</i> < 0.0001 and *** <i>p</i> < 0.005 vs vehicle group for nociceptive events. Statistical significance of results was calculated by two-way ANOVA using Prism version 7 (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0008.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Dose–response effect of <b>33</b> in the mouse formalin model. (A) Time course of inhibition of formalin-evoked pain behavior. Each point represents the mean number of times that a mouse (<i>n</i> = 4) shook or licked its injected paw over a 5 min period. (B) Quantification of the response to formalin binned into two different phases: phase I (0–10 min after formalin injection) and phase II (11–40 min after formalin injection). Each bar represents the mean of four animals. The error bars represent standard errors of the mean. *** <i>p</i> = 0.0021 vs vehicle group. Statistical significance of results was calculated by two-way ANOVA using prism version 7 software (GraphPad software).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Compounds <b>7</b>–<b>14</b>, <b>16</b>, <b>21</b>–<b>23</b>, and <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) for <b>37</b> and <b>38</b>: MeSO<sub>2</sub>NH<sub>2</sub>, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI), 4-dimethylaminopyridine (DMAP), CH<sub>2</sub>Cl<sub>2</sub>, room temperature (rt), 58–96%; for <b>39</b>: MeSO<sub>2</sub>NH<sub>2</sub>, Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 54%; (b) R<sup>1</sup>OH, <i>t-</i>BuOK, DMSO, rt, 9–58%.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) adamantan-1-ylmethyl methanesulfonate, K<sub>2</sub>CO<sub>3</sub>, dimethylformamide (DMF), 65 °C, 71%; (b) MeSO<sub>2</sub>NH<sub>2</sub>, Mo(CO)<sub>6</sub>, Pd(OAc)<sub>2</sub>, Xantphos, Et<sub>3</sub>N, 1,4-dioxane, 100 °C, microwave irradiation, 45 min, 10%.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-adamantane methanol, <i>t-</i>BuOK, DMSO, rt to 50 °C, 17%; (b) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 27%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) di-<i>tert</i>-butyl dicarbonate, DMAP, <i>tert</i>-butanol, 50 °C, 99%; (b) (adamantan-1-yl)methanol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 62%; (c) vinylboronic acid pinacol ester, tris(dibenzylideneacetone)dipalladium(0) (Pd<sub>2</sub>(dba)<sub>3</sub>), <i>t-</i>Bu<sub>3</sub>P·HBF<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C, 92%; (d) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 97%; (e) Pd–C, H<sub>2</sub>, EtOAc, rt, 74%; (f) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 69%.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-isopropenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>t-</i>Bu<sub>3</sub>P·HBF<sub>4,</sub> Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C, 64%; (b) Pd–C, H<sub>2</sub>, EtOAc, rt, 94%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 84%; (d) MeSO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 33%.</p></p></figure><figure data-id="sch6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Compounds <b>20</b> and <b>26</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 43–95%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 86–99%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 50–86%; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40–70%.</p></p></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>1</sup>OH, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 43–95%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 86–99%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 50–86%; (d) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40–70%.</p></p></figure><figure data-id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/medium/jm-2018-01621d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0016.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-2/acs.jmedchem.8b01621/20190212/images/large/jm-2018-01621d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01621&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (8-methyl-1,4-dioxaspiro[4.5]decan-8-yl)methanol, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 70 °C, 54%; (b) cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, Cy<sub>3</sub>P·HBF<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, toluene, H<sub>2</sub>O, 100 °C, 83%; (c) trifluoroacetic acid (TFA), H<sub>2</sub>O, tetrahydrofuran (THF), rt, 90%; (e) MePPh<sub>3</sub>Br, LiHMDS, THF, −20 °C to rt, 82%; (e) ClCH<sub>2</sub>I, Et<sub>2</sub>Zn, ClCH<sub>2</sub>CH<sub>2</sub>Cl, 0 °C, 93%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 90%; (g) cyclopropanesulfonamide, EDCI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, 41%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulroy, M. F.</span></span> <span> </span><span class="NLM_article-title">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span>. <i>Reg. Anesth. Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1053/rapm.2002.37127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1053%2Frapm.2002.37127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=12430104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=556-561&author=M.+F.+Mulroy&title=Systemic+toxicity+and+cardiotoxicity+from+local+anesthetics%3A+incidence+and+preventive+measures&doi=10.1053%2Frapm.2002.37127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span></div><div class="casAuthors">Mulroy, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Regional Anesthesia and Pain Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-561</span>CODEN:
                <span class="NLM_cas:coden">RAPMFX</span>;
        ISSN:<span class="NLM_cas:issn">1098-7339</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Central nervous system toxicity from unintentionally high blood levels has been a significant concern and risk with local anesthetics since their discovery.  Cardiotoxicity assocd. with toxic blood levels of long-acting local anesthetics has heightened concern about systemic blood levels in the last 20 yr.  This review will discuss the apparent incidence of systemic toxicity, the situations in which it occurs, some of the other risks of regional anesthesia, and appropriate safety steps to reduce the frequency of both systemic reactions and cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMkLHgF6vjrVg90H21EOLACvtfcHk0lgavDkcoUe_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D&md5=6ddb4d2bbba7485049e85a3f8df71038</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1053%2Frapm.2002.37127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Frapm.2002.37127%26sid%3Dliteratum%253Aachs%26aulast%3DMulroy%26aufirst%3DM.%2BF.%26atitle%3DSystemic%2520toxicity%2520and%2520cardiotoxicity%2520from%2520local%2520anesthetics%253A%2520incidence%2520and%2520preventive%2520measures%26jtitle%3DReg.%2520Anesth.%2520Pain%2520Med.%26date%3D2002%26volume%3D27%26spage%3D556%26epage%3D561%26doi%3D10.1053%2Frapm.2002.37127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walia, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Y. N.</span></span> <span> </span><span class="NLM_article-title">Side effects of antiepileptics – a review</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1533-2500.2004.04304.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1533-2500.2004.04304.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17173601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=194-203&author=K.+S.+Waliaauthor=E.+A.+Khanauthor=D.+H.+Koauthor=S.+S.+Razaauthor=Y.+N.+Khan&title=Side+effects+of+antiepileptics+%E2%80%93+a+review&doi=10.1111%2Fj.1533-2500.2004.04304.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Side effects of antiepileptics--a review</span></div><div class="casAuthors">Walia Kulbir S; Khan Elizabeth A; Ko Dong H; Raza Shariq S; Khan Yasin N</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-203</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Older generation antiepileptic drugs like Phenobarbital (Luminal), carbamazepine (Tegretol), phenytoin (Dilantin), and valproic acid (Depakote) have several shortcomings such as suboptimal response rates, significant adverse effects, several drug interactions, and a narrow therapeutic index.  New antiepileptic drugs have been developed in the last decade to overcome some of these problems.  These newer generation antiepileptics like felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), tiagabine (Gabitril), topiramate (Topamax), and zonisamide (Zonegran) have better tolerability profiles, low interaction potential, and significantly less enzyme inducing or inhibiting properties.  As the use of antiepileptic drugs has expanded to include treatment of neuropathic pain, newer side effects have been reported.  In addition to the common side effects of antiepileptic drugs, like dizziness, drowsiness, and mental slowing; other side effects like weight gain, metabolic acidosis, nephrolithiasis, angle closure glaucoma, skin rash, hepatotoxicity, colitis, and movement and behavioral disorders, to name a few, have been brought to our attention.  This review is an attempt to highlight the features and incidences of some of these side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq8w-gtiU7_bYtC3U5jeOifW6udTcc2ea53wG5tjjQbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D&md5=0bd5221a573a26194b0ea14116d9ce7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1533-2500.2004.04304.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1533-2500.2004.04304.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalia%26aufirst%3DK.%2BS.%26aulast%3DKhan%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DD.%2BH.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKhan%26aufirst%3DY.%2BN.%26atitle%3DSide%2520effects%2520of%2520antiepileptics%2520%25E2%2580%2593%2520a%2520review%26jtitle%3DPain%2520Pract.%26date%3D2004%26volume%3D4%26spage%3D194%26epage%3D203%26doi%3D10.1111%2Fj.1533-2500.2004.04304.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattachacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaplan, S. R.</span></span> <span> </span><span class="NLM_article-title">Sodium channel blockers for the treatment of neuropathic pain</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/j.nurt.2009.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.nurt.2009.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19789071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=663-678&author=A.+Bhattachacharyaauthor=A.+D.+Wickendenauthor=S.+R.+Chaplan&title=Sodium+channel+blockers+for+the+treatment+of+neuropathic+pain&doi=10.1016%2Fj.nurt.2009.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.nurt.2009.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nurt.2009.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachacharya%26aufirst%3DA.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DChaplan%26aufirst%3DS.%2BR.%26atitle%3DSodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D663%26epage%3D678%26doi%3D10.1016%2Fj.nurt.2009.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">From genes to pain: Na<sub>V</sub>1.7 and human pain disorders</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2007.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.tins.2007.08.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=555-563&author=S.+D.+Dib-Hajjauthor=T.+R.+Cumminsauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=From+genes+to+pain%3A+NaV1.7+and+human+pain+disorders&doi=10.1016%2Fj.tins.2007.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2007.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2007.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DFrom%2520genes%2520to%2520pain%253A%2520NaV1.7%2520and%2520human%2520pain%2520disorders%26jtitle%3DTrends%2520Neurosci.%26date%3D2007%26volume%3D30%26spage%3D555%26epage%3D563%26doi%3D10.1016%2Fj.tins.2007.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na<sub>V</sub>1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+NaV1.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0liVuMeMsxXAXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520NaV1.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamponi, G. W.</span></span> <span> </span><span class="NLM_article-title">Regulating excitability of peripheral afferents: emerging ion channel targets</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1038/nn.3602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnn.3602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=24473263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlemtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=153-163&author=S.+G.+Waxmanauthor=G.+W.+Zamponi&title=Regulating+excitability+of+peripheral+afferents%3A+emerging+ion+channel+targets&doi=10.1038%2Fnn.3602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Regulating excitability of peripheral afferents: emerging ion channel targets</span></div><div class="casAuthors">Waxman, Stephen G.; Zamponi, Gerald W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-163</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The transmission and processing of pain signals relies critically on the activities of ion channels that are expressed in afferent pain fibers.  This includes voltage-gated channels, as well as background (or leak) channels that collectively regulate resting membrane potential and action potential firing properties.  Dysregulated ion channel expression in response to nerve injury and inflammation results in enhanced neuronal excitability that underlies chronic neuropathic and inflammatory pain.  Pharmacol. modulators of ion channels, particularly those that target channels on peripheral neurons, are being pursued as possible analgesics.  Over the past few years, a no. of different types of ion channels have been implicated in afferent pain signaling.  Here we give an overview of recent advances on sodium, calcium, potassium and chloride channels that are emerging as esp. attractive targets for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b-g0NGYOYrVg90H21EOLACvtfcHk0lgbGRkWhLHpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlemtbo%253D&md5=bc89fb490f383cdbca7ed272213d4494</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnn.3602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3602%26sid%3Dliteratum%253Aachs%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DZamponi%26aufirst%3DG.%2BW.%26atitle%3DRegulating%2520excitability%2520of%2520peripheral%2520afferents%253A%2520emerging%2520ion%2520channel%2520targets%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D153%26epage%3D163%26doi%3D10.1038%2Fnn.3602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasako, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oaklander, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span> <span> </span><span class="NLM_article-title">Congenital insensitivity to pain: an update</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(02)00482-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2FS0304-3959%2802%2900482-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=12583863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fntlygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2003&pages=213-219&author=E.+M.+Nagasakoauthor=A.+L.+Oaklanderauthor=R.+H.+Dworkin&title=Congenital+insensitivity+to+pain%3A+an+update&doi=10.1016%2FS0304-3959%2802%2900482-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Congenital insensitivity to pain: an update</span></div><div class="casAuthors">Nagasako Elna M; Oaklander Anne Louise; Dworkin Robert H</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-9</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBp-x8XzwmS-_Q9URG6Dx8fW6udTcc2eacEW_qUR3j37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fntlygug%253D%253D&md5=9f0657d750e7a7fb2a8178a11f1113a6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2802%2900482-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252802%252900482-7%26sid%3Dliteratum%253Aachs%26aulast%3DNagasako%26aufirst%3DE.%2BM.%26aulast%3DOaklander%26aufirst%3DA.%2BL.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26atitle%3DCongenital%2520insensitivity%2520to%2520pain%253A%2520an%2520update%26jtitle%3DPain%26date%3D2003%26volume%3D101%26spage%3D213%26epage%3D219%26doi%3D10.1016%2FS0304-3959%2802%2900482-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicolasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lgbGRkWhLHpzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oves, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ovesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eZkFHUPH1VX8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DOves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellgren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meury, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morinville, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynoschek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouleau, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krupp, J. J.</span></span> <span> </span><span class="NLM_article-title">A stop codon mutation in SCN9A causes lack of pain sensation</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2114</span>– <span class="NLM_lpage">2121</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddm160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1093%2Fhmg%2Fddm160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17597096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=2114-2121&author=S.+Ahmadauthor=L.+Dahllundauthor=A.+B.+Erikssonauthor=D.+Hellgrenauthor=U.+Karlssonauthor=P.-E.+Lundauthor=I.+A.+Meijerauthor=L.+Meuryauthor=T.+Millsauthor=A.+Moodyauthor=A.+Morinvilleauthor=J.+Mortenauthor=D.+O%E2%80%99Donnellauthor=C.+Raynoschekauthor=H.+Salterauthor=G.+A.+Rouleauauthor=J.+J.+Krupp&title=A+stop+codon+mutation+in+SCN9A+causes+lack+of+pain+sensation&doi=10.1093%2Fhmg%2Fddm160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A stop codon mutation in SCN9A causes lack of pain sensation</span></div><div class="casAuthors">Ahmad, Sultan; Dahllund, Leif; Eriksson, Anders B.; Hellgren, Dennis; Karlsson, Urban; Lund, Per-Eric; Meijer, Inge A.; Meury, Luc; Mills, Tracy; Moody, Adrian; Morinville, Anne; Morten, John; O'Donnell, Dajan; Raynoschek, Carina; Salter, Hugh; Rouleau, Guy A.; Krupp, Johannes J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2114-2121</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The general lack of pain experience is a rare occurrence in humans, and the mol. causes for this phenotype are not well understood.  Here we have studied a Canadian family from Newfoundland with members who exhibit a congenital inability to experience pain.  We have mapped the locus to a 13.7 Mb region on chromosome 2q (2q24.3-2q31.1).  Screening of candidate genes in this region identified a protein-truncating mutation in SCN9A, which encodes for the voltage-gated sodium channel Nav1.7.  The mutation is a C-A transversion at nucleotide 984 transforming the codon for tyrosine 328 to a stop codon.  The predicted product lacks all pore-forming regions of Nav1.7.  Indeed, expression of this altered gene in a cell line did not produce functional responses, nor did it cause compensatory effects on endogenous voltage-gated sodium currents when expressed in ND7/23 cells.  Because a homozygous knockout of Nav1.7 in mice has been shown to be lethal, we explored why a deficiency of Nav1.7 is non-lethal in humans.  Expression studies in monkey, human, mouse and rat tissue indicated species-differences in the Nav1.7 expression profile.  Whereas in rodents the channel was strongly expressed in hypothalamic nuclei, only weak mRNA levels were detected in this area in primates.  Furthermore, primate pituitary and adrenal glands were devoid of signal, whereas these two glands were mRNA-pos. in rodents.  This species difference may explain the non-lethality of the obsd. mutation in humans.  Our data further establish Nav1.7 as a crit. element of peripheral nociception in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-UExUOmeYrVg90H21EOLACvtfcHk0lim_Q5ci3FBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVWqt7o%253D&md5=4800e0aee1230c46ada3e29e551b1833</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm160%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DDahllund%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DHellgren%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DU.%26aulast%3DLund%26aufirst%3DP.-E.%26aulast%3DMeijer%26aufirst%3DI.%2BA.%26aulast%3DMeury%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DT.%26aulast%3DMoody%26aufirst%3DA.%26aulast%3DMorinville%26aufirst%3DA.%26aulast%3DMorten%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DD.%26aulast%3DRaynoschek%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DRouleau%26aufirst%3DG.%2BA.%26aulast%3DKrupp%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520stop%2520codon%2520mutation%2520in%2520SCN9A%2520causes%2520lack%2520of%2520pain%2520sensation%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2007%26volume%3D16%26spage%3D2114%26epage%3D2121%26doi%3D10.1093%2Fhmg%2Fddm160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellgren, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebuchennykh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasly, J.</span></span> <span> </span><span class="NLM_article-title">Two novel SCN9A mutations causing insensitivity to pain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2009.02.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.pain.2009.02.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19304393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2msrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2009&pages=155-158&author=K.+B.+Nilsenauthor=A.+K.+Nicholasauthor=C.+G.+Woodsauthor=S.+I.+Mellgrenauthor=M.+Nebuchennykhauthor=J.+Aasly&title=Two+novel+SCN9A+mutations+causing+insensitivity+to+pain&doi=10.1016%2Fj.pain.2009.02.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel SCN9A mutations causing insensitivity to pain</span></div><div class="casAuthors">Nilsen, K. B.; Nicholas, A. K.; Woods, C. G.; Mellgren, S. I.; Nebuchennykh, M.; Aasly, J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-158</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The sensation of pain is important and there may be serious consequences if it is missing.  Recently, the genetic basis for a channelopathy characterised by a congenital inability to experience pain has been described and channelopathy-assocd. insensitivity to pain has been proposed as a suitable name for this condition.  Different mutations in the SCN9A gene causing loss of function of the voltage-gated sodium channel Nav1.7 have been reported in patients with this rare disease.  Here we describe a woman with insensitivity to pain with two novel mutations in the SCN9A gene, coding for the Nav1.7 channel.  We also discuss the finding of anosmia which apparently is a common feature in these patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCKc-xMMonrVg90H21EOLACvtfcHk0ljVDegPc0TTow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2msrg%253D&md5=ab329cd3892ba364968c99ef503ee0e4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.02.016%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DK.%2BB.%26aulast%3DNicholas%26aufirst%3DA.%2BK.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DMellgren%26aufirst%3DS.%2BI.%26aulast%3DNebuchennykh%26aufirst%3DM.%26aulast%3DAasly%26aufirst%3DJ.%26atitle%3DTwo%2520novel%2520SCN9A%2520mutations%2520causing%2520insensitivity%2520to%2520pain%26jtitle%3DPain%26date%3D2009%26volume%3D143%26spage%3D155%26epage%3D158%26doi%3D10.1016%2Fj.pain.2009.02.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheynin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholasm, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubovic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baralle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraige, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parvari, R.</span></span> <span> </span><span class="NLM_article-title">Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">E1670</span>– <span class="NLM_lpage">E1686</span>, <span class="refDoi"> DOI: 10.1002/humu.21325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fhumu.21325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=20635406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=E1670-E1686&author=J.+J.+Coxauthor=J.+Sheyninauthor=Z.+Shorerauthor=F.+Reimannauthor=A.+K.+Nicholasmauthor=L.+Zubovicauthor=M.+Baralleauthor=E.+Wraigeauthor=E.+Manorauthor=J.+Levyauthor=C.+G.+Woodsauthor=R.+Parvari&title=Congenital+insensitivity+to+pain%3A+novel+SCN9A+missense+and+in-frame+deletion+mutations&doi=10.1002%2Fhumu.21325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations</span></div><div class="casAuthors">Cox, James J.; Sheynin, Jony; Shorer, Zamir; Reimann, Frank; Nicholas, Adeline K.; Zubovic, Lorena; Baralle, Marco; Wraige, Elizabeth; Manor, Esther; Levy, Jacov; Woods, C. Geoffrey; Parvari, Ruti</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1670-e1686</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">SCN9A encodes the voltage-gated sodium channel Nav1.7, a protein highly expressed in pain-sensing neurons.  Mutations in SCN9A cause three human pain disorders: bi-allelic loss of function mutations result in Channelopathy-assocd. Insensitivity to Pain (CIP), whereas activating mutations cause severe episodic pain in Paroxysmal Extreme Pain Disorder (PEPD) and Primary Erythermalgia (PE).  To date, all mutations in SCN9A that cause a complete inability to experience pain are protein truncating and presumably lead to no protein being produced.  Here, we describe the identification and functional characterization of two novel non-truncating mutations in families with CIP: a homozygously-inherited missense mutation found in a consanguineous Israeli Bedouin family (Nav1.7-R896Q) and a five amino acid in-frame deletion found in a sporadic compd. heterozygote (Nav1.7-ΔR1370-L1374).  Both of these mutations map to the pore region of the Nav1.7 sodium channel.  Using transient transfection of PC12 cells we found a significant redn. in membrane localization of the mutant protein compared to the wild type.  Furthermore, voltage clamp expts. of mutant-transfected HEK293 cells show a complete loss of function of the sodium channel, consistent with the absence of pain phenotype.  In summary, this study has identified crit. amino acids needed for the normal subcellular localization and function of Nav1.7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrOjG6MZDj4rVg90H21EOLACvtfcHk0ljVDegPc0TTow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqtLrL&md5=59caf383a04ef957ca0c0aa74e7d753b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fhumu.21325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.21325%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DSheynin%26aufirst%3DJ.%26aulast%3DShorer%26aufirst%3DZ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicholasm%26aufirst%3DA.%2BK.%26aulast%3DZubovic%26aufirst%3DL.%26aulast%3DBaralle%26aufirst%3DM.%26aulast%3DWraige%26aufirst%3DE.%26aulast%3DManor%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DJ.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26aulast%3DParvari%26aufirst%3DR.%26atitle%3DCongenital%2520insensitivity%2520to%2520pain%253A%2520novel%2520SCN9A%2520missense%2520and%2520in-frame%2520deletion%2520mutations%26jtitle%3DHum.%2520Mutat.%26date%3D2010%26volume%3D31%26spage%3DE1670%26epage%3DE1686%26doi%3D10.1002%2Fhumu.21325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanova-Mihaylova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, S. M.</span></span> <span> </span><span class="NLM_article-title">SCN9A-associated congenital insensitivity to pain and anosmia in an Irish patient</span>. <i>J. Peripher. Nerv. Syst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1111/jns.12123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fjns.12123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26292973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC287ltVWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=86-87&author=P.+Bogdanova-Mihaylovaauthor=M.+D.+Alexanderauthor=R.+P.+J.+Murphyauthor=S.+M.+Murphy&title=SCN9A-associated+congenital+insensitivity+to+pain+and+anosmia+in+an+Irish+patient&doi=10.1111%2Fjns.12123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A-associated congenital insensitivity to pain and anosmia in an Irish patient</span></div><div class="casAuthors">Bogdanova-Mihaylova Petya; Murphy Raymond P J; Murphy Sinead M; Alexander Michael D; Murphy Sinead M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the peripheral nervous system : JPNS</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTNt9w0am7_iA3UY9EwTNrfW6udTcc2eY8B1zRMNuQRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ltVWitg%253D%253D&md5=3e91ae04a0da63eeab0de470d39c04c5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fjns.12123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjns.12123%26sid%3Dliteratum%253Aachs%26aulast%3DBogdanova-Mihaylova%26aufirst%3DP.%26aulast%3DAlexander%26aufirst%3DM.%2BD.%26aulast%3DMurphy%26aufirst%3DR.%2BP.%2BJ.%26aulast%3DMurphy%26aufirst%3DS.%2BM.%26atitle%3DSCN9A-associated%2520congenital%2520insensitivity%2520to%2520pain%2520and%2520anosmia%2520in%2520an%2520Irish%2520patient%26jtitle%3DJ.%2520Peripher.%2520Nerv.%2520Syst.%26date%3D2015%26volume%3D20%26spage%3D86%26epage%3D87%26doi%3D10.1111%2Fjns.12123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finley, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breedveld, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heutink, P.</span></span> <span> </span><span class="NLM_article-title">The primary erythemyalgia-susceptibility gene is located on chromosome 2q31-32</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1282</span>, <span class="refDoi"> DOI: 10.1086/320107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1086%2F320107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=11283792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvF2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2001&pages=1277-1282&author=J.+P.+Drenthauthor=W.+H.+Finleyauthor=G.+L.+Breedveldauthor=L.+Testersauthor=J.+J.+Michielsauthor=G.+Guilletauthor=A.+Taiebauthor=R.+L.+Kirbyauthor=P.+Heutink&title=The+primary+erythemyalgia-susceptibility+gene+is+located+on+chromosome+2q31-32&doi=10.1086%2F320107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32</span></div><div class="casAuthors">Drenth, Joost P. H.; Finley, Wayne H.; Breedveld, Guido J.; Testers, Leon; Michiels, Jan J.; Guillet, G.; Taieb, Alain; Kirby, R. Lee; Heutink, Peter</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1277-1282</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm, and painful hands and/or feet.  The symptoms are generally refractory to treatment and persist throughout life.  5 Kindreds with multiple cases of primary erythermalgia were identified, and the largest was subjected to a genomewide search.  We detected strong evidence for linkage of the primary erythermalgia locus to markers from chromosome 2q.  The highest LOD score (Z) was obtained with D2S2330 (Zmax = 6.51).  Anal. of recombination events identified D2S2370 and D2S1776 as flanking markers, on chromosome 2q31-32.  This defines a crit. interval of 7.94 cM that harbors the primary erythermalgia gene.  Affected members within the addnl. families also shared a common haplotype on chromosome 2q31-32, supporting our linkage results.  Identification of the primary erythermalgia gene will allow a better clin. classification of this pleomorphic group of disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIafRc7tMRbVg90H21EOLACvtfcHk0lhkJJnOtdx46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvF2nu7o%253D&md5=80afefeb67ffe1ac4f0a00d438e24608</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1086%2F320107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F320107%26sid%3Dliteratum%253Aachs%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DFinley%26aufirst%3DW.%2BH.%26aulast%3DBreedveld%26aufirst%3DG.%2BL.%26aulast%3DTesters%26aufirst%3DL.%26aulast%3DMichiels%26aufirst%3DJ.%2BJ.%26aulast%3DGuillet%26aufirst%3DG.%26aulast%3DTaieb%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DR.%2BL.%26aulast%3DHeutink%26aufirst%3DP.%26atitle%3DThe%2520primary%2520erythemyalgia-susceptibility%2520gene%2520is%2520located%2520on%2520chromosome%25202q31-32%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2001%26volume%3D68%26spage%3D1277%26epage%3D1282%26doi%3D10.1086%2F320107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xe, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span> <span> </span><span class="NLM_article-title">Mutations in <i>SCN9A</i>, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1136/jmg.2003.012153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1136%2Fjmg.2003.012153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=14985375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=171-174&author=Y.+Yangauthor=Y.+Wangauthor=S.+Liauthor=Z.+Xeauthor=H.+Liauthor=L.+Maauthor=J.+Fanauthor=D.+Buauthor=B.+Liuauthor=Z.+Fanauthor=G.+Wuauthor=J.+Jinauthor=B.+Dingauthor=X.+Zhuauthor=Y.+Shen&title=Mutations+in+SCN9A%2C+encoding+a+sodium+channel+alpha+subunit%2C+in+patients+with+primary+erythermalgia&doi=10.1136%2Fjmg.2003.012153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia</span></div><div class="casAuthors">Yang, Y.; Wang, Y.; Li, S.; Xu, Z.; Li, H.; Ma, L.; Fan, J.; Bu, D.; Liu, B.; Fan, Z.; Wu, G.; Jin, J.; Ding, B.; Zhu, X.; Shen, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-174</span>CODEN:
                <span class="NLM_cas:coden">JMDGAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-2593</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Primary erythermalgia is a rare autosomal dominant disease characterized by intermittent burning pain with redness and heat in the extremities.  A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified.  We performed linkage anal. in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient.  Linkage anal. yielded a max. lod score of 2.11 for both markers D2S2370 and D2S2330.  Based on crit. recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345.  We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C).  Our data suggest that mutations in SCN9A cause primary erythermalgia.  SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurons, may play an important role in nociception and vasomotor regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBMPc9seMturVg90H21EOLACvtfcHk0lhkJJnOtdx46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFCgsrw%253D&md5=bf4ca6710278dd25a4de4ac5d8fdab2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2003.012153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2003.012153%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DXe%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26atitle%3DMutations%2520in%2520SCN9A%252C%2520encoding%2520a%2520sodium%2520channel%2520alpha%2520subunit%252C%2520in%2520patients%2520with%2520primary%2520erythermalgia%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2004%26volume%3D41%26spage%3D171%26epage%3D174%26doi%3D10.1136%2Fjmg.2003.012153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisama, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function mutation in Na<sub>V</sub>1.7 in familial erythromelalgia induces bursting of sensory neurons</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1093/brain/awh514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1093%2Fbrain%2Fawh514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=15958509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1847-1854&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=F.+M.+Hisamaauthor=S.+Novellaauthor=L.+Tyrrellauthor=L.+Marshallauthor=S.+G.+Waxman&title=Gain-of-function+mutation+in+NaV1.7+in+familial+erythromelalgia+induces+bursting+of+sensory+neurons&doi=10.1093%2Fbrain%2Fawh514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons</span></div><div class="casAuthors">Dib-Hajj S D; Rush A M; Cummins T R; Hisama F M; Novella S; Tyrrell L; Marshall L; Waxman S G</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1847-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Erythromelalgia is an autosomal dominant disorder characterized by burning pain in response to warm stimuli or moderate exercise.  We describe a novel mutation in a family with erythromelalgia in SCN9A, the gene that encodes the Na(v)1.7 sodium channel.  Na(v)1.7 produces threshold currents and is selectively expressed within sensory neurons including nociceptors.  We demonstrate that this mutation, which produces a hyperpolarizing shift in activation and a depolarizing shift in steady-state inactivation, lowers thresholds for single action potentials and high frequency firing in dorsal root ganglion neurons.  Erythromelalgia is the first inherited pain disorder in which it is possible to link a mutation with an abnormality in ion channel function and with altered firing of pain signalling neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfGPgL4LrC-0VfW6udTcc2eZxwD63nYNgl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D&md5=6befcde7de47dd574901a333c2f14909</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh514%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DHisama%26aufirst%3DF.%2BM.%26aulast%3DNovella%26aufirst%3DS.%26aulast%3DTyrrell%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DGain-of-function%2520mutation%2520in%2520NaV1.7%2520in%2520familial%2520erythromelalgia%2520induces%2520bursting%2520of%2520sensory%2520neurons%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1847%26epage%3D1854%26doi%3D10.1093%2Fbrain%2Fawh514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Mutation in the sodium channel Na<sub>V</sub>1.7 underlie inherited erythromelalgia</span>. <i>Drug Discovery Today: Dis. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.ddmec.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.ddmec.2006.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=343-350&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=S.+G.+Waxman&title=Mutation+in+the+sodium+channel+NaV1.7+underlie+inherited+erythromelalgia&doi=10.1016%2Fj.ddmec.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMutation%2520in%2520the%2520sodium%2520channel%2520NaV1.7%2520underlie%2520inherited%2520erythromelalgia%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2006%26volume%3D3%26spage%3D343%26epage%3D350%26doi%3D10.1016%2Fj.ddmec.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title"><i>SCN9A</i> mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0ljOxtLhsniqNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+Na%CE%BD1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0ljOxtLhsniqNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520Na%25CE%25BD1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asghari-Roodsari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. L.</span></span> <span> </span><span class="NLM_article-title">Cardiac sodium channelopathies</span>. <i>Pflugers Arch.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1007/s00424-009-0761-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs00424-009-0761-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=20091048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC3cvps1Kgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2010&pages=223-237&author=A.+S.+Aminauthor=A.+Asghari-Roodsariauthor=H.+L.+Tan&title=Cardiac+sodium+channelopathies&doi=10.1007%2Fs00424-009-0761-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac sodium channelopathies</span></div><div class="casAuthors">Amin Ahmad S; Asghari-Roodsari Alaleh; Tan Hanno L</div><div class="citationInfo"><span class="NLM_cas:title">Pflugers Archiv : European journal of physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cardiac sodium channel are protein complexes that are expressed in the sarcolemma of cardiomyocytes to carry a large inward depolarizing current (INa) during phase 0 of the cardiac action potential.  The importance of INa for normal cardiac electrical activity is reflected by the high incidence of arrhythmias in cardiac sodium channelopathies, i.e., arrhythmogenic diseases in patients with mutations in SCN5A, the gene responsible for the pore-forming ion-conducting alpha-subunit, or in genes that encode the ancillary beta-subunits or regulatory proteins of the cardiac sodium channel.  While clinical and genetic studies have laid the foundation for our understanding of cardiac sodium channelopathies by establishing links between arrhythmogenic diseases and mutations in genes that encode various subunits of the cardiac sodium channel, biophysical studies (particularly in heterologous expression systems and transgenic mouse models) have provided insights into the mechanisms by which INa dysfunction causes disease in such channelopathies.  It is now recognized that mutations that increase INa delay cardiac repolarization, prolong action potential duration, and cause long QT syndrome, while mutations that reduce INa decrease cardiac excitability, reduce electrical conduction velocity, and induce Brugada syndrome, progressive cardiac conduction disease, sick sinus syndrome, or combinations thereof.  Recently, mutation-induced INa dysfunction was also linked to dilated cardiomyopathy, atrial fibrillation, and sudden infant death syndrome.  This review describes the structure and function of the cardiac sodium channel and its various subunits, summarizes major cardiac sodium channelopathies and the current knowledge concerning their genetic background and underlying molecular mechanisms, and discusses recent advances in the discovery of mutation-specific therapies in the management of these channelopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3D1Kd32EnTX6CEoQgWY10fW6udTcc2eY3kmQs5hHfc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvps1Kgug%253D%253D&md5=cad45f34d71373258332117f8c9af527</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0761-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0761-0%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BS.%26aulast%3DAsghari-Roodsari%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DH.%2BL.%26atitle%3DCardiac%2520sodium%2520channelopathies%26jtitle%3DPflugers%2520Arch.%26date%3D2010%26volume%3D460%26spage%3D223%26epage%3D237%26doi%3D10.1007%2Fs00424-009-0761-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage-gated sodium channels with small molecules</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=22945552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage-gated+sodium+channels+with+small+molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules</span></div><div class="casAuthors">Nardi, Antonio; Damann, Nils; Hertrampf, Torsten; Kless, Achim</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1712-1740</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blockade of voltage-gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathol. firing patterns that occur in conditions as diverse as chronic pain, epilepsy, and arrhythmias.  Herein we review the state of the art in marketed sodium channel inhibitors, including a brief compendium of their binding sites and of the cellular and mol. biol. of sodium channels.  Despite the preferential action of this drug class toward over-excited cells, which significantly limits potential undesired side effects on other cells, the need to develop a second generation of sodium channel inhibitors to overcome their crit. clin. shortcomings is apparent.  Current approaches in drug discovery to deliver novel and truly innovative sodium channel inhibitors is next presented by surveying the most recent medicinal chem. breakthroughs in the field of small mols. and developments in automated patch-clamp platforms.  Various strategies aimed at identifying small mols. that target either particular isoforms of sodium channels involved in specific diseases or anomalous sodium channel currents, irresp. of the isoform by which they have been generated, are critically discussed and revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25xI9xQpdebVg90H21EOLACvtfcHk0linCW21xoCW2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN&md5=a4072539ac2084d994eb4a2143844d3c</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage-gated%2520sodium%2520channels%2520with%2520small%2520molecules%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0linCW21xoCW2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lhwvZG1bhfh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: Structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+Structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lhwvZG1bhfh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520Structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lhwvZG1bhfh1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0lgdTFhruY43pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surujbally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of the Na<sub>V</sub>1.7 blocker PF-05089771 in a randomized, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1476</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000001227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1097%2Fj.pain.0000000000001227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29578944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=1465-1476&author=A.+McDonnellauthor=S.+Collinsauthor=Z.+Aliauthor=L.+Iavaroneauthor=R.+Surujballyauthor=S.+Kirbyauthor=R.+P.+Butt&title=Efficacy+of+the+NaV1.7+blocker+PF-05089771+in+a+randomized%2C+placebo-controlled%2C+double-blind+clinical+study+in+subjects+with+painful+diabetic+peripheral+neuropathy&doi=10.1097%2Fj.pain.0000000000001227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span></div><div class="casAuthors">McDonnell, Aoibhinn; Collins, Susie; Ali, Zahid; Iavarone, Laura; Surujbally, Raulin; Kirby, Simon; Butt, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1465-1476</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The effect of PF-05089771, a selective, peripherally restricted Nav1.7 sodium channel blocker on pain due to diabetic peripheral neuropathy was investigated in a randomised, placebo and active-controlled parallel group clin. trial (NCT02215252).  A 1-wk placebo-run in the period was followed by a 4-wk treatment period and a 1-wk placebo run-out/taper-down period.  Single-blind placebo was administered throughout run-in and run-out periods.  Subjects were randomised to receive either PF-05089771 150 mg twice daily, pregabalin 150 mg twice daily, or placebo during the 4-wk treatment period.  One hundred thirty-five subjects were randomised.  The primary endpoint was the av. pain score derived from subjects' Numerical Rating Scale scores over the past 7 days of week 4 of the double-blind treatment period.  Predefined efficacy criteria for the trial were the effect of PF-05089771 being >0.5 units better than placebo at interim anal. after completion of the first part of the study.  Although a trend for a redn. in the weekly av. pain score in the PF-05089771 treatment group was obsd., this was not statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.41 (90% credible interval: -1.00 to 0.17).  The effect of PF-05089771 was smaller than that seen with pregabalin, which was statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.53 (90% credible interval: -0.91 to -0.20).  As predefined efficacy criteria were not met, the study did not proceed to the second part.  PF-05089771 was well tolerated.  Possible reasons for the modest efficacy obsd. with PF-05089771 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiEsCT64-q7Vg90H21EOLACvtfcHk0lgfbTDx4z_QWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM&md5=61d83a34d992b85b828cea56f0a4f7b9</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000001227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000001227%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DSurujbally%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DR.%2BP.%26atitle%3DEfficacy%2520of%2520the%2520NaV1.7%2520blocker%2520PF-05089771%2520in%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520clinical%2520study%2520in%2520subjects%2520with%2520painful%2520diabetic%2520peripheral%2520neuropathy%26jtitle%3DPain%26date%3D2018%26volume%3D159%26spage%3D1465%26epage%3D1476%26doi%3D10.1097%2Fj.pain.0000000000001227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0lgfbTDx4z_QWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=77-82&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D77%26epage%3D82%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tari, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B.</span></span> <span> </span><span class="NLM_article-title">Design of conformationally constrained acyl sulfonamide isosteres: Identification of <i>N</i>-([1,2,4]triazolo[4,3-<i>a</i>]pyridin-3-yl)methane-sulfonamides as potent and selective <i>h</i>Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4810</span>– <span class="NLM_lpage">4831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01826</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01826" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4810-4831&author=T.+Fockenauthor=S.+Chowdhuryauthor=A.+Zenovaauthor=M.+Grimwoodauthor=C.+Chabotauthor=T.+Shengauthor=I.+Hemeonauthor=S.+Deckerauthor=M.+Wilsonauthor=P.+Bichlerauthor=Q.+Jiaauthor=S.+Sunauthor=C.+Youngauthor=S.+Linauthor=S.+J.+Goodchildauthor=N.+G.+Shuartauthor=E.+Changauthor=Z.+Xieauthor=B.+Liauthor=K.+Khakhauthor=G.+Bankarauthor=M.+Waldbrookauthor=R.+Kwanauthor=K.+Nelkenbrecherauthor=P.+K.+Tariauthor=N.+Chahalauthor=L.+Sojoauthor=L.+Robinetteauthor=A.+Whiteauthor=C.+Chenauthor=Y.+Zhangauthor=J.+Pangauthor=J.+H.+Changauthor=D.+Hackosauthor=J.+P.+Johnsonauthor=C.+J.+Cohenauthor=D.+Ortwineauthor=D.+Sutherlinauthor=C.+Dehnhardtauthor=B.+Safina&title=Design+of+conformationally+constrained+acyl+sulfonamide+isosteres%3A+Identification+of+N-%28%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyridin-3-yl%29methane-sulfonamides+as+potent+and+selective+hNaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.7b01826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNaV1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Focken, Thilo; Chowdhury, Sultan; Zenova, Alla; Grimwood, Michael E.; Chabot, Christine; Sheng, Tao; Hemeon, Ivan; Decker, Shannon M.; Wilson, Michael; Bichler, Paul; Jia, Qi; Sun, Shaoyi; Young, Clint; Lin, Sophia; Goodchild, Samuel J.; Shuart, Noah G.; Chang, Elaine; Xie, Zhiwei; Li, Bowen; Khakh, Kuldip; Bankar, Girish; Waldbrook, Matthew; Kwan, Rainbow; Nelkenbrecher, Karen; Karimi Tari, Parisa; Chahal, Navjot; Sojo, Luis; Robinette, C. Lee; White, Andrew D.; Chen, Chien-An; Zhang, Yi; Pang, Jodie; Chang, Jae H.; Hackos, David H.; Johnson, J. P.; Cohen, Charles J.; Ortwine, Daniel F.; Sutherlin, Daniel P.; Dehnhardt, Christoph M.; Safina, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4810-4831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sodium channel NaV1.7 has emerged as a promising target for the treatment of pain based on strong genetic validation of its role in nociception.  In recent years, a no. of aryl and acyl sulfonamides have been reported as potent inhibitors of NaV1.7, with high selectivity over the cardiac isoform NaV1.5.  Herein, we report on the discovery of a novel series of N-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanesulfonamides as selective NaV1.7 inhibitors.  Starting with the crystal structure of an acyl sulfonamide, we rationalized that cyclization to form a fused heterocycle would improve physicochem. properties, in particular lipophilicity.  Our design strategy focused on optimization of potency for block of NaV1.7 and human metabolic stability.  Lead compds. I (R1 = cPr, R2 = Me), I (R1 = cPr, R2 = cPr) (GNE-131), and II showed excellent potency, good in vitro metabolic stability, and low in vivo clearance in mouse, rat, and dog.  Compd. I (R1 = cPr, R2 = cPr) also displayed excellent efficacy in a transgenic mouse model of induced pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXjwguDi_ClbVg90H21EOLACvtfcHk0ljhicwlU-8gFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWit78%253D&md5=90523ea6500363ed8efd4112d644f3b6</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01826%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DZenova%26aufirst%3DA.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%2BG.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DTari%26aufirst%3DP.%2BK.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DRobinette%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DSafina%26aufirst%3DB.%26atitle%3DDesign%2520of%2520conformationally%2520constrained%2520acyl%2520sulfonamide%2520isosteres%253A%2520Identification%2520of%2520N-%2528%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridin-3-yl%2529methane-sulfonamides%2520as%2520potent%2520and%2520selective%2520hNaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4810%26epage%3D4831%26doi%3D10.1021%2Facs.jmedchem.7b01826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E.
F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.%0AF.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0ljhicwlU-8gFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lgILs2HXGawTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lgILs2HXGawTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+Activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0ljEYJ_ypLyt1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: Tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.+J.+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+Tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0ljEYJ_ypLyt1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520Tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0lhNT_GpZZ_jww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of non-zwitterionic aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+non-zwitterionic+aryl+sulfonamides+as+NaV1.7+inhibitors+with+efficacy+in+preclinical+behavioral+models+and+translational+measures+of+nociceptive+neuron+activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0lhNT_GpZZ_jww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520non-zwitterionic%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%2520with%2520efficacy%2520in%2520preclinical%2520behavioral%2520models%2520and%2520translational%2520measures%2520of%2520nociceptive%2520neuron%2520activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, <i>N</i>-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0ljkFy-Jv2wtLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in <i>vivo</i> efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0ljkFy-Jv2wtLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as hNa<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0lhS4eJJckr1tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNa<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0lhS4eJJckr1tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukundl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriverl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aac5464</span> <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=S.+Ahujaauthor=S.+Mukundlauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverlauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukundl%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriverl%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span>; <span class="NLM_string-name">Laufer-Sweiler, M. C.</span>; <span class="NLM_string-name">Markworth, C. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Reister, S. M.</span>; <span class="NLM_string-name">Sasaki, K.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span>; <span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT International Application <span class="NLM_patent">WO2010079443</span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Beaudoin&author=M.+C.+Laufer-Sweiler&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=S.+M.+Reister&author=K.+Sasaki&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeaudoin%26aufirst%3DS.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span>; <span class="NLM_string-name">Zhou, S.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012004706</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Markworth&author=B.+E.+Marron&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&author=C.+W.+West&author=S.+Zhou&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012004714</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+Greener&author=B.+E.+Marron&author=D.+S.+Millan&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreener%26aufirst%3DB.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Marron, B. E.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Ryckmans, T.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span>; <span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Benzenesulfonamides Useful As Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012004743</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=M.+J.+de+Groot&author=B.+E.+Marron&author=D.+J.+Rawson&author=T.+Ryckmans&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&author=C.+W.+West&title=Benzenesulfonamides+Useful+As+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DBenzenesulfonamides%2520Useful%2520As%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Gaulier, S. M.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Sulfonamide Derivatives Useful as Voltage Gated Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012007861</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+de+Groot&author=S.+M.+Gaulier&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=P.+M.+Perez&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=N-Sulfonamide+Derivatives+Useful+as+Voltage+Gated+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DN-Sulfonamide%2520Derivatives%2520Useful%2520as%2520Voltage%2520Gated%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007868</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007869</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+D.+Brown&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Chemical Compounds</span>. PCT International Application <span class="NLM_patent">WO2012007877</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=R.+A.+Lewthwaite&author=P.+M.+Perez&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Chemical+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DChemical%2520Compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Perez, P. M.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives as Na<sub>V</sub>1.7 Inhibitors for the Treatment of Pain</span>. PCT International Application <span class="NLM_patent">WO2012007883</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=A.+D.+Brown&author=M.+J.+de+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=D.+S.+Millan&author=P.+M.+Perez&author=D.+J.+Rawson&author=N.+Sciammetta&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&title=Sulfonamide+Derivatives+as+NaV1.7+Inhibitors+for+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DSulfonamide%2520Derivatives%2520as%2520NaV1.7%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pain%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, A. S.</span>; <span class="NLM_string-name">de Groot, M. J.</span>; <span class="NLM_string-name">Lewthwaite, R. A.</span>; <span class="NLM_string-name">Marsh, I. R.</span>; <span class="NLM_string-name">Sciammetta, N.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Indazole Derivatives as Sodium Channel Inhibitors</span>. PCT International Application <span class="NLM_patent">WO2012095781</span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+S.+Bell&author=M.+J.+de+Groot&author=R.+A.+Lewthwaite&author=I.+R.+Marsh&author=N.+Sciammetta&author=R.+I.+Storer&author=N.+A.+Swain&title=Indazole+Derivatives+as+Sodium+Channel+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DA.%2BS.%26atitle%3DIndazole%2520Derivatives%2520as%2520Sodium%2520Channel%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives</span>. PCT International Application <span class="NLM_patent">WO2013088315</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+J.+Rawson&author=R.+I.+Storer&author=N.+A.+Swain&title=Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26atitle%3DSulfonamide%2520Derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Derivatives and use Thereof as VGSC Inhibitors</span>. <span class="NLM_patent">WO2013093688</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+I.+Storer&author=N.+A.+Swain&title=Sulfonamide+Derivatives+and+use+Thereof+as+VGSC+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26atitle%3DSulfonamide%2520Derivatives%2520and%2520use%2520Thereof%2520as%2520VGSC%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span>; <span class="NLM_string-name">Galan, S. R. G.</span>; <span class="NLM_string-name">Millan, D. S.</span>; <span class="NLM_string-name">Rawson, D. J.</span>; <span class="NLM_string-name">Storer, R. I.</span>; <span class="NLM_string-name">Stupple, P. A.</span>; <span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Aminosulfonyl Benzamides</span>. PCT International Application <span class="NLM_patent">WO2013102826</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+D.+Brown&author=S.+R.+G.+Galan&author=D.+S.+Millan&author=D.+J.+Rawson&author=R.+I.+Storer&author=P.+A.+Stupple&author=N.+A.+Swain&title=N-Aminosulfonyl+Benzamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DN-Aminosulfonyl%2520Benzamides%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Both series displayed the same average LLE of 2.5.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljynmYr620xIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability–are too many aromatic rings a liability in drug design?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1011</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.drudis.2009.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=19729075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%93are+too+many+aromatic+rings+a+liability+in+drug+design%3F&doi=10.1016%2Fj.drudis.2009.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: Are too many aromatic rings a liability in drug design?</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21/22</span>),
    <span class="NLM_cas:pages">1011-1020</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of arom. ring count (the no. of arom. and heteroarom. rings) in mols. has been analyzed against various developability parameters, aq. soly., lipophilicity, serum albumin binding, CyP450 inhibition and hERG inhibition.  On the basis of this anal., it was concluded that the fewer arom. rings contained in an oral drug candidate, the more developable that candidate is probably to be; in addn., more than three arom. rings in a mol. correlates with poorer compd. developability and, thus, an increased risk of attrition in development.  Data are also presented that demonstrate that even within a defined lipophilicity range, increased arom. ring count leads to decreased aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2hOeD6TNGUbVg90H21EOLACvtfcHk0lhC8gnU1gGKOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCgt7nP&md5=48454c9809e8225b4336ea76aad3f3ba</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2593are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26doi%3D10.1016%2Fj.drudis.2009.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span> <span> </span><span class="NLM_article-title">Prediction of aqueous solubility of organic compounds by topological descriptors</span>. <i>QSAR Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1002/qsar.200330822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fqsar.200330822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWgsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=821-829&author=A.+Yanauthor=J.+Gasteiger&title=Prediction+of+aqueous+solubility+of+organic+compounds+by+topological+descriptors&doi=10.1002%2Fqsar.200330822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of aqueous solubility of organic compounds by topological descriptors</span></div><div class="casAuthors">Yan, Aixia; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">QSAR & Combinatorial Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">821-829</span>CODEN:
                <span class="NLM_cas:coden">QCSSAU</span>;
        ISSN:<span class="NLM_cas:issn">1611-020X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two quant. models for the prediction of aq. soly. of 1293 org. compds. were generated by a Multilinear Regression (MLR) anal., and a Backpropagation (BPG) neural network.  The mols. were represented by 18 topol. descriptors.  The physicochem. relation between soly. and the descriptors for different individual classes of monofunctional group compds. such as hydrocarbons, ethers, halocarbons, alcs., aldehydes and ketones, acids, esters, and amines was studied.  The 1293 compds. were divided into a training set of 741 compds. and a test set of 552 compds. based on a Kohonen's self-organizing neural network map.  The models obtained show a good predictive power: for the test set, a correlation coeff. of 0.97 and a std. deviation of 0.52 were achieved by the backpropagation neural network approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjxmnjMpbJ7Vg90H21EOLACvtfcHk0lhC8gnU1gGKOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWgsbjM&md5=a787dd158657ac4f404947077197b215</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fqsar.200330822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqsar.200330822%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DA.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DPrediction%2520of%2520aqueous%2520solubility%2520of%2520organic%2520compounds%2520by%2520topological%2520descriptors%26jtitle%3DQSAR%2520Comb.%2520Sci.%26date%3D2003%26volume%3D22%26spage%3D821%26epage%3D829%26doi%3D10.1002%2Fqsar.200330822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The holding potential was chosen to produce optimal potent block. Drug effects at physiological relevant voltages would be half as potent.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C</span>; <span class="NLM_string-name">Chowdhury, S.</span>; <span class="NLM_string-name">Decker, S.</span>; <span class="NLM_string-name">Dehnhardt, C. M.</span>; <span class="NLM_string-name">Focken, T.</span>; <span class="NLM_string-name">Grimwood, M. E.</span>; <span class="NLM_string-name">Hemeon, I. W.</span>; <span class="NLM_string-name">Jia, Q.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Ortwine, D. F.</span>; <span class="NLM_string-name">Safina, B. S.</span>; <span class="NLM_string-name">Sheng, T.</span>; <span class="NLM_string-name">Sun, S.</span>; <span class="NLM_string-name">Sutherlin, D. P.</span>; <span class="NLM_string-name">Wilson, M. S.</span>; <span class="NLM_string-name">Zenova, A. Y.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Substituted Benzamides and Their Use in the Treatment of Pain</span>. PCT International Application <span class="NLM_patent">WO2013177224A1</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-C+Andrez&author=S.+Chowdhury&author=S.+Decker&author=C.+M.+Dehnhardt&author=T.+Focken&author=M.+E.+Grimwood&author=I.+W.+Hemeon&author=Q.+Jia&author=J.+Li&author=D.+F.+Ortwine&author=B.+S.+Safina&author=T.+Sheng&author=S.+Sun&author=D.+P.+Sutherlin&author=M.+S.+Wilson&author=A.+Y.+Zenova&title=N-Substituted+Benzamides+and+Their+Use+in+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrez%26aufirst%3DJ.-C%26atitle%3DN-Substituted%2520Benzamides%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520Pain%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dress, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Using golden triangle to optimize clearance and oral absorption</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5560</span>– <span class="NLM_lpage">5564</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.%0AW.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+golden+triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520golden%2520triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span> <span> </span><span class="NLM_article-title">Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1016/s0065-7743(10)45023-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fs0065-7743%2810%2945023-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.%0AP.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+ligand+lipophilicity+efficiency+in+addressing+drug+safety+risks&doi=10.1016%2Fs0065-7743%2810%2945023-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1016%2Fs0065-7743%2810%2945023-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0065-7743%252810%252945023-x%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520ligand%2520lipophilicity%2520efficiency%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391%26doi%3D10.1016%2Fs0065-7743%2810%2945023-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lg-Y_A6HfC0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silber, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rance, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wastall, P.</span></span> <span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lg-Y_A6HfC0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kümmerle, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraga, C. A. M.</span></span> <span> </span><span class="NLM_article-title">The methylation effect in medicinal chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">5215</span>– <span class="NLM_lpage">5246</span>, <span class="refDoi"> DOI: 10.1021/cr200060g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200060g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFChsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=5215-5246&author=E.%0AJ.+Barreiroauthor=A.+E.+K%C3%BCmmerleauthor=C.+A.+M.+Fraga&title=The+methylation+effect+in+medicinal+chemistry&doi=10.1021%2Fcr200060g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">The Methylation Effect in Medicinal Chemistry</span></div><div class="casAuthors">Barreiro, Eliezer J.; Kummerle, Arthur E.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5215-5246</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this review, we aimed to highlight the importance of the simple Me group as a very useful structural modification in the rational design of bioactive compds. and drugs.  We selected different examples from distinct classes of org. compds. with several pharmacol. properties in order to illustrate that an apparent subtle mol. modification can strongly alter the biol. profile of a drug.  The Me effect alter both biol. phases of a drug, represented by its pharmacodynamic and pharmacokinetc profile, due to the modifications introduced in the stereoeletronic properties.  In fact, it was illustrated that distinct metabolic behavior or receptor affinity could be modified by the Me effect.  Among the examples included many other important ones could be used, such as the importance of the Me in modified the bioprofile of Ph ethanolamines with differentiation in the mol. recognition pattern among different adrenergic receptor subtypes.  The introduction of an simple extra Me connected to the N-alkylpiperidine moiety present in PDE5 inhibitor raisng the discovery of me-too drug vardenafil for erectile dysfunction.  In fact, the correct use of this strategy for mol. modification and design of drugs or drug-candidate compds. may be useful from both a pharmacokinetic and a pharmacodynamic point of view, representing an important tool for the medicinal chemist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx5w0XiOyJ7bVg90H21EOLACvtfcHk0lg-Y_A6HfC0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFChsrk%253D&md5=1cfdacf68ea53408c0f671a1dffb6d3a</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1021%2Fcr200060g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200060g%26sid%3Dliteratum%253Aachs%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DK%25C3%25BCmmerle%26aufirst%3DA.%2BE.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DThe%2520methylation%2520effect%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D5215%26epage%3D5246%26doi%3D10.1021%2Fcr200060g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schönherr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Profound methyl effects in drug discovery and a call for new C–H methylation reactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12256</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1002/anie.201303207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1002%2Fanie.201303207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12256-12267&author=H.+Sch%C3%B6nherrauthor=T.+Cernak&title=Profound+methyl+effects+in+drug+discovery+and+a+call+for+new+C%E2%80%93H+methylation+reactions&doi=10.1002%2Fanie.201303207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Profound methyl effects in drug discovery and a call for new C-H methylation reactions</span></div><div class="casAuthors">Schonherr Heike; Cernak Tim</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12256-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The methyl group is one of the most commonly occurring carbon fragments in small-molecule drugs.  This simplest alkyl fragment appears in more than 67 % of the top-selling drugs of 2011 and can modulate both the biological and physical properties of a molecule.  This Review focuses on so-called magic methyl effects on binding potency, where the seemingly mundane change of C H to C Me improves the IC50  value of a drug candidate more than 100-fold.  This discussion is followed by a survey of recent advances in synthetic chemistry that allow the direct methylation of C(sp(2) ) H and C(sp(3) ) H bonds.  It is our hope that the relevance of the meager methyl group to drug discovery as presented herein will inspire reports on new C H methylation reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyoLZDDgvsMh0LsK7uFuY7fW6udTcc2eZbCDpY05QleLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FptVahuw%253D%253D&md5=ef08f80e55b2c530b49e4306da024902</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201303207%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DH.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DProfound%2520methyl%2520effects%2520in%2520drug%2520discovery%2520and%2520a%2520call%2520for%2520new%2520C%25E2%2580%2593H%2520methylation%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12256%26epage%3D12267%26doi%3D10.1002%2Fanie.201303207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dourado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective Na<sub>V</sub>1.7 antagonists with long residence time show improved efficacy against inflammatory and neuropathic pain</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3145</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.08.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.celrep.2018.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=30231997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3133-3145&author=G.+Bankarauthor=S.+Howardauthor=K.+Nelkenbrecherauthor=M.+Waldbrookauthor=M.+Douradoauthor=S.+J.+Goodchildauthor=N.+Shuartauthor=S.+Linauthor=C.+Youngauthor=Z.+Xieauthor=K.+Khakhauthor=E.+Changauthor=L.+E.+Sojoauthor=A.+Lindgrenauthor=S.+Chowdhuryauthor=S.+Deckerauthor=M.+Grimwoodauthor=J.+C.+Andrezauthor=C.+M.+Dehnhardtauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=D.+H.+Hackosauthor=C.+L.+Robinetteauthor=C.+J.+Cohen&title=Selective+NaV1.7+antagonists+with+long+residence+time+show+improved+efficacy+against+inflammatory+and+neuropathic+pain&doi=10.1016%2Fj.celrep.2018.08.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain</span></div><div class="casAuthors">Bankar, Girish; Goodchild, Samuel J.; Howard, Sarah; Nelkenbrecher, Karen; Waldbrook, Matthew; Dourado, Michelle; Shuart, Noah G.; Lin, Sophia; Young, Clint; Xie, Zhiwei; Khakh, Kuldip; Chang, Elaine; Sojo, Luis E.; Lindgren, Andrea; Chowdhury, Sultan; Decker, Shannon; Grimwood, Michael; Andrez, Jean-Christophe; Dehnhardt, Christoph M.; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, James P. Jr.; Hackos, David H.; Robinette, C. Lee; Cohen, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3133-3145</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Selective block of NaV1.7 promises to produce non-narcotic analgesic activity without motor or cognitive impairment.  Several NaV1.7-selective blockers have been reported, but efficacy in animal pain models required high multiples of the IC50 for channel block.  Here, we report a target engagement assay using transgenic mice that has enabled the development of a second generation of selective Nav1.7 inhibitors that show robust analgesic activity in inflammatory and neuropathic pain models at low multiples of the IC50.  Like earlier arylsulfonamides, these newer acylsulfonamides target a binding site on the surface of voltage sensor domain 4 to achieve high selectivity among sodium channel isoforms and steeply state-dependent block.  The improved efficacy correlates with very slow dissocn. from the target channel.  Chronic dosing increases compd. potency about 10-fold, possibly due to reversal of sensitization arising during chronic injury, and provides efficacy that persists long after the compd. has cleared from plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ByCcGmC1abVg90H21EOLACvtfcHk0lgYSNN3Y59Gug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnur3J&md5=f84e48e3e176446f3134d04dae1ac605</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DDourado%26aufirst%3DM.%26aulast%3DGoodchild%26aufirst%3DS.%2BJ.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DAndrez%26aufirst%3DJ.%2BC.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520NaV1.7%2520antagonists%2520with%2520long%2520residence%2520time%2520show%2520improved%2520efficacy%2520against%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D24%26spage%3D3133%26epage%3D3145%26doi%3D10.1016%2Fj.celrep.2018.08.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osoegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frengen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catanese, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P.</span></span> <span> </span><span class="NLM_article-title">An improved approach for construction of bacterial artificial chromosome libraries</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1006/geno.1998.5423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1006%2Fgeno.1998.5423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9740665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1998&pages=1-8&author=K.+Osoegawaauthor=P.+Y.+Woonauthor=B.+Zhaoauthor=E.+Frengenauthor=M.+Tatenoauthor=J.+J.+Cataneseauthor=P.+de+Jong&title=An+improved+approach+for+construction+of+bacterial+artificial+chromosome+libraries&doi=10.1006%2Fgeno.1998.5423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">An improved approach for construction of bacterial artificial chromosome libraries</span></div><div class="casAuthors">Osoegawa, Kazutoyo; Woon, Peng Yeong; Zhao, Baohui; Frengen, Eirik; Tateno, Minako; Catanese, Joseph J.; De Jong, Pieter J.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Presented here are improved methodologies that enable the generation of highly redundant bacterial artificial chromosome/P1-derived artificial chromosome libraries, with larger and relatively uniform insert sizes.  Improvements in vector prepn. and enhanced ligation conditions reduce the no. of background nonrecombinant clones.  Preelectrophoresis of immobilized high-mol.-wt. DNA removes inhibitors of the cloning process, while sizing DNA fragments twice within a single gel effectively eliminates small restriction fragments, thus increasing the av. insert size of the clones.  The size-fractionated DNA fragments are recovered by electroelution rather than the more common melting of gel slices with subsequent β-agarase treatment.  Concn.of the ligation products yields a 6- to 12-fold redn. in the no. of electroporations required in prepg. a library of desirable size.  These improved methods have been applied to prep. PAC and BAC libraries from the human murine, rat, canine, and baboon genomes with av. insert sizes ranging between 160 and 235 kb.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozEr_poMXX_bVg90H21EOLACvtfcHk0lgYSNN3Y59Gug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlamtr4%253D&md5=dc3022e1fe5b366db7ceac27b2d36c59</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1998.5423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1998.5423%26sid%3Dliteratum%253Aachs%26aulast%3DOsoegawa%26aufirst%3DK.%26aulast%3DWoon%26aufirst%3DP.%2BY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DFrengen%26aufirst%3DE.%26aulast%3DTateno%26aufirst%3DM.%26aulast%3DCatanese%26aufirst%3DJ.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DP.%26atitle%3DAn%2520improved%2520approach%2520for%2520construction%2520of%2520bacterial%2520artificial%2520chromosome%2520libraries%26jtitle%3DGenomics%26date%3D1998%26volume%3D52%26spage%3D1%26epage%3D8%26doi%3D10.1006%2Fgeno.1998.5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dubuisson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, S. G.</span></span> <span> </span><span class="NLM_article-title">The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(77)90130-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2F0304-3959%2877%2990130-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1977&pages=161-177&author=D.+Dubuissonauthor=S.+G.+Dennis&title=The+formalin+test%3A+a+quantitative+study+of+the+analgesic+effects+of+morphine%2C+meperidine%2C+and+brain+stem+stimulation+in+rats+and+cats&doi=10.1016%2F0304-3959%2877%2990130-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test:  a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats</span></div><div class="casAuthors">Dubuisson, David; Dennis, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-74</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">In a procedure to evaluate the analgesic strengths of morphine sulfate  [64-31-3] and meperidine-HCl  [50-13-5], cats or rats, which were pretreated with an appropriate analgesic dose of either drug, were injected with a soln. of formalin  [50-00-0] in the paws and the pain-related behavior was obsd. and compared with that obsd. in the control animals which received formalin but no analgesic.  Pretreatment with either of the 2 analgesics or brain stem stimulation significantly decreased the effect of the pain stimuli.  Morphine and brain stem stimulation provided similar and greater analgesia than meperidine.  The behavioral patterns of the animals seemed to be similar following morphine or the brain stem stimultion.  Thus, formalin injection can be used effectively to evaluate the potencies of analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0ErPKDkXGbVg90H21EOLACvtfcHk0lgYSNN3Y59Gug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhsVGrt7s%253D&md5=bd26bbc3c46b9c964d0b3aa011580980</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2877%2990130-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252877%252990130-0%26sid%3Dliteratum%253Aachs%26aulast%3DDubuisson%26aufirst%3DD.%26aulast%3DDennis%26aufirst%3DS.%2BG.%26atitle%3DThe%2520formalin%2520test%253A%2520a%2520quantitative%2520study%2520of%2520the%2520analgesic%2520effects%2520of%2520morphine%252C%2520meperidine%252C%2520and%2520brain%2520stem%2520stimulation%2520in%2520rats%2520and%2520cats%26jtitle%3DPain%26date%3D1977%26volume%3D4%26spage%3D161%26epage%3D177%26doi%3D10.1016%2F0304-3959%2877%2990130-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCumber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathbun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malkmus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaksh, M. C.</span></span> <span> </span><span class="NLM_article-title">An automated flinch detecting system for use in the formalin nociceptive. bioassay</span>. <i>J. Appl. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">2386</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1152/jappl.2001.90.6.2386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1152%2Fjappl.2001.90.6.2386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=2386-2402&author=T.+L.+Yakshauthor=G.+Ozakiauthor=D.+McCumberauthor=M.+Rathbunauthor=C.+Svenssonauthor=S.+Malkmusauthor=M.+C.+Yaksh&title=An+automated+flinch+detecting+system+for+use+in+the+formalin+nociceptive.+bioassay&doi=10.1152%2Fjappl.2001.90.6.2386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1152%2Fjappl.2001.90.6.2386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjappl.2001.90.6.2386%26sid%3Dliteratum%253Aachs%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26aulast%3DOzaki%26aufirst%3DG.%26aulast%3DMcCumber%26aufirst%3DD.%26aulast%3DRathbun%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DMalkmus%26aufirst%3DS.%26aulast%3DYaksh%26aufirst%3DM.%2BC.%26atitle%3DAn%2520automated%2520flinch%2520detecting%2520system%2520for%2520use%2520in%2520the%2520formalin%2520nociceptive.%2520bioassay%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2001%26volume%3D90%26spage%3D2386%26epage%3D2402%26doi%3D10.1152%2Fjappl.2001.90.6.2386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abbadie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocain</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/S0304-3959(96)03285-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2FS0304-3959%2896%2903285-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=9060019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFSgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=101-110&author=C.+Abbadieauthor=B.+K.+Taylorauthor=M.+A.+Petersonauthor=A.+I.+Basbaum&title=differential+contribution+of+the+two+phases+of+the+formalin+test+to+the+pattern+of+c-fos+expression+in+the+rat+spinal+cord%3A+studies+with+remifentanil+and+lidocain&doi=10.1016%2FS0304-3959%2896%2903285-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39cR"><div class="casContent"><span class="casTitleNuber">39c</span><div class="casTitle"><span class="NLM_cas:atitle">Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine</span></div><div class="casAuthors">Abbadie, Catherine; Taylor, Bradley K.; Peterson, M. Alex; Basbaum, Allan I.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Injection of formalin in the rat hindpaw produces two phases of nociceptive behavior.  Although it is generally agreed that the first phase results from direct chem. activation of nociceptive primary afferent fibers, the factors that contribute to the second phase are not established.  In the present study, we monitored the expression of the c-fos protein to evaluate whether the pattern of activity of dorsal horn neurons differs as a result of ongoing afferent activity during the two phases.  To selectively block the first or second phase, we resp. used remifentanil, a potent and short acting opiate agonist, and QX-314, a quaternary deriv. of lidocaine, which does not cross the blood brain barrier.  We also evaluated the effect of eliminating nociceptive behavior in both phases using both remifentanil and lidocaine or a combination of local anesthetics, bupivacaine and quaternary lidocaine.  In all groups, formalin (5%, 50 μl) was injected s.c. into the plantar surface of the hindpaw.  To assess the nociceptive behavior produced by formalin, we monitored the no. of flinches.  Injection of remifentanil during the first phase completely blocked the first phase formalin-evoked nociceptive behavior, and had no effect on the second phase.  Injection of lidocaine during the interphase completely blocked second phase nociceptive behavior.  As expected, when remifentanil was administered during the first phase and lidocaine during the second phase, all formalin-evoked nociceptive behavior was blocked.  The same was true for rats that received injections of bupivacaine and lidocaine during phases 1 and 2, resp.  In laminae I-II of the L4-L5 segment, the magnitude of the decrease in Fos expression was comparable for remifentanil (26.5%) and lidocaine (27.3%); the decrease was greater when both remifentanil and lidocaine were administered (50.5%), and even greater when bupivacaine and lidocaine were used (74.2%).  In laminae V-VI, remifentanil, by itself, decreased c-fos expression by 39.4%; for lidocaine alone, the decrease was 58.4%.  We did not observe further significant decreases when both remifentanil and lidocaine, or bupivacaine and lidocaine were injected (69.7% and 74.6%, resp.).  Our results not only provide strong evidence that activity during the second phase is necessary for maintaining the maximal expression of c-fos in the spinal cord, but also reveal significant regional differences in the central patterns of activity generated during the two phases.  These results also confirm our previous reports that c-fos expression is not eliminated when the behavioral manifestation of the noxious stimulus is completely blocked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbT2_N8WyT_bVg90H21EOLACvtfcHk0lhHDAuKkQfbUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFSgsrk%253D&md5=41de7a4652ae9b558504e4d9d280795f</span></div><a href="/servlet/linkout?suffix=cit39c&amp;dbid=16384&amp;doi=10.1016%2FS0304-3959%2896%2903285-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3959%252896%252903285-X%26sid%3Dliteratum%253Aachs%26aulast%3DAbbadie%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DB.%2BK.%26aulast%3DPeterson%26aufirst%3DM.%2BA.%26aulast%3DBasbaum%26aufirst%3DA.%2BI.%26atitle%3Ddifferential%2520contribution%2520of%2520the%2520two%2520phases%2520of%2520the%2520formalin%2520test%2520to%2520the%2520pattern%2520of%2520c-fos%2520expression%2520in%2520the%2520rat%2520spinal%2520cord%253A%2520studies%2520with%2520remifentanil%2520and%2520lidocain%26jtitle%3DPain%26date%3D1997%26volume%3D69%26spage%3D101%26epage%3D110%26doi%3D10.1016%2FS0304-3959%2896%2903285-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Priest, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middletion, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiseter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmalhofer, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorowski, G. J.</span></span> <span> </span><span class="NLM_article-title">A disubstituted succinamide is a Potent sodium channel blocker with efficacy in a rat pain model</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">9866</span>– <span class="NLM_lpage">9876</span>, <span class="refDoi"> DOI: 10.1021/bi0493259</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0493259" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFahsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=9866-9876&author=B.+T.+Priestauthor=M.+L.+Garciaauthor=R.+E.+Middletionauthor=R.+M.+Brochuauthor=S.+Clarkauthor=G.+Daiauthor=I.+E.+Dickauthor=J.+P.+Felixauthor=C.+J.+Liuauthor=B.+Reiseterauthor=W.+A.+Schmalhoferauthor=P.+Shaoauthor=Y.+S.+Tangauthor=M.+Z.+Chouauthor=M.+G.+Kohlerauthor=M.+M.+Smithauthor=V.+A.+Warrenauthor=B.+S.+Williamsauthor=C.+J.+Cohenauthor=W.+J.+Martinauthor=P.+T.+Meinkeauthor=W.+H.+Parsonsauthor=K.+A.+Waffordauthor=G.+J.+Kaczorowski&title=A+disubstituted+succinamide+is+a+Potent+sodium+channel+blocker+with+efficacy+in+a+rat+pain+model&doi=10.1021%2Fbi0493259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">A Disubstituted Succinamide Is a Potent Sodium Channel Blocker with Efficacy in a Rat Pain Model</span></div><div class="casAuthors">Priest, Birgit T.; Garcia, Maria L.; Middleton, Richard E.; Brochu, Richard M.; Clark, Samantha; Dai, Ge; Dick, Ivy E.; Felix, John P.; Liu, Chou J.; Reiseter, Brita S.; Schmalhofer, William A.; Shao, Pengcheng P.; Tang, Yui S.; Chou, Margaret Z.; Kohler, Martin G.; Smith, McHardy M.; Warren, Vivien A.; Williams, Brande S.; Cohen, Charles J.; Martin, William J.; Meinke, Peter T.; Parsons, William H.; Wafford, Keith A.; Kaczorowski, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9866-9876</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium channel blockers are used clin. to treat a no. of neuropathic pain conditions, but more potent and selective agents should improve on the therapeutic index of currently used drugs.  In a high-throughput functional assay, a novel sodium channel (NaV) blocker, N-{[2'-(aminosulfonyl)biphenyl-4-yl]methyl}-N'-(2,2'-bithien-5-ylmethyl)succinamide (BPBTS), was discovered.  BPBTS is 2 orders of magnitude more potent than anticonvulsant and antiarrhythmic sodium channel blockers currently used to treat neuropathic pain.  Resembling block by these agents, block of NaV1.2, NaV1.5, and NaV1.7 by BPBTS was voltage- and use-dependent.  BPBTS appeared to bind preferentially to open and inactivated states and caused a dose-dependent hyperpolarizing shift in the steady-state availability curves for all sodium channel subtypes tested.  The affinity of BPBTS for the resting and inactivated states of NaV1.2 was 1.2 and 0.14 μM, resp.  BPBTS blocked NaV1.7 and NaV1.2 with similar potency, whereas block of NaV1.5 was slightly more potent.  The slow tetrodotoxin-resistant Na+ current in small-diam. DRG neurons was also potently blocked by BPBTS.  [3H]BPBTS bound with high affinity to a single class of sites present in rat brain synaptosomal membranes (Kd = 6.1 nM), and in membranes derived from HEK cells stably expressing NaV1.5 (Kd = 0.9 nM).  BPBTS dose-dependently attenuated nociceptive behavior in the formalin test, a rat model of tonic pain.  On the basis of these findings, BPBTS represents a structurally novel and potent sodium channel blocker that may be used as a template for the development of analgesic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUHRgORU0r7Vg90H21EOLACvtfcHk0lhHDAuKkQfbUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFahsbY%253D&md5=1244a358dc7ee38a1fa61a0270fad4e7</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fbi0493259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0493259%26sid%3Dliteratum%253Aachs%26aulast%3DPriest%26aufirst%3DB.%2BT.%26aulast%3DGarcia%26aufirst%3DM.%2BL.%26aulast%3DMiddletion%26aufirst%3DR.%2BE.%26aulast%3DBrochu%26aufirst%3DR.%2BM.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DG.%26aulast%3DDick%26aufirst%3DI.%2BE.%26aulast%3DFelix%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DC.%2BJ.%26aulast%3DReiseter%26aufirst%3DB.%26aulast%3DSchmalhofer%26aufirst%3DW.%2BA.%26aulast%3DShao%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%2BS.%26aulast%3DChou%26aufirst%3DM.%2BZ.%26aulast%3DKohler%26aufirst%3DM.%2BG.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DWarren%26aufirst%3DV.%2BA.%26aulast%3DWilliams%26aufirst%3DB.%2BS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DKaczorowski%26aufirst%3DG.%2BJ.%26atitle%3DA%2520disubstituted%2520succinamide%2520is%2520a%2520Potent%2520sodium%2520channel%2520blocker%2520with%2520efficacy%2520in%2520a%2520rat%2520pain%2520model%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D9866%26epage%3D9876%26doi%3D10.1021%2Fbi0493259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingfan Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hierl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janosky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilenkin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Identification of potent, state-dependent inhibitors of Na<sub>V</sub>1.7 with oral efficacy in the formalin model of persistent pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4427</span>– <span class="NLM_lpage">4445</span>, <span class="refDoi"> DOI: 10.1021/jm200018k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200018k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4427-4445&author=H.+Bregmanauthor=L.+Berryauthor=J.+L.+Buchananauthor=A.+Chenauthor=B.+Bingfan+Duauthor=E.+Fericauthor=M.+Hierlauthor=L.+Huangauthor=D.+Immkeauthor=B.+Janoskyauthor=D.+Johnsonauthor=X.+Liauthor=J.+Liguttiauthor=D.+Liuauthor=A.+Malmbergauthor=D.+Matsonauthor=J.+McDermottauthor=P.+Miuauthor=H.+N.+Nguyenauthor=V.+F.+Patelauthor=D.+Waldonauthor=B.+Wilenkinauthor=X.+Zhengauthor=A.+Zouauthor=S.+I.+McDonoughauthor=E.+F.+DiMauro&title=Identification+of+potent%2C+state-dependent+inhibitors+of+NaV1.7+with+oral+efficacy+in+the+formalin+model+of+persistent+pain&doi=10.1021%2Fjm200018k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fjm200018k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200018k%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DBingfan%2BDu%26aufirst%3DB.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DHierl%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DImmke%26aufirst%3DD.%26aulast%3DJanosky%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMalmberg%26aufirst%3DA.%26aulast%3DMatson%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%26aulast%3DMiu%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DWaldon%26aufirst%3DD.%26aulast%3DWilenkin%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DIdentification%2520of%2520potent%252C%2520state-dependent%2520inhibitors%2520of%2520NaV1.7%2520with%2520oral%2520efficacy%2520in%2520the%2520formalin%2520model%2520of%2520persistent%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4427%26epage%3D4445%26doi%3D10.1021%2Fjm200018k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Macsari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besidski, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csjernyik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yngve, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åhlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venyike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakeman, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvidsson, P. I.</span></span> <span> </span><span class="NLM_article-title">3-Oxoisoindoline-1-carboxamides: Potent, state-dependent blockers of voltage-gated sodium channel Na<sub>V</sub>1.7 with efficacy in rat pain models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6866</span>– <span class="NLM_lpage">6880</span>, <span class="refDoi"> DOI: 10.1021/jm300623u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300623u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpsl2ju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6866-6880&author=I.+Macsariauthor=Y.+Besidskiauthor=G.+Csjernyikauthor=L.+I.+Nilssonauthor=L.+Sandbergauthor=U.+Yngveauthor=K.+%C3%85hlinauthor=T.+Buetersauthor=A.+B.+Erikssonauthor=P.-E.+Lundauthor=E.+Venyikeauthor=S.+Oertherauthor=K.+H.+Blakemanauthor=L.+Luoauthor=P.+I.+Arvidsson&title=3-Oxoisoindoline-1-carboxamides%3A+Potent%2C+state-dependent+blockers+of+voltage-gated+sodium+channel+NaV1.7+with+efficacy+in+rat+pain+models&doi=10.1021%2Fjm300623u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40cR"><div class="casContent"><span class="casTitleNuber">40c</span><div class="casTitle"><span class="NLM_cas:atitle">3-Oxoisoindoline-1-carboxamides: Potent, State-Dependent Blockers of Voltage-Gated Sodium Channel NaV1.7 with Efficacy in Rat Pain Models</span></div><div class="casAuthors">Macsari, Istvan; Besidski, Yevgeni; Csjernyik, Gabor; Nilsson, Linda I.; Sandberg, Lars; Yngve, Ulrika; Aahlin, Kristofer; Bueters, Tjerk; Eriksson, Anders B.; Lund, Per-Eric; Venyike, Elisabet; Oerther, Sandra; Hygge Blakeman, Karin; Luo, Lei; Arvidsson, Per I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6866-6880</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 is believed to be a crit. mediator of pain sensation based on clin. genetic studies and pharmacol. results.  Clin. utility of nonselective sodium channel blockers is limited due to serious adverse drug effects.  Here, we present the optimization, structure-activity relationships, and in vitro and in vivo characterization of a novel series of NaV1.7 inhibitors based on the oxoisoindoline core.  Extensive studies with focus on optimization of NaV1.7 potency, selectivity over NaV1.5, and metabolic stability properties produced several interesting oxoisoindoline carboxamides (16A, 26B, 28, 51, 60, and 62) that were further characterized.  The oxoisoindoline carboxamides interacted with the local anesthetics binding site.  In spite of this, several compds. showed functional selectivity vs. NaV1.5 of more than 100-fold.  This appeared to be a combination of subtype and state-dependent selectivity.  Compd. 28 showed concn.-dependent inhibition of nerve injury-induced ectopic in an ex vivo DRG prepn. from SNL rats.  Compds. 16A and 26B demonstrated concn.-dependent efficacy in preclin. behavioral pain models.  The oxoisoindoline carboxamides series described here may be valuable for further investigations for pain therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHVyRjfbFVzrVg90H21EOLACvtfcHk0lhUwMCu-ebiRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpsl2ju7g%253D&md5=c4ffe7eeec76079250c073f764f2b7f5</span></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1021%2Fjm300623u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300623u%26sid%3Dliteratum%253Aachs%26aulast%3DMacsari%26aufirst%3DI.%26aulast%3DBesidski%26aufirst%3DY.%26aulast%3DCsjernyik%26aufirst%3DG.%26aulast%3DNilsson%26aufirst%3DL.%2BI.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DYngve%26aufirst%3DU.%26aulast%3D%25C3%2585hlin%26aufirst%3DK.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DLund%26aufirst%3DP.-E.%26aulast%3DVenyike%26aufirst%3DE.%26aulast%3DOerther%26aufirst%3DS.%26aulast%3DBlakeman%26aufirst%3DK.%2BH.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DArvidsson%26aufirst%3DP.%2BI.%26atitle%3D3-Oxoisoindoline-1-carboxamides%253A%2520Potent%252C%2520state-dependent%2520blockers%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%2520with%2520efficacy%2520in%2520rat%2520pain%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6866%26epage%3D6880%26doi%3D10.1021%2Fjm300623u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csjernyik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macsari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nylöf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandberg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skogholm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueters, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venyike, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besidski, Y.</span></span> <span> </span><span class="NLM_article-title">Structure and activity relationship in the (S)-<i>N</i>-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5618</span>– <span class="NLM_lpage">5624</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmcl.2012.06.105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5618-5624&author=I.+Kersauthor=G.+Csjernyikauthor=I.+Macsariauthor=M.+Nyl%C3%B6fauthor=L.+Sandbergauthor=K.+Skogholmauthor=T.+Buetersauthor=A.+B.+Erikssonauthor=S.+Oertherauthor=P.+Lundauthor=E.+Venyikeauthor=J.+Nystr%C3%B6mauthor=Y.+Besidski&title=Structure+and+activity+relationship+in+the+%28S%29-N-chroman-3-ylcarboxamide+series+of+voltage-gated+sodium+channel+blockers&doi=10.1016%2Fj.bmcl.2012.06.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.105%26sid%3Dliteratum%253Aachs%26aulast%3DKers%26aufirst%3DI.%26aulast%3DCsjernyik%26aufirst%3DG.%26aulast%3DMacsari%26aufirst%3DI.%26aulast%3DNyl%25C3%25B6f%26aufirst%3DM.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DSkogholm%26aufirst%3DK.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DA.%2BB.%26aulast%3DOerther%26aufirst%3DS.%26aulast%3DLund%26aufirst%3DP.%26aulast%3DVenyike%26aufirst%3DE.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBesidski%26aufirst%3DY.%26atitle%3DStructure%2520and%2520activity%2520relationship%2520in%2520the%2520%2528S%2529-N-chroman-3-ylcarboxamide%2520series%2520of%2520voltage-gated%2520sodium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5618%26epage%3D5624%26doi%3D10.1016%2Fj.bmcl.2012.06.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel-Brehm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deranian, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span> <span> </span><span class="NLM_article-title">TRPA1 mediates formalin-induced pain</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">13525</span>– <span class="NLM_lpage">13530</span>, <span class="refDoi"> DOI: 10.1073/pnas.0705924104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1073%2Fpnas.0705924104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=17686976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1eqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=13525-13530&author=C.+R.+McNamaraauthor=J.+Mandel-Brehmauthor=D.+M.+Bautistaauthor=J.+Siemensauthor=K.+L.+Deranianauthor=M.+Zhao&title=TRPA1+mediates+formalin-induced+pain&doi=10.1073%2Fpnas.0705924104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">TRPA1 mediates formalin-induced pain</span></div><div class="casAuthors">McNamara, Colleen R.; Mandel-Brehm, Josh; Bautista, Diana M.; Siemens, Jan; Deranian, Kari L.; Zhao, Michael; Hayward, Neil J.; Chong, Jayhong A.; Julius, David; Moran, Magdalene M.; Fanger, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13525-13530</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The formalin model is widely used for evaluating the effects of analgesic compds. in lab. animals.  Injection of formalin into the hind paw induces a biphasic pain response; the first phase is thought to result from direct activation of primary afferent sensory neurons, whereas the second phase has been proposed to reflect the combined effects of afferent input and central sensitization in the dorsal horn.  Here we show that formalin excites sensory neurons by directly activating transient receptor potential ion channel TRPA1, a cation channel that plays an important role in inflammatory pain.  Formalin induced robust calcium influx in cells expressing cloned or native TRPA1 channels, and these responses were attenuated by a previously undescribed TRPA1-selective antagonist.  Moreover, sensory neurons from TRPA1-deficient mice lacked formalin sensitivity.  At the behavioral level, pharmacol. blockade or genetic ablation of TRPA1 produced marked attenuation of the characteristic flinching, licking, and lifting responses resulting from intraplantar injection of formalin.  Our results show that TRPA1 is the principal site of formalin's pain-producing action in vivo, and that activation of this excitatory channel underlies the physiol. and behavioral responses assocd. with this model of pain hypersensitivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgRKOZy2rNILVg90H21EOLACvtfcHk0li8ucBY3Sxc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1eqsL8%253D&md5=2482d7b071a4eb6c3131d3d95ea05ae2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0705924104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0705924104%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DC.%2BR.%26aulast%3DMandel-Brehm%26aufirst%3DJ.%26aulast%3DBautista%26aufirst%3DD.%2BM.%26aulast%3DSiemens%26aufirst%3DJ.%26aulast%3DDeranian%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DM.%26atitle%3DTRPA1%2520mediates%2520formalin-induced%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D13525%26epage%3D13530%26doi%3D10.1073%2Fpnas.0705924104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tjølsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berge, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunskaar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosland, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, K.</span></span> <span> </span><span class="NLM_article-title">The formalin test: an evaluation of the method</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/0304-3959(92)90003-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2F0304-3959%2892%2990003-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1454405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=5-17&author=A.+Tj%C3%B8lsenauthor=O.+G.+Bergeauthor=S.+Hunskaarauthor=J.+H.+Roslandauthor=K.+Hole&title=The+formalin+test%3A+an+evaluation+of+the+method&doi=10.1016%2F0304-3959%2892%2990003-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The formalin test: an evaluation of the method</span></div><div class="casAuthors">Tjolsen Arne; Berge Odd-Geir; Hunskaar Steinar; Rosland Jan Henrik; Hole Kjell</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">The formalin test for nociception, which is predominantly used with rats and mice, involves moderate, continuous pain generated by injured tissue.  In this way it differs from most traditional tests of nociception which rely upon brief stimuli of threshold intensity.  In this article we describe the main features of the formalin test, including the characteristics of the stimulus and how changes in nociceptive behaviour may be measured and interpreted.  The response to formalin shows an early and a late phase.  The early phase seems to be caused predominantly by C-fibre activation due to the peripheral stimulus, while the late phase appears to be dependent on the combination of an inflammatory reaction in the peripheral tissue and functional changes in the dorsal horn of the spinal cord.  These functional changes seem to be initiated by the C-fibre barrage during the early phase.  In mice, the behavioural response in the late phase depends on the ambient temperature.  We argue that the peripheral tissue temperature as well as other factors influencing the peripheral inflammation may affect the response, possibly confounding the results obtained with the test.  Furthermore, we discuss the methods of recording the response and the value of observing more than one aspect of behaviour.  Scoring of several behavioural variables provides a means of assessing motor or sensorimotor function as possible causes for changes in behaviour.  In conclusion, the formalin test is a valuable addition to the battery of methods available to study nociception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvkEksK8CslK8fW6udTcc2eb41rQgWnvrbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslSnsA%253D%253D&md5=d56dc5eb88d109dd30d319dcf580c781</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990003-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990003-T%26sid%3Dliteratum%253Aachs%26aulast%3DTj%25C3%25B8lsen%26aufirst%3DA.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DHunskaar%26aufirst%3DS.%26aulast%3DRosland%26aufirst%3DJ.%2BH.%26aulast%3DHole%26aufirst%3DK.%26atitle%3DThe%2520formalin%2520test%253A%2520an%2520evaluation%2520of%2520the%2520method%26jtitle%3DPain%26date%3D1992%26volume%3D51%26spage%3D5%26epage%3D17%26doi%3D10.1016%2F0304-3959%2892%2990003-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gossas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Easy-to-execute carbonylations: microwave synthesis of acyl sulfonamides using Mo(CO)<sub>6</sub> as a solid carbon monoxide source</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3094</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1021/jo050080v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo050080v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=3094-3098&author=X.+Wuauthor=R.+Ronnauthor=T.+Gossasauthor=M.+Larhed&title=Easy-to-execute+carbonylations%3A+microwave+synthesis+of+acyl+sulfonamides+using+Mo%28CO%296+as+a+solid+carbon+monoxide+source&doi=10.1021%2Fjo050080v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Easy-to-Execute Carbonylations: Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)6 as a Solid Carbon Monoxide Source</span></div><div class="casAuthors">Wu, Xiongyu; Roenn, Robert; Gossas, Thomas; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3094-3098</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of a robust palladium-catalyzed amidocarbonylation protocol for the prepn. of arom. acyl sulfonamides utilizing high-d. microwave heating is described.  This synthetic approach employs Mo(CO)6 as a convenient CO-releasing reagent and allows for the direct prepn. of acyl sulfonamides from both aryl iodides and aryl bromides.  The reactions can be performed under air, employing only 15 min of microwave irradn., to produce acyl sulfonamide derivs. in good to excellent yields.  To illustrate the usefulness of this method, we reported the synthesis of a novel hepatitis C virus NS3 protease inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp281_WOJXTW7Vg90H21EOLACvtfcHk0li8ucBY3Sxc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVynurg%253D&md5=443608fb9917b8194efc9fb778a2aede</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo050080v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050080v%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DEasy-to-execute%2520carbonylations%253A%2520microwave%2520synthesis%2520of%2520acyl%2520sulfonamides%2520using%2520Mo%2528CO%25296%2520as%2520a%2520solid%2520carbon%2520monoxide%2520source%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D3094%26epage%3D3098%26doi%3D10.1021%2Fjo050080v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lhdN5pMbjLoSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3Dpalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denmark, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span> <span> </span><span class="NLM_article-title">A comparison of (chloromethyl)- and (iodomethyl)zinc cyclopropanation reagents</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6974</span>– <span class="NLM_lpage">6981</span>, <span class="refDoi"> DOI: 10.1021/jo00025a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00025a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADyaK3MXmsl2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=6974-6981&author=S.+E.+Denmarkauthor=J.+P.+Edwards&title=A+comparison+of+%28chloromethyl%29-+and+%28iodomethyl%29zinc+cyclopropanation+reagents&doi=10.1021%2Fjo00025a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of (chloromethyl)- and (iodomethyl)zinc cyclopropanation reagents</span></div><div class="casAuthors">Denmark, Scott E.; Edwards, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6974-81</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A study comparing the rate of cyclopropanation of a range of olefins with (chloromethyl)- and (iodomethyl)zinc reagents is described.  The (chloromethyl)zinc reagent derived from diethylzinc and chloroiodomethane is generally more reactive than the (iodomethyl)zinc analog.  The use of 1,2-dichloroethane as the solvent for these reactions was a crucial factor necessary to achieve clean, rapid, high-yielding cyclopropanations.  The well-known directing effect of proximal oxygen substituents on the stereochem. outcome of Simmons-Smith cyclopropanations held for the (chloromethyl)zinc reagent as well.  The diethylzinc/chloroiodoethane reagent system in 1,2-dichloroethane should prove to be a valuable alternative to traditional (iodomethyl)zinc-based cyclopropanation reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9nyu8ULBXjrVg90H21EOLACvtfcHk0lhdN5pMbjLoSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmsl2jsrk%253D&md5=26396a744ad5ce598f60a4f3ab537768</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00025a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00025a007%26sid%3Dliteratum%253Aachs%26aulast%3DDenmark%26aufirst%3DS.%2BE.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comparison%2520of%2520%2528chloromethyl%2529-%2520and%2520%2528iodomethyl%2529zinc%2520cyclopropanation%2520reagents%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D6974%26epage%3D6981%26doi%3D10.1021%2Fjo00025a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+Parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eaX8VYgPOskurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520Parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note">b<p class="last">Schrödinger Release 2014-1: Schrödinger Suite 2017-4. Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY, 2017.</p></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearlstein, R. A.</span></span> <span> </span><span class="NLM_article-title">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3160</span>– <span class="NLM_lpage">3173</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1016%2Fj.bmc.2005.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=16413785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3160-3173&author=R.+Faridauthor=T.+Dayauthor=R.+A.+Friesnerauthor=R.+A.+Pearlstein&title=New+insights+about+HERG+blockade+obtained+from+protein+modeling%2C+potential+energy+mapping%2C+and+docking+studies&doi=10.1016%2Fj.bmc.2005.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies</span></div><div class="casAuthors">Farid, Ramy; Day, Tyler; Friesner, Richard A.; Pearlstein, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3160-3173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We created a homol. model of the homo-tetrameric pore domain of HERG using the crystal structure of the bacterial potassium channel, KvAP, as a template.  We docked a set of known blockers with well-characterized effects on channel function into the lumen of the pore between the selectivity filter and extracellular entrance using a novel docking and refinement procedure incorporating Glide and Prime.  Key arom. groups of the blockers are predicted to form multiple simultaneous ring stacking and hydrophobic interactions among the eight arom. residues lining the pore.  Furthermore, each blocker can achieve these interactions via multiple docking configurations.  To further interpret the docking results, we mapped hydrophobic and hydrophilic potentials within the lumen of each refined docked complex.  Hydrophilic iso-potential contours define a 'propeller-shaped' vol. at the selectivity filter entrance.  Hydrophobic contours define a hollow 'crown-shaped' vol. located above the 'propeller', whose hydrophobic 'rim' extends along the pore axis between Tyr652 and Phe656.  Blockers adopt conformations/binding orientations that closely mimic the shapes and properties of these contours.  Blocker basic groups are localized in the hydrophilic 'propeller', forming electrostatic interactions with Ser624 rather than a generally accepted π-cation interaction with Tyr652.  Terfenadine, cisapride, sertindole, ibutilide, and clofilium adopt similar docked poses, in which their N-substituents bridge radially across the hollow interior of the 'crown' (analogous to the hub and spokes of a wheel), and project arom./hydrophobic portions into the hydrophobic 'rim'.  MK-499 docks with its longitudinal axis parallel to the axis of the pore and crown', and its hydrophobic groups buried within the hydrophobic 'rim'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1RsiljwGxrVg90H21EOLACvtfcHk0lhdN5pMbjLoSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehs7o%253D&md5=8df638aa78d2d35337bb82d8a94357c4</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DPearlstein%26aufirst%3DR.%2BA.%26atitle%3DNew%2520insights%2520about%2520HERG%2520blockade%2520obtained%2520from%2520protein%2520modeling%252C%2520potential%2520energy%2520mapping%252C%2520and%2520docking%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3160%26epage%3D3173%26doi%3D10.1016%2Fj.bmc.2005.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lijnqvTcjikjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Use of an induced fit receptor structure in virtual screening</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2005.00327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=10.1111%2Fj.1747-0285.2005.00327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=16492153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=83-84&author=W.+Shermanauthor=H.+S.+Beardauthor=R.+Farid&title=Use+of+an+induced+fit+receptor+structure+in+virtual+screening&doi=10.1111%2Fj.1747-0285.2005.00327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47cR"><div class="casContent"><span class="casTitleNuber">47c</span><div class="casTitle"><span class="NLM_cas:atitle">Use of an induced fit receptor structure in virtual screening</span></div><div class="casAuthors">Sherman, Woody; Beard, Hege S.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-84</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The automated induced fit docking protocol was used to generate the DFG-out conformation from a p38 MAP kinase activation loop starting from a DFG-in structure (1a9u) and the ligand from 1kv1 (BMU).  In a virtual screening study of 25K decoy ligands and 46 known actives, using an ensemble consisting of the induced fit docking structure (DFG-out) and the 1a9u crystal structure (DFG-in), 14 actives were identified in the top 1% of the database, including BMU and BIRB 796.  3 Actives were identified when 1a9u was used alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PRgtFzy8u7Vg90H21EOLACvtfcHk0lijnqvTcjikjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjtL0%253D&md5=efe9900aacaaea6af805c1cbdb350c73</span></div><a href="/servlet/linkout?suffix=cit47c&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00327.x%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DUse%2520of%2520an%2520induced%2520fit%2520receptor%2520structure%2520in%2520virtual%2520screening%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D83%26epage%3D84%26doi%3D10.1111%2Fj.1747-0285.2005.00327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EK0','PDB','5EK0'); return false;">PDB: 5EK0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01621">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_77273"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01621">10.1021/acs.jmedchem.8b01621</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Description of in vitro biological assays, in vivo rodent pain assays, acute dissociation of mouse DRG neuron and patch clamp recording, CEREP screening data for compound <b>33</b>, <sup>1</sup>H NMR spectra of compounds <b>7–33</b>, HPLC purity data for compounds <b>7</b>, <b>20</b>, <b>26</b>, <b>30</b>, and <b>33</b>, and experimental procedure and small-molecule X-ray coordinates for compound <b>7</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_001.csv">jm8b01621_si_001.csv (3.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01621/suppl_file/jm8b01621_si_002.pdf">jm8b01621_si_002.pdf (1.43 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01621%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-2%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01621" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d671b8ee23e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
